Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3000570	f-elast1	ug/g (ug/g)	7232	10146	1.99%
3000570	f-elast1	— (—)	6600	8055	100.00%	Distribution not available
3000570	f-elast1	µg/g (ug/g)	362	455	0.00%
3000570	f-elast1	ug/g______ (ug/g)	197	245	0.00%
3000570	f-elast1	ug/g_ulostetta (ug/g)	176	235	0.00%
3000570	f-elast1	UG/G (ug/g)	34	39	0.00%
3000570	f-elast1	ug/g_ulost (ug/g)	29	35	0.00%
3000570	f-elast1	ug/g_F (ug/g)	8	10	0.00%	Distribution not available
3000570	f-elast1	ug/gulostetta (ug/g)	5	6	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Functional dyspepsia

1102

3174

3.68

322.61

1.5

1.4

299.59

271.85

ug/g

3.67

621

1813

Infections, IBD-co-morbidities

612

685

6.65

317.89

1.5

1.3

263.66

271.92

ug/g

0.31

371

403

Paralytic ileus and intestinal obstruction

942

2490

3.98

311.56

1.5

1.4

234.99

267.18

ug/g

3.91

601

1493

First line medication for Crohn's disease

3250

8209

2.18

311.48

1.5

1.4

271.38

281.10

ug/g

1.46

1863

4661

Diabetes mellitus

3058

8163

2.22

310.86

1.5

1.4

248.01

295.14

ug/g

24.19

1844

4553

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3228

9725

2.30

307.65

1.5

1.4

262.22

279.40

ug/g

4.13

1966

5498

Constipation

3529

8402

2.97

307.65

1.5

1.4

273.24

273.66

ug/g

0.03

2100

4809

Codeine

2668

5820

2.54

307.65

1.5

1.4

281.22

290.42

ug/g

1.01

1602

3211

Tramadol

2833

5506

3.21

307.65

1.5

1.4

259.80

288.10

ug/g

7.97

1705

3075

Malignant neoplasm of pancreas, including Hilmo

1128

951

16.31

307.65

1.5

1.4

146.43

287.87

ug/g

56.27

675

583

Insulin, fast-acting

1582

4561

3.69

307.65

1.6

1.4

211.82

284.43

ug/g

31.29

973

2630

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

3024

7799

2.37

307.65

1.5

1.4

241.96

293.07

ug/g

28.61

1844

4411

Insulin medication

2413

6730

3.12

307.65

1.6

1.4

216.32

286.39

ug/g

44.64

1488

3851

Adenocarcinoma and ductal carcinoma of pancreas

545

362

23.21

307.65

1.6

1.4

119.43

296.40

ug/g

34.91

302

222

Alcohol-induced chronic pancreatitis

551

657

10.39

307.65

1.8

1.4

158.17

270.59

ug/g

18.88

298

406

Malignant neoplasm of digestive organs

1884

4240

3.63

307.65

1.5

1.4

188.74

281.54

ug/g

62.07

1191

2527

Diseases of oesophagus, stomach and duodenum

4090

8163

3.08

307.65

1.5

1.4

274.44

273.27

ug/g

0.11

2357

4680

Cholelithiasis, broad definition with cholecystitis

2823

6773

2.87

307.65

1.5

1.3

269.69

311.03

ug/g

14.30

1670

3818

Noninfectious colitis NAS

823

1565

5.87

307.65

1.5

1.4

271.15

281.29

ug/g

0.59

531

903

Diverticular disease of intestine

2481

4850

3.32

307.65

1.5

1.4

273.28

266.54

ug/g

0.70

1498

2863

Any gastric operation

2289

2953

4.01

307.65

1.5

1.3

271.35

310.36

ug/g

10.10

1275

1624

Hernia of abdominal wall, postoperative

678

1276

5.59

307.65

1.6

1.3

274.01

295.01

ug/g

0.90

416

748

Fever of other and unknown origin

1969

5696

3.11

307.65

1.5

1.4

247.73

276.96

ug/g

6.35

1160

3239

Other noninfective gastroenteritis and colitis

1520

3022

5.57

307.65

1.6

1.4

271.56

275.61

ug/g

0.27

958

1745

General symptoms and signs

3305

6503

2.62

307.65

1.5

1.4

274.51

281.80

ug/g

0.89

1892

3691

Intestinal malabsorption

721

473

23.55

307.65

2.2

1.4

139.63

296.37

ug/g

35.51

474

278

Other diseases of pancreas

955

761

16.71

307.65

1.8

1.3

196.58

303.17

ug/g

27.44

637

445

Insulin, combination of fast acting with intermediate-acting or long-acting

2414

7805

2.93

307.65

1.6

1.4

216.32

280.31

ug/g

39.28

1488

4547

Irritable bowel syndrome

1977

2540

8.81

307.65

1.5

1.4

314.44

274.27

ug/g

9.87

1088

1440

Malaise and fatigue

1926

4921

3.21

307.65

1.5

1.4

265.44

273.12

ug/g

0.73

1149

2816

Collagenous colitis

726

1091

7.88

307.65

1.6

1.4

266.29

283.88

ug/g

1.17

467

637

Examination and observation for other reasons

2070

3452

3.52

307.65

1.4

270.60

269.43

ug/g

0.08

1235

2013

Symptoms and signs concerning food and fluid intake

719

1102

7.38

307.65

1.5

1.4

288.53

272.49

ug/g

0.88

420

649

Adenocarcinoma of pancreas

391

275

20.65

307.65

1.6

1.4

127.77

301.49

ug/g

25.44

223

165

Pain in throat and chest

2621

6357

2.51

307.65

1.5

1.4

283.96

268.74

ug/g

2.53

1472

3642

Other functional intestinal disorders

2365

4252

5.43

307.65

1.5

1.4

272.96

270.80

ug/g

0.15

1365

2466

Headache

2105

6089

2.76

307.65

1.4

294.32

282.36

ug/g

1.47

1154

3444

Other diseases of intestines

4209

6216

3.94

307.65

1.5

1.4

282.17

276.44

ug/g

0.68

2342

3529

Anaemias

896

693

8.78

307.65

1.5

1.2

260.35

361.53

ug/g

18.67

557

336

Persons encountering health services for specific procedures and health care

3309

8945

2.24

307.65

1.5

1.4

254.39

288.54

ug/g

12.07

2022

4945

Diseases of the digestive system

2083

6300

3.48

307.65

1.7

1.4

219.19

275.45

ug/g

23.48

1279

3694

Pain in joint

1707

3335

3.24

307.65

1.5

1.4

284.86

272.03

ug/g

1.36

939

1933

Opioids

2837

5878

2.56

307.65

1.5

1.4

270.82

290.92

ug/g

4.19

1632

3230

Chronic pancreatitis

2306

1078

35.91

307.65

2.0

1.3

113.03

308.04

ug/g

140.46

1438

635

Symptoms and signs involving the digestive system and abdomen

3332

5042

3.43

307.65

1.5

1.3

266.85

281.89

ug/g

2.40

1938

2898

Malignant neoplasm of pancreas

948

744

17.83

307.65

1.6

1.4

146.18

283.32

ug/g

43.81

562

469

Disorders of gallbladder, biliary tract and pancreas

5006

7194

4.62

307.65

1.6

1.3

222.40

312.16

ug/g

102.95

3036

4055

Intestinal infectious diseases, including avohilmo, including avohilmo

3993

8938

2.57

307.65

1.5

1.4

270.52

275.95

ug/g

0.66

2366

5092

Intestinal infectious diseases

3186

10232

2.39

307.65

1.5

1.4

268.34

278.54

ug/g

1.48

1906

5803

GASTRO-related operations

2289

2953

4.01

307.65

1.5

1.3

271.35

310.36

ug/g

10.10

1275

1624

Diabetes, insulin treatment (Kela reimbursement)

3198

8664

2.26

307.65

1.5

1.4

241.33

290.26

ug/g

27.43

1958

4941

Other diseases of biliary tract

725

813

10.72

307.65

1.6

1.3

165.38

297.36

ug/g

35.61

428

467

Acute pancreatitis (for exclusion)

1456

2466

6.78

307.65

1.7

1.4

214.24

277.25

ug/g

13.53

905

1469

Noninfective enteritis and colitis

2168

6226

3.70

307.65

1.6

1.4

273.74

277.34

ug/g

0.30

1319

3539

Malignant neoplasm of digestive organs, including Hilmo

2103

4523

3.66

307.65

1.5

1.4

191.58

281.94

ug/g

63.96

1333

2691

Weight loss

655

1267

5.88

307.65

1.5

1.4

293.59

273.32

ug/g

1.22

385

740

Gastro-oesophageal reflux disease

2550

7455

3.01

307.65

1.5

1.4

286.57

270.23

ug/g

3.03

1411

4322

Diarrhoea and gastroenteritis of presumed infectious origin

2469

8717

2.62

307.65

1.5

1.4

269.95

278.63

ug/g

0.92

1466

4905

Oxycodone

1683

3974

3.83

307.65

1.5

1.4

220.62

274.81

ug/g

18.04

1036

2271

Mood disorders, excluding more controls

2918

7599

2.32

307.65

1.5

1.4

279.48

270.96

ug/g

0.97

1627

4453

Cholelithiasis

2677

6692

2.82

307.65

1.5

1.3

270.89

311.06

ug/g

16.11

1578

3777

Insulin, intermediate and long-acting

2255

7329

3.12

307.65

1.6

1.4

214.84

279.75

ug/g

38.25

1397

4286

Other antidepressants

3081

6866

2.35

307.65

1.5

1.4

275.21

272.05

ug/g

0.27

1744

4027

Insulin, fast-acting or short human

1587

4828

3.49

307.65

1.6

1.4

212.49

279.83

ug/g

27.80

977

2794

Acute pancreatitis

1456

1852

9.09

307.65

1.7

1.3

214.24

306.66

ug/g

26.82

905

1091

Abnormal weight loss

626

1181

6.08

307.65

1.5

1.4

294.37

272.21

ug/g

1.32

364

695

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

3504

9152

2.53

307.65

1.5

1.4

275.43

276.30

ug/g

0.07

2043

5209

Gastrointestinal diseases

1502

1423

5.45

307.65

1.4

1.2

291.74

327.75

ug/g

5.16

803

761

Other soft tissue disorders, not elsewhere classified

2913

7092

2.40

307.65

1.5

1.4

283.86

271.09

ug/g

2.14

1660

4049

Nausea and vomiting

1199

2411

5.17

307.65

1.5

1.3

257.91

278.84

ug/g

2.31

730

1389

Other symptoms and signs involving the digestive system and abdomen

774

1552

5.37

307.65

1.6

1.3

276.35

278.65

ug/g

0.10

456

901

Abdominal and pelvic pain

3329

5041

3.43

307.65

1.5

1.3

270.25

281.89

ug/g

1.57

1924

2898

Autoimmune diseases excluding thyroid diseases

3103

7817

2.20

305.62

1.5

1.4

264.27

278.64

ug/g

2.74

1862

4399

Diabetes, varying definitions

3033

8182

2.20

303.74

1.5

1.4

247.33

295.33

ug/g

24.92

1828

4565

Benign neoplasm of colon, rectum, anus and anal canal

2263

8224

2.42

301.83

1.5

1.4

271.48

265.03

ug/g

0.72

1376

4845

Diabetes medication

3126

8634

2.17

301.36

1.5

1.4

244.22

294.28

ug/g

27.74

1898

4843

Abnormalities of breathing

2586

6444

2.35

300.68

1.4

290.12

269.52

ug/g

4.15

1446

3685

Pain in limb

2508

6997

2.34

295.39

1.5

1.4

277.99

270.85

ug/g

0.83

1428

3994

Implicit Sepsis

2497

8210

2.31

294.65

1.5

1.4

255.60

277.96

ug/g

5.67

1536

4766

Dysphagia

899

2408

3.93

292.20

1.6

1.3

278.63

273.76

ug/g

0.27

535

1447

Medical observation and evaluation for suspected diseases and conditions

1844

3474

2.79

289.70

1.5

1.4

282.07

269.04

ug/g

1.44

1036

2022

Inflammatory bowel disease treatment related agents

3368

9205

2.08

287.81

1.5

1.4

279.09

274.31

ug/g

0.55

1926

5251

Autoimmune diseases excluding thyroid diseases, strict definition

2970

7571

2.18

286.90

1.5

1.4

263.96

278.09

ug/g

2.59

1794

4262

Pain (limb, back, neck, head abdominally)

1854

3445

2.76

285.56

1.5

1.4

276.09

272.41

ug/g

0.26

1068

1995

Low back pain

2365

6985

2.35

285.20

1.5

1.4

281.99

269.38

ug/g

1.82

1349

4022

Implicit Sepsis, including avohilmo

2618

8609

2.23

284.36

1.5

1.4

259.22

280.77

ug/g

5.49

1607

4965

Type 1 diabetes

956

2747

3.66

279.62

1.7

1.4

214.21

294.12

ug/g

25.61

641

1543

Metabolic disorders

2851

8097

2.17

276.24

1.5

1.4

262.00

281.82

ug/g

4.73

1741

4569

Depression

2913

9416

2.12

274.70

1.5

1.4

279.47

276.04

ug/g

0.29

1608

5466

Other bacterial diseases

2909

9345

2.12

271.57

1.5

1.4

241.10

285.36

ug/g

21.83

1768

5363

Mood disorders

3091

9785

2.07

270.65

1.5

1.4

280.32

274.39

ug/g

0.63

1714

5684

Mood [affective] disorders

3086

9782

2.07

270.65

1.5

1.4

279.95

274.49

ug/g

0.56

1712

5682

ILD medications: prednisolone, methylprednisolone, prednisone

3182

8740

2.07

270.03

1.4

276.11

275.08

ug/g

0.09

1813

4998

Persons encountering health services in other circumstances, wide

3318

8499

2.05

269.47

1.5

1.4

271.91

275.82

ug/g

0.41

1932

4885

Cholecystectomy

2332

9056

2.26

268.11

1.5

1.4

269.72

273.55

ug/g

0.35

1383

5233

Depression or dysthymia

1933

4215

2.57

267.10

1.5

1.4

271.79

264.06

ug/g

0.58

1100

2530

Budesonide

689

1645

4.53

264.92

1.5

1.4

281.49

279.77

ug/g

0.07

415

944

Anxiety disorders, excluding more controls

2449

7140

2.25

263.96

1.5

1.4

287.73

274.49

ug/g

1.62

1340

4180

Benzodiazepine use

3029

10246

2.04

259.72

1.5

1.4

274.70

274.69

ug/g

0.00

1697

5943

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3186

8464

2.04

258.81

1.5

1.4

275.77

276.12

ug/g

0.03

1883

4868

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2699

8761

2.13

258.55

1.5

1.4

262.29

282.52

ug/g

4.89

1654

4975

All kidney diseases

2928

9726

2.06

258.09

1.5

1.4

259.45

283.70

ug/g

7.33

1817

5441

Other bacterial diseases, including avohilmo

3012

9365

2.05

257.87

1.5

1.4

247.09

288.79

ug/g

19.72

1813

5309

Other disorders of fluid, electrolyte and acid-base balance

1227

4033

3.01

256.82

1.5

1.4

231.40

269.76

ug/g

7.93

772

2369

Type 2 diabetes

2815

7920

2.11

252.40

1.5

1.4

251.25

293.47

ug/g

18.12

1673

4439

Recurrent or chronic depression

1216

2829

3.08

249.43

1.4

282.64

279.52

ug/g

0.13

664

1661

Renal tubulo-interstitial diseases

2672

9585

2.10

249.10

1.5

1.4

254.11

280.54

ug/g

8.17

1666

5399

Other medical care

1677

5765

2.53

248.12

1.5

1.4

211.44

275.15

ug/g

27.23

1032

3285

Benign neoplasm: Colon

1892

7770

2.37

247.76

1.5

1.4

268.60

263.44

ug/g

0.49

1159

4596

Oral corticosteroids

3042

9032

2.02

244.81

1.5

1.4

279.11

272.63

ug/g

0.80

1754

5168

Type 2 diabetes, wide definition

2299

6658

2.24

243.52

1.5

1.4

255.04

288.37

ug/g

10.49

1433

3818

Dorsalgia

2763

7100

2.11

242.96

1.5

1.4

282.96

270.15

ug/g

2.01

1540

4075

Bacterial infection, other or unspecified, including avohilmo

1955

7091

2.33

241.43

1.5

1.4

236.86

277.26

ug/g

13.23

1211

4106

Cholangitis (primary sclerosing, PSC)

366

541

7.65

240.89

1.6

1.3

178.43

310.80

ug/g

19.58

223

312

Complications of surgical and medical care, not elsewhere classified

2962

10110

2.00

239.24

1.5

1.4

259.84

278.13

ug/g

4.41

1807

5724

Codeine or tramadol medication

3199

8972

1.98

239.06

1.4

278.71

273.58

ug/g

0.53

1913

5057

ILD medications

3177

8835

1.98

237.23

1.5

1.4

277.40

275.94

ug/g

0.13

1825

5039

Condition for Implicit Sepsis (Organ dysfunction codes)

2569

8710

2.09

236.66

1.5

1.4

257.97

281.47

ug/g

6.34

1582

5006

Endocrine, nutritional and metabolic diseases

1989

4255

2.41

236.17

1.5

1.3

273.39

301.28

ug/g

5.45

1145

2296

Ductal carcinoma of pancreas

154

51.83

235.42

1.6

1.3

95.89

301.33

ug/g

9.86

Other diseases of anus and rectum

945

2997

3.27

233.88

1.5

1.4

277.55

267.14

ug/g

0.66

511

1766

Pain, not elsewhere classified

965

3116

3.23

233.76

1.5

1.4

279.10

278.49

ug/g

0.03

566

1756

Type 1 diabetes, wide definition, subgroup 1

740

2029

3.84

232.30

1.7

1.3

220.68

304.74

ug/g

22.81

518

1102

Diseases of liver

1288

4904

2.75

231.64

1.5

1.4

260.91

270.72

ug/g

0.78

764

2892

Bacterial infection, other or unspecified

1811

6685

2.36

231.51

1.5

1.4

233.36

276.31

ug/g

13.84

1121

3885

Alcohol-induced acute pancreatitis

299

381

9.66

227.86

1.9

1.4

156.32

268.72

ug/g

12.11

178

228

Autoimmune diseases

3023

7857

1.99

226.82

1.5

1.4

267.33

278.50

ug/g

1.76

1771

4422

Lower back pain or/and sciatica

3112

10215

1.93

225.25

1.5

1.4

282.74

272.30

ug/g

1.70

1764

5883

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

798

991

4.13

223.11

1.4

1.3

293.38

281.22

ug/g

0.60

445

546

Depression medications

660

695

4.90

222.83

1.4

1.2

300.71

360.23

ug/g

5.43

336

Other or unspecified ileus, impaction or obstruction

651

1686

4.07

222.10

1.5

1.4

226.35

267.16

ug/g

4.65

409

1029

Certain infectious and parasitic diseases

2590

6320

2.09

221.45

1.5

1.4

268.76

290.15

ug/g

4.60

1506

3530

Alcohol use disorder, Swedish definition

1703

6772

2.36

220.64

1.6

1.4

236.09

273.14

ug/g

8.51

960

3969

Selective serotonin reuptake inhibitors

2670

6890

2.06

219.63

1.5

1.4

282.44

272.43

ug/g

1.11

1489

4041

Symptoms and signs involving the circulatory and respiratory systems

2614

6454

2.07

216.88

1.5

1.4

289.69

269.70

ug/g

3.96

1466

3689

General examination and investigation of persons without complaint and reported diagnosis

1646

3468

2.52

216.18

1.5

1.4

283.96

269.24

ug/g

1.57

935

2020

Any mental disorder

2979

7727

1.97

215.91

1.4

277.47

271.29

ug/g

0.62

1685

4533

1763

7072

2.29

213.62

1.6

1.4

238.64

273.60

ug/g

7.84

990

4129

Other diseases of intestine

580

1429

4.31

212.65

1.5

1.4

259.93

269.56

ug/g

0.47

386

867

1824

7245

2.25

211.11

1.6

1.4

239.39

274.92

ug/g

8.42

1030

4225

Dyspnoea

2661

9958

1.97

210.55

1.4

287.50

270.42

ug/g

3.56

1516

5771

Parasetamol

1774

3813

2.40

209.17

1.4

277.88

282.39

ug/g

0.32

982

2173

Unspecified jaundice

284

370

8.66

208.82

1.4

1.3

149.97

268.75

ug/g

11.38

149

222

Hypothyroidism (congenital or acquired)

582

677

4.95

208.58

1.5

1.2

296.47

357.10

ug/g

5.82

310

326

Other dorsopathies, not elsewhere classified

2690

7108

2.00

206.91

1.5

1.4

284.79

270.26

ug/g

2.01

1514

4081

Use of hypnotics and sedatives

2994

9149

1.91

204.78

1.5

1.4

273.20

275.16

ug/g

0.16

1748

5259

Other bacterial intestinal infections, including avohilmo

871

2878

3.18

203.83

1.5

1.4

264.94

272.31

ug/g

0.44

511

1662

Neurotic, stress-related and somatoform disorders

2562

9107

1.98

203.37

1.5

1.4

290.26

275.19

ug/g

2.10

1382

5284

Anxiety (asthma-related co-morbidities)

1715

5820

2.30

203.12

1.5

1.4

292.13

287.33

ug/g

0.28

890

3274

Hypothyroidism, levothyroxine purchases

573

676

4.88

202.64

1.5

1.2

297.85

357.10

ug/g

5.49

301

326

Hypothyroidism and >3 levothyroxin purchases

573

676

4.88

202.64

1.5

1.2

297.85

357.10

ug/g

5.49

301

326

Implicit bacterial Sepsis, including avohilmo

1531

5484

2.40

202.57

1.5

1.4

241.86

269.89

ug/g

5.72

943

3274

Asthma, unspecified (mode), excluding more controls

1524

4604

2.43

202.21

1.5

1.4

278.83

276.81

ug/g

0.13

919

2601

Substance abuse, excluding more controls

1588

5798

2.35

202.15

1.5

1.4

252.62

266.55

ug/g

1.52

881

3405

Nerve, nerve root and plexus disorders

3022

9815

1.89

201.98

1.5

1.4

271.90

273.85

ug/g

0.16

1751

5656

Anxiety disorders

2581

9182

1.97

201.77

1.5

1.4

289.86

274.81

ug/g

2.12

1396

5332

Complications of procedures, not elsewhere classified

2391

9853

2.00

201.25

1.5

1.4

256.30

277.37

ug/g

4.86

1466

5594

Benign neoplasm of other and ill-defined parts of digestive system

775

2431

3.42

199.96

1.6

1.4

255.74

271.04

ug/g

1.10

509

1447

Asthma, unspecified (mode)

1573

4919

2.37

197.38

1.5

1.4

277.00

275.00

ug/g

0.13

952

2806

Type 1 diabetes, wide definition

752

2322

3.39

196.31

1.7

1.4

221.34

297.21

ug/g

20.02

528

1300

Used for control exclusion in common control thyroid runs

2746

7227

1.95

194.76

1.5

1.4

268.13

277.77

ug/g

1.30

1594

4061

Faecal incontinence

415

851

5.30

192.82

1.6

1.3

283.74

283.20

ug/g

0.02

244

510

Other special examinations and investigations of persons without complaint or reported diagnosis

1612

3474

2.40

190.22

1.5

1.4

275.83

269.04

ug/g

0.52

924

2022

Other gastritis (incl. Duodenitis)

783

2556

3.22

187.13

1.5

1.4

279.51

269.07

ug/g

0.63

479

1537

Implicit bacterial Sepsis

1386

5098

2.41

186.29

1.5

1.4

240.55

269.40

ug/g

5.54

858

3049

Bacterial Sepsis

1521

5608

2.32

185.11

1.5

1.4

238.69

269.93

ug/g

6.78

931

3328

Asthma, excluding more controls

1966

4761

2.17

183.95

1.5

1.4

281.52

277.88

ug/g

0.28

1142

2698

Other specific joint derangements/joint disorders

2020

6127

2.10

183.91

1.5

1.4

289.22

272.98

ug/g

2.39

1111

3434

Shoulder lesions

2133

6332

2.07

183.84

1.5

1.4

275.69

265.20

ug/g

1.08

1283

3699

Renal failure

1553

6019

2.27

181.60

1.5

1.4

239.68

265.19

ug/g

5.12

1012

3582

Asthma

2044

5084

2.12

181.13

1.5

1.4

281.26

276.02

ug/g

0.45

1186

2907

Sub-endpoint used in defining T1D endpoints

957

3481

2.81

180.87

1.7

1.4

213.32

278.87

ug/g

19.03

642

2002

Explicit Sepsis, including avohilmo

1430

5737

2.33

180.55

1.5

1.4

231.62

272.43

ug/g

9.44

834

3349

Cardiac arrhythmias

1508

4220

2.34

180.15

1.5

1.3

299.02

301.42

ug/g

0.15

848

2243

Symptoms and signs involving cognition, perception, emotional state and behaviour

2708

9883

1.87

179.72

1.5

1.4

281.03

272.56

ug/g

0.98

1523

5718

Explicit Sepsis

1403

5625

2.35

179.60

1.5

1.4

230.73

272.43

ug/g

9.63

817

3289

Spondylosis

1617

5832

2.23

178.51

1.5

1.4

277.67

263.11

ug/g

1.90

960

3441

Complications of medical and surgical care

2174

10170

1.97

177.72

1.5

1.4

259.41

275.55

ug/g

2.89

1321

5825

Intestinal stricture

1091

4361

2.61

177.61

1.5

1.4

237.11

269.43

ug/g

5.34

707

2596

Spondylopathies

2149

6385

2.03

177.47

1.5

1.4

276.09

265.12

ug/g

1.44

1279

3746

Other diseases of the digestive system

1067

4219

2.63

177.15

1.5

1.4

244.78

273.76

ug/g

3.87

633

2522

Psychiatric diseases

2538

6691

1.94

175.60

1.4

280.80

268.39

ug/g

1.51

1437

3956

Other anxiety disorders

1335

4904

2.38

175.53

1.4

298.05

285.16

ug/g

0.83

690

2759

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2422

7451

1.94

174.55

1.5

1.4

261.31

277.65

ug/g

2.91

1441

4276

2422

7451

1.94

174.55

1.5

1.4

261.31

277.65

ug/g

2.91

1441

4276

Other septicaemia, including avohilmo

1265

5077

2.42

174.53

1.5

1.4

228.78

275.69

ug/g

11.12

745

3005

Asthma (mode)

2006

5132

2.10

174.22

1.5

1.4

278.96

275.65

ug/g

0.25

1152

2922

Diaphragmatic hernia

1234

5271

2.44

173.63

1.5

1.4

283.16

262.48

ug/g

2.91

761

3141

Other septicaemia

1241

4989

2.43

172.56

1.5

1.4

228.12

275.98

ug/g

11.34

729

2958

All anxiety disorders

1739

6485

2.13

172.38

1.4

293.28

282.41

ug/g

0.84

902

3652

Hypertensive diseases (excluding secondary)

1354

3309

2.44

171.79

1.5

1.4

273.62

301.91

ug/g

4.14

817

1750

Certain infectious and parasitic diseases, including avohilmo

1760

4078

2.20

171.28

1.4

273.93

286.66

ug/g

1.39

1019

2287

Septicaemia

1357

5484

2.33

171.10

1.5

1.4

228.91

275.20

ug/g

11.55

794

3236

Chronic gastritis

886

3254

2.84

170.69

1.5

1.4

269.28

265.26

ug/g

0.22

535

1966

Other intervertebral disc disorders

2193

6733

1.98

169.25

1.5

1.4

277.27

267.37

ug/g

1.26

1301

3913

Other (not insulin) diabetes medications

2596

8292

1.87

169.15

1.5

1.4

255.40

290.91

ug/g

12.18

1537

4692

Other disorders of urethra and urinary system

1953

6811

2.04

168.79

1.4

279.54

273.73

ug/g

0.53

1128

3908

Autoimmune diseases related-to ILD

2376

10761

1.88

168.57

1.5

1.4

282.65

273.81

ug/g

1.17

1352

6170

Implicit viral Sepsis, including avohilmo

1036

4129

2.61

168.40

1.5

1.4

267.31

275.16

ug/g

0.56

639

2415

Dental caries

803

2641

2.98

167.78

1.5

1.4

250.56

267.37

ug/g

1.38

490

1573

Nutritional anaemias

1575

7148

2.16

167.60

1.5

1.4

257.88

271.03

ug/g

1.65

956

4168

Abnormalities of heart beat

1074

4225

2.54

166.93

1.5

1.4

295.63

263.58

ug/g

4.79

602

2452

Oedema, not elsewhere classified

988

3776

2.64

166.12

1.5

1.4

269.05

268.99

ug/g

0.00

573

2189

Influenza and pneumonia

2852

9954

1.80

165.76

1.5

1.4

265.42

281.95

ug/g

3.42

1679

5636

Intracranial trauma

1507

4631

2.25

165.68

1.4

278.26

273.05

ug/g

0.37

841

2642

Type 2 diabetes, definitions combined

2465

7733

1.89

164.95

1.5

1.4

259.93

292.09

ug/g

9.53

1430

4361

Soft tissue disorders

2570

7122

1.88

164.43

1.4

284.76

271.31

ug/g

2.14

1445

4061

Other bacterial intestinal infections

671

2168

3.26

163.55

1.5

1.4

258.04

267.98

ug/g

0.57

404

1282

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

724

2454

3.13

162.99

1.5

1.4

204.41

281.74

ug/g

18.13

455

1478

Hypertension, essential

2031

5811

2.02

162.51

1.5

1.4

265.38

287.29

ug/g

4.07

1221

3235

Any reimbursement code in KELA

1276

2621

2.49

162.14

1.5

1.2

282.92

338.56

ug/g

12.27

711

1297

Asthma (only as main-diagnosis), excluding more controls

1788

4761

2.12

162.12

1.5

1.4

281.83

277.88

ug/g

0.30

1023

2698

Aplastic and other anaemias

1477

6350

2.20

161.61

1.5

1.4

245.76

266.50

ug/g

3.26

928

3754

Pneumonia, organism unspecified

2530

9608

1.84

161.54

1.5

1.4

262.40

281.04

ug/g

3.98

1506

5479

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1685

6471

2.10

160.33

1.5

1.4

247.17

272.00

ug/g

4.71

990

3843

Persons encountering health services in other circumstances

1209

5225

2.36

159.88

1.5

1.4

277.72

277.33

ug/g

0.02

635

2975

All pneumoniae

2750

10147

1.79

159.50

1.5

1.4

262.25

281.96

ug/g

4.64

1634

5743

All chronic kidney diseases

1639

6352

2.11

159.19

1.5

1.4

244.90

271.61

ug/g

5.79

1074

3663

Pneumonias (Asthma/COPD co-morbidities)

2732

10128

1.79

158.94

1.5

1.4

262.00

282.15

ug/g

4.82

1625

5732

Caries of dentine

720

2360

3.06

158.31

1.5

1.4

249.59

263.25

ug/g

0.92

439

1394

Type 2 diabetes, strict (exclude DM1)

2476

7889

1.86

157.93

1.5

1.4

260.05

289.37

ug/g

8.11

1437

4455

Concussion

1327

4596

2.29

157.49

1.4

281.94

272.45

ug/g

0.78

742

2625

Symptoms and signs involving the urinary system

2204

8960

1.90

156.90

1.5

1.4

275.04

269.85

ug/g

0.41

1233

5279

Dorsopathies

2563

7133

1.85

155.79

1.5

1.4

287.08

270.65

ug/g

2.38

1438

4098

Care involving dialysis

354

763

5.06

155.44

1.6

1.4

235.49

275.48

ug/g

2.84

243

469

Non-selective monoamine reuptake inhibitors

1106

4509

2.43

155.30

1.5

1.4

280.57

271.80

ug/g

0.46

624

2699

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2688

10195

1.79

155.24

1.5

1.4

260.85

281.31

ug/g

4.92

1608

5774

GI-bleeding

1022

4214

2.52

155.03

1.5

1.4

245.89

272.89

ug/g

3.33

614

2520

Bleeding

2360

9108

1.86

154.88

1.5

1.4

254.23

272.50

ug/g

3.70

1426

5305

Asthma (only as main-diagnosis)

1831

5084

2.05

153.56

1.5

1.4

280.90

276.02

ug/g

0.40

1052

2907

Sleep disorders (combined)

2879

8653

1.77

151.90

1.4

292.32

267.76

ug/g

5.54

1598

5068

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2613

9362

1.80

151.50

1.5

1.4

267.85

280.34

ug/g

2.07

1578

5265

Other heart diseases

1194

3327

2.39

149.44

1.5

1.4

271.67

302.19

ug/g

4.47

696

1760

Type 2 diabetes, definitions combined, including avohilmo

2430

7779

1.84

149.37

1.5

1.4

260.19

290.61

ug/g

8.52

1412

4384

Follow-up examination after treatment for conditions other than malignant neoplasms

1099

3029

2.47

149.32

1.4

272.95

268.23

ug/g

0.21

637

1770

Other headache syndromes

1238

5617

2.26

148.57

1.4

299.74

274.20

ug/g

3.65

667

3211

Personality disorders, excluding more controls

701

2435

2.97

148.31

1.4

293.62

287.85

ug/g

0.17

376

1338

Implicit viral Sepsis

729

2617

2.92

147.00

1.5

1.4

266.78

274.28

ug/g

0.43

448

1555

Viral Sepsis

729

2621

2.91

146.57

1.5

1.4

266.78

274.42

ug/g

0.44

448

1557

Haemorrhoids and perianal venous thrombosis

880

3436

2.62

146.55

1.5

1.4

273.97

264.92

ug/g

0.56

484

2008

Sciatica+with lumbago

1447

6185

2.12

145.84

1.4

283.95

267.76

ug/g

1.99

806

3596

Other anaemias

1356

6019

2.18

145.51

1.5

1.4

246.61

265.94

ug/g

2.71

850

3565

Other and unspecified anaemias

1345

5973

2.18

145.35

1.5

1.4

246.47

265.85

ug/g

2.70

842

3532

Other diseases of urinary system

2541

8064

1.80

144.85

1.4

277.09

272.69

ug/g

0.42

1451

4657

Cardiovascular diseases (excluding rheumatic etc)

1480

3983

2.17

143.55

1.5

1.3

283.22

310.25

ug/g

4.15

845

2045

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

166

181

11.17

142.65

1.7

1.4

127.36

299.84

ug/g

15.65

109

115

Benign neoplasm: Pancreas

222

345

7.89

142.27

1.6

1.5

233.24

277.39

ug/g

1.84

166

211

Hypertension

1998

5939

1.93

142.27

1.5

1.4

266.51

288.74

ug/g

4.18

1199

3288

Hypokalaemia

499

1470

3.62

142.06

1.5

1.4

228.28

276.43

ug/g

5.55

331

867

Hypertensive diseases

1997

5944

1.93

141.71

1.5

1.4

266.57

288.84

ug/g

4.19

1198

3291

Other/unspecified dorsalgia

1080

4678

2.35

141.50

1.4

276.32

269.89

ug/g

0.43

626

2689

Polyarthropathies

1754

5757

2.00

140.98

1.5

1.4

270.54

268.41

ug/g

0.14

1039

3264

Disorders of lipoprotein metabolism and other lipidaemias

2198

7335

1.86

140.90

1.5

1.4

264.83

276.60

ug/g

1.72

1364

4216

Acute renal failure

783

2991

2.74

140.27

1.6

1.4

234.72

265.25

ug/g

3.67

520

1827

Mental and behavioural disorders due to psychoactive substance use

1636

7702

1.99

139.34

1.5

1.4

253.30

273.78

ug/g

2.98

908

4475

Chronic kidney disease

1018

4234

2.40

138.05

1.5

1.4

242.61

263.55

ug/g

2.57

658

2588

Rotator cuff syndrome

1698

5991

2.00

138.00

1.5

1.4

272.62

263.62

ug/g

0.93

1021

3518

Cardiovascular diseases

1345

3252

2.23

137.97

1.4

1.3

296.41

309.04

ug/g

1.06

714

1665

Syncope and collapse

1182

4481

2.26

137.38

1.5

1.4

259.89

268.81

ug/g

0.70

682

2576

Gastroduodenal ulcer

780

2988

2.70

137.08

1.5

1.4

244.92

263.13

ug/g

1.44

490

1810

Hypothyroidism, drug reimbursement

333

466

5.15

136.97

1.5

1.2

290.53

357.04

ug/g

4.76

197

226

Substance abuse

1588

7558

2.00

136.93

1.5

1.4

252.62

272.96

ug/g

2.87

881

4408

Dialysis, with operation codes

493

1478

3.56

136.72

1.6

1.4

233.18

272.78

ug/g

3.99

343

901

Heart failure, not strict

2104

7807

1.85

135.97

1.5

1.4

253.75

271.76

ug/g

2.74

1348

4517

Other diseases of liver

665

2380

2.94

135.42

1.5

1.4

279.01

274.06

ug/g

0.22

400

1392

Benign neoplasms

2394

7363

1.80

135.41

1.5

1.4

279.11

274.34

ug/g

0.39

1415

4125

Neoplasms

1706

4511

2.02

134.84

1.5

1.3

271.50

301.52

ug/g

5.90

991

2374

Inflammatory bowel disease

967

4145

2.41

134.59

1.5

1.4

282.55

276.57

ug/g

0.36

559

2371

Myalgia

749

2852

2.73

134.23

1.5

1.4

302.80

273.69

ug/g

2.92

423

1637

Bacterial intestinal infections, IBD co-morbidities

671

2425

2.91

134.06

1.6

1.4

257.57

269.75

ug/g

0.77

407

1448

Hernia

2479

9576

1.75

133.49

1.5

1.4

279.40

274.05

ug/g

0.49

1470

5511

Cystitis

2168

7170

1.83

132.46

1.4

277.42

274.41

ug/g

0.24

1222

4111

Nephropathy related operations

476

1428

3.57

132.00

1.6

1.4

239.48

272.68

ug/g

2.82

328

872

ILD medications: immunosuppressive drugs

1710

8220

1.92

131.88

1.5

1.4

281.12

275.76

ug/g

0.47

1011

4705

Episodal and paroxysmal disorders

2719

8114

1.73

131.64

1.4

286.11

270.97

ug/g

2.84

1503

4689

Neurological diseases

2024

5465

1.89

131.38

1.5

1.4

286.86

271.20

ug/g

2.20

1132

3120

Heartburn

365

913

4.21

130.94

1.5

1.3

271.57

285.82

ug/g

0.57

194

527

Dizziness and giddiness

2049

8904

1.83

130.57

1.5

1.4

286.88

270.77

ug/g

2.10

1153

5175

Persons encountering health services for examination and investigation

1450

3474

2.13

130.38

1.5

1.4

276.18

269.04

ug/g

0.53

833

2022

Ascites

292

625

5.02

128.79

1.6

1.3

229.02

276.32

ug/g

2.98

193

380

Injuries to the head

2891

10431

1.67

128.38

1.4

273.82

276.74

ug/g

0.28

1647

5977

Other pulmonary diagnosis

1918

5126

1.91

127.65

1.5

1.4

271.94

275.63

ug/g

0.27

1107

2933

Other heart diseases, wide

2328

8116

1.76

126.72

1.5

1.4

279.17

281.82

ug/g

0.22

1340

4529

Other disorders of skin and subcutaneous tissue

2026

9664

1.81

126.33

1.5

1.4

270.60

272.30

ug/g

0.13

1197

5611

Viral and other specified intestinal infections, including avohilmo

755

2845

2.63

126.13

1.6

1.4

283.81

291.16

ug/g

0.40

460

1529

COPD/asthma/ILD related infections

2546

7451

1.74

126.11

1.4

277.57

277.65

ug/g

0.00

1454

4276

COPD/asthma related infections

2546

7451

1.74

126.11

1.4

277.57

277.65

ug/g

0.00

1454

4276

Neuroendocrine tumor and carcinoma of pancreas

28.59

125.79

1.9

1.3

197.73

331.92

ug/g

3.63

Osteopathies and chondropathies

1652

8067

1.92

125.67

1.5

1.4

268.72

272.99

ug/g

0.28

997

4639

2896

8900

1.67

125.58

1.4

282.87

273.25

ug/g

1.38

1611

5180

Neurological diseases, wide definition

628

1003

3.21

125.33

1.4

1.3

310.58

293.10

ug/g

0.84

332

553

Excluding asthma or asthma-COPD overlap

1907

5126

1.90

124.74

1.5

1.4

272.68

275.63

ug/g

0.21

1092

2933

Pure hypercholesterolaemia

1991

7020

1.84

124.32

1.5

1.4

256.71

275.01

ug/g

3.40

1233

4056

Disorders of eyelid, lacrimal system and orbit

2336

10045

1.73

124.10

1.5

1.4

286.32

271.41

ug/g

2.72

1369

5768

Asthma-related infections

1642

8593

1.90

124.01

1.5

1.4

278.38

275.49

ug/g

0.21

973

4899

Asthma, hospital admission 2, infections

1642

8593

1.90

124.01

1.5

1.4

278.38

275.49

ug/g

0.21

973

4899

Iron deficiency anaemia

1282

6228

2.08

123.46

1.5

1.4

260.12

272.64

ug/g

1.29

759

3628

Exposure to unspecified factor

2646

10910

1.68

122.44

1.5

1.4

273.36

276.83

ug/g

0.34

1546

6231

Non-invasive ventilation

586

1741

2.98

121.99

1.7

1.3

247.60

288.31

ug/g

4.48

358

957

Rheumatism, unspecified

497

1610

3.27

121.09

1.5

1.4

285.57

272.30

ug/g

0.65

278

950

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1694

9095

1.87

120.42

1.5

1.4

258.78

274.56

ug/g

2.33

1035

5235

Insulin, fast-acting (human)

457

1409

3.40

120.21

1.7

1.4

222.94

299.25

ug/g

13.56

327

761

COPD differential diagnosis

1889

5133

1.87

119.60

1.5

1.4

273.21

275.65

ug/g

0.17

1083

2922

ILD differential diagnosis

1888

5132

1.87

119.38

1.5

1.4

273.21

275.65

ug/g

0.17

1083

2922

Diseases of the skin and subcutaneous tissue

2398

7021

1.74

119.25

1.5

1.4

273.47

273.29

ug/g

0.01

1397

4018

Cough

1103

4862

2.17

118.99

1.4

298.05

266.34

ug/g

5.05

665

2852

Lumbar disc prolapse

1634

6473

1.91

118.56

1.5

1.4

275.54

266.99

ug/g

0.85

988

3766

Asthma (diagnoses ohter than nonallergic)

2288

10983

1.71

117.94

1.5

1.4

281.87

274.81

ug/g

0.83

1356

6243

Continuous positive airway pressure

497

1323

3.24

116.95

1.5

1.3

262.71

276.71

ug/g

0.69

297

753

Other joint disorders

2108

6248

1.79

115.88

1.5

1.4

291.41

272.89

ug/g

2.38

1172

3500

Somatoform disorder

545

1924

2.97

113.59

1.5

1.4

315.14

275.58

ug/g

3.83

296

1116

Hypo-osmolality and hyponatraemia

610

2267

2.79

113.46

1.5

1.4

246.04

271.85

ug/g

2.13

366

1359

Biguanides

2444

8886

1.69

113.37

1.5

1.4

252.75

281.51

ug/g

8.19

1468

5109

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

281

650

4.68

113.00

1.6

1.5

171.38

281.94

ug/g

13.77

175

412

Fibromyalgia

351

952

3.92

113.00

1.5

1.4

320.11

287.33

ug/g

1.83

195

531

Other reaction to severe stress, and adjustment disorders

949

4333

2.24

112.83

1.5

1.4

287.03

285.19

ug/g

0.09

528

2434

Mental and behavioural disorders due to alcohol

1356

6711

1.97

112.80

1.5

1.4

249.25

270.03

ug/g

2.55

750

3928

Fall on same level

2829

9375

1.63

112.52

1.4

268.20

281.36

ug/g

2.26

1631

5334

Transplanted organ and tissue status

380

1093

3.72

112.48

1.5

1.4

265.40

272.22

ug/g

0.24

252

651

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

681

2655

2.60

112.43

1.4

278.20

287.23

ug/g

0.45

380

1467

Malignant neoplasm of other and unspecified parts of biliary tract

123

124

12.17

111.99

1.6

1.3

113.83

303.73

ug/g

13.77

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1209

6021

2.04

111.89

1.5

1.4

244.65

267.03

ug/g

2.60

663

3574

Antihypertensive medication - note that there are other indications

1313

3370

2.07

111.26

1.4

295.23

304.13

ug/g

0.64

682

1791

Other disorders of lacrimal gland

1112

5449

2.10

111.04

1.5

1.4

294.38

272.46

ug/g

2.84

634

3149

Other disorders of glucose regulation and pancreatic internal secretion

344

942

3.92

109.66

1.8

1.4

194.82

286.62

ug/g

11.18

211

553

Other and unspecified iron deficiency

1035

4950

2.15

109.60

1.5

1.4

264.93

272.63

ug/g

0.55

607

2888

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1838

9187

1.78

109.10

1.5

1.4

272.08

268.42

ug/g

0.24

1089

5381

Diseases of arteries, arterioles and capillaries (FINNGEN)

680

1811

2.68

108.44

1.5

1.4

243.31

279.88

ug/g

4.36

438

1034

Fentanyl

345

951

3.81

107.64

1.5

1.4

203.61

274.04

ug/g

7.50

209

565

Disorders of thyroid, IBD co-morbidities

399

766

3.66

107.53

1.4

1.3

281.93

279.27

ug/g

0.07

231

425

Enterocolitis due to Clostridium difficile

417

1312

3.38

106.94

1.6

1.4

251.79

274.12

ug/g

1.34

258

783

Vocal cord dysfunction

357

868

3.75

106.77

1.4

1.3

301.93

283.07

ug/g

0.79

207

482

Care involving use of rehabilitation procedures

1611

8065

1.83

106.62

1.5

1.4

276.44

285.19

ug/g

0.72

1043

4532

1228

6257

1.99

106.60

1.4

286.03

279.68

ug/g

0.47

715

3549

Alcohol use disorder, ICD-based

1125

5634

2.05

105.42

1.5

1.4

242.78

266.79

ug/g

2.71

616

3353

Disorders of other endocrine glands

1240

6317

1.98

105.26

1.5

1.4

269.37

278.85

ug/g

0.83

729

3592

Behavioural syndromes associated with physiological disturbances and physical factors

2401

9987

1.65

105.25

1.4

294.35

271.93

ug/g

3.98

1337

5775

Gastric ulcer

534

1940

2.87

105.20

1.5

1.4

251.38

263.64

ug/g

0.66

336

1176

Fissure and fistula of anal and rectal regions

588

2238

2.71

105.14

1.5

1.4

289.87

275.65

ug/g

0.74

324

1312

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1038

3065

2.18

104.76

1.5

1.4

269.61

300.23

ug/g

3.90

603

1618

Disorders of lacrimal system

1290

6671

1.95

104.73

1.5

1.4

291.48

273.33

ug/g

2.38

735

3874

Intestinal adhesions without obstruction

289

724

4.23

103.92

1.5

1.4

241.44

275.10

ug/g

1.67

188

446

Other nutritional deficiencies

1763

9287

1.77

103.79

1.4

283.82

277.26

ug/g

0.60

967

5316

Urinary track infection

1454

3801

1.95

103.63

1.4

1.3

291.15

295.40

ug/g

0.28

799

2061

Other diseases of stomach and duodenum

268

640

4.52

103.40

1.6

1.4

233.82

269.40

ug/g

1.81

155

379

Spinal stenosis

1339

5207

1.94

101.61

1.5

1.4

270.74

259.00

ug/g

1.25

826

3129

Nonorganic sleeping disorders, excluding more controls

548

2061

2.74

100.48

1.4

319.86

278.24

ug/g

1.95

309

1174

Chronic lower respiratory diseases

2943

9997

1.57

100.03

1.5

1.4

279.46

276.08

ug/g

0.34

1701

5704

Acute tubulo-interstitial nephritis

1640

7892

1.79

99.25

1.5

1.4

251.62

279.17

ug/g

5.90

974

4453

Bronchitis

2720

10428

1.59

98.97

1.4

281.47

274.44

ug/g

0.85

1514

6029

Other arrhythmias

1660

7055

1.79

98.76

1.5

1.4

289.44

276.54

ug/g

1.62

948

3995

Acute upper respiratory infections

2603

9890

1.60

98.10

1.4

285.91

272.36

ug/g

2.27

1444

5756

Sleep apnoea

2409

9482

1.63

97.97

1.5

1.4

288.16

268.51

ug/g

4.10

1340

5575

Migraine

1255

5131

1.94

97.17

1.4

317.56

282.28

ug/g

6.40

644

2877

Genitourinary diseases

1237

3126

2.02

96.96

1.5

1.4

277.70

269.57

ug/g

0.53

718

1821

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

502

1855

2.85

96.49

1.5

251.52

262.52

ug/g

0.46

290

1128

Sleep apnoea, including avohilmo

2509

9583

1.61

96.38

1.4

289.56

269.60

ug/g

4.28

1407

5611

Haemorrhage from respiratory passages

915

3854

2.15

96.10

1.5

1.4

270.98

255.63

ug/g

1.30

547

2305

Obesity related asthma

1007

5030

2.06

95.41

1.5

1.4

287.73

273.61

ug/g

1.22

570

2901

Extracorporeal dialysis

265

670

4.32

95.24

1.6

1.4

239.85

273.05

ug/g

1.67

176

421

Falls/tendency to fall

2532

7973

1.61

94.93

1.4

279.69

280.67

ug/g

0.06

1434

4524

Malignant neoplasm of small intestine, including Hilmo

170

300

6.44

94.57

1.5

209.58

301.26

ug/g

6.56

130

182

Finngen Rheumatological endpoints

2279

7991

1.64

94.38

1.4

290.83

272.48

ug/g

3.44

1321

4500

L04AD Calcineurin inhibitors

391

1278

3.25

94.14

1.5

1.4

265.65

287.87

ug/g

1.25

260

770

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1548

8880

1.78

93.76

1.5

1.4

258.33

274.14

ug/g

2.22

947

5123

Alcoholic liver disease

361

1128

3.40

93.72

1.6

1.5

246.86

261.41

ug/g

0.49

201

694

Sleep disorders

2270

9771

1.62

93.46

1.4

297.80

272.03

ug/g

4.81

1261

5649

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

286

492

4.23

93.42

1.5

1.3

278.74

258.91

ug/g

0.32

168

299

Benign neoplasm: Colon, unspecified

790

3638

2.25

93.36

1.5

268.26

263.25

ug/g

0.27

483

2193

Kidney transplant status

235

552

4.66

93.17

1.5

1.4

259.36

282.03

ug/g

0.82

153

330

Ulcerative colitis

673

2898

2.40

92.79

1.5

1.4

278.24

272.81

ug/g

0.27

414

1658

Dermatitis and eczema

2756

10617

1.56

92.50

1.4

280.18

273.60

ug/g

0.79

1556

6136

Crohn disease

405

1366

3.10

91.72

1.5

1.4

286.44

285.69

ug/g

0.02

221

771

Acute sinusitis

1323

6626

1.85

90.95

1.4

298.53

279.84

ug/g

2.26

735

3775

Malignant neoplasm, wide definition

2096

7468

1.66

90.74

1.5

1.4

243.51

293.54

ug/g

20.72

1278

4212

Codes for special purposes

1400

7823

1.81

90.71

1.5

1.4

276.85

273.48

ug/g

0.23

824

4463

Provisional assignment of new diseases of uncertain etiology

1397

7818

1.81

90.09

1.5

1.4

277.12

273.54

ug/g

0.25

821

4462

Malignant neoplasm, including Hilmo

2088

7458

1.65

89.73

1.5

1.4

243.82

293.73

ug/g

20.49

1273

4207

Volume depletion

339

1045

3.42

89.65

1.5

1.4

238.33

270.43

ug/g

1.89

213

620

Hypothyroidism, strict autoimmune

1699

6520

1.74

89.42

1.4

287.60

276.48

ug/g

1.18

956

3686

Secondary hypertension

272

716

3.95

88.99

1.6

1.4

256.47

283.01

ug/g

1.05

174

417

Mycoses, including avohilmo

2292

11106

1.59

88.98

1.5

1.4

276.23

275.95

ug/g

0.02

1337

6358

Polyneuropathies and other disorders of the peripheral nervous system

676

2979

2.36

88.92

1.6

1.4

243.77

267.37

ug/g

2.17

419

1816

Convulsions, not elsewhere classified

570

2288

2.53

88.69

1.5

1.4

247.19

279.10

ug/g

2.58

335

1299

KRA_PSY_EATING, excluding more controls

223

510

4.51

88.50

1.4

1.3

304.23

315.60

ug/g

0.25

103

241

Glomerular disorders in diseases classified elsewhere

394

1339

3.10

88.49

1.6

1.4

216.62

276.88

ug/g

7.21

274

811

Other retinal disorders

1725

7814

1.71

87.53

1.5

1.4

249.62

266.87

ug/g

2.97

1096

4567

Other and unspecified polyneuropathies, also in other diseases

603

2552

2.46

87.17

1.6

1.4

242.60

265.92

ug/g

2.05

374

1562

Candidiasis, including avohilmo

872

4281

2.10

86.71

1.5

1.4

283.25

277.04

ug/g

0.36

514

2434

Cholecystitis

384

1297

3.08

86.45

1.5

1.3

244.56

301.10

ug/g

2.24

241

766

Nonalcoholic fatty liver disease

373

1248

3.17

86.33

1.5

1.4

282.95

287.91

ug/g

0.15

214

728

Symptoms and signs involving the skin and subcutaneous tissue

1846

10713

1.65

86.05

1.4

292.26

272.02

ug/g

3.59

1051

6181

Disorders of adult personality and behaviour

734

3382

2.23

85.89

1.4

296.78

286.92

ug/g

0.34

396

1836

Abnormal findings on examination of blood, without diagnosis

1247

6229

1.85

85.61

1.5

1.4

260.80

262.66

ug/g

0.11

737

3730

Ischemic heart diseases

2102

7797

1.63

85.50

1.5

1.4

275.86

271.36

ug/g

0.40

1256

4531

Diseases of the musculoskeletal system and connective tissue

1122

2867

1.99

85.26

1.4

297.63

274.81

ug/g

2.33

609

1596

Acute upper respiratory infections of multiple and unspecified sites

1880

8399

1.66

84.94

1.4

284.70

274.50

ug/g

1.12

1040

4857

Other diseases of upper respiratory tract

2617

8902

1.55

84.22

1.4

284.52

267.50

ug/g

3.40

1495

5167

Other CVD (FINNGEN)

372

920

3.23

84.12

1.5

1.4

268.97

278.99

ug/g

0.39

238

540

Diabetic maculopathy, excluding more controls

342

1102

3.26

83.95

1.6

1.4

216.35

292.76

ug/g

9.64

236

646

Alcohol abuse, main dg, excluding more controls

403

1423

2.94

83.70

1.5

1.4

254.30

273.96

ug/g

0.86

225

815

Percutaneous Coronary Intervention

2011

7588

1.64

83.65

1.5

1.4

275.42

270.66

ug/g

0.42

1213

4411

Symptoms and signs involving the nervous and musculoskeletal systems

1520

8978

1.73

83.54

1.5

1.4

290.79

271.01

ug/g

3.03

930

5167

Solid cancers, including Hilmo

2035

7359

1.63

83.48

1.5

1.4

240.13

293.38

ug/g

22.55

1239

4150

Missing teeth due to accident, extraction or parodontitis

1661

8938

1.69

83.41

1.5

1.4

268.23

268.16

ug/g

0.00

959

5282

Malignant neoplasm

2023

7349

1.64

83.30

1.5

1.4

242.61

292.96

ug/g

20.15

1231

4155

Diseases of the eye and adnexa

1724

5085

1.72

83.20

1.5

1.4

281.06

280.78

ug/g

0.02

1000

2801

Generalized anxiety disorder

430

1577

2.81

82.68

1.4

1.3

288.03

296.76

ug/g

0.31

198

849

Other general symptoms and signs

197

434

4.80

82.68

1.4

305.43

305.31

ug/g

0.00

102

231

Personality disorders

701

3222

2.24

82.62

1.4

293.62

284.38

ug/g

0.30

376

1763

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

208

489

4.59

81.99

1.5

169.37

286.28

ug/g

11.48

129

313

Malignant neoplasm

2010

7331

1.63

81.43

1.5

1.4

243.54

293.09

ug/g

19.50

1223

4143

Special screening examination for infectious and parasitic diseases

505

1424

2.64

80.96

1.5

1.4

288.78

283.42

ug/g

0.18

254

783

Coronary revascularization (ANGIO or CABG)

2001

7593

1.63

80.95

1.5

1.4

275.22

270.73

ug/g

0.39

1211

4414

Emergency coronary revascularization (for ACS)

2154

8269

1.60

80.75

1.5

1.4

273.46

269.39

ug/g

0.37

1308

4820

Solid cancers

1981

7226

1.63

80.58

1.5

1.4

240.64

292.47

ug/g

20.84

1198

4081

Factors influencing health status and contact with health services

578

1138

2.59

80.52

1.4

275.95

284.80

ug/g

0.38

352

660

Ulcerative colitis, NAS

410

1496

2.85

80.36

1.6

1.4

279.28

284.18

ug/g

0.18

260

850

Hard cardiovascular diseases

2066

7696

1.61

79.93

1.5

1.4

276.03

273.67

ug/g

0.18

1219

4440

Diseases of arteries, arterioles and capillaries

1718

7680

1.67

79.65

1.5

1.4

243.42

266.90

ug/g

4.98

1099

4509

Pain and other conditions associated with female genital organs and menstrual cycle

514

1723

2.56

79.54

1.3

338.28

281.08

ug/g

6.35

250

889

Infections of the skin and subcutaneous tissue

1473

8593

1.72

79.50

1.5

1.4

260.12

277.86

ug/g

2.48

878

4925

Polyuria

652

2966

2.27

79.28

1.5

1.4

278.42

262.31

ug/g

1.08

374

1825

Asthma, including avohilmo

2809

10413

1.50

79.24

1.4

286.17

273.14

ug/g

2.32

1624

5947

Other external causes of accidental injury

1838

5591

1.67

79.23

1.4

274.84

280.08

ug/g

0.43

1050

3187

Persistent mood disorders

542

2279

2.46

79.09

1.5

1.4

279.59

272.29

ug/g

0.18

299

1303

Insomnia

2176

9757

1.57

78.84

1.4

298.33

272.65

ug/g

4.55

1201

5616

Pain in thoracic spine

441

1686

2.71

78.72

1.5

1.4

286.82

270.26

ug/g

0.83

243

966

L04AA Selective immunosuppressants

652

2976

2.27

78.69

1.5

1.4

277.30

275.11

ug/g

0.10

407

1712

Glomerular diseases

540

2281

2.46

78.36

1.6

1.4

226.70

271.76

ug/g

5.88

373

1362

Obesity and other hyperalimentation

1589

9058

1.68

78.17

1.4

282.25

278.09

ug/g

0.32

881

5163

Obesity

1581

9021

1.68

77.95

1.4

282.84

278.04

ug/g

0.38

875

5142

Obesity due to excess calories

1214

6873

1.80

77.80

1.4

282.04

281.14

ug/g

0.05

659

3866

Cervical disc disorders

907

4687

1.98

77.76

1.5

1.4

280.15

262.62

ug/g

1.61

515

2761

Any event in cancer register

2123

7929

1.58

76.85

1.5

1.4

248.66

293.53

ug/g

16.02

1266

4432

Alcohol dependence

708

3367

2.16

76.68

1.5

1.4

247.11

269.07

ug/g

1.52

371

2010

Covid-19 confirmed case

1000

5362

1.91

76.44

1.5

1.4

269.47

267.75

ug/g

0.09

595

3129

Other arthrosis

1302

4962

1.79

76.25

1.5

1.4

287.43

262.60

ug/g

2.58

775

2885

Poisoning by drugs, medicaments and biological substances

625

2839

2.27

75.97

1.5

1.4

284.57

284.44

ug/g

0.00

363

1552

Dermatitis

1586

9496

1.66

75.64

1.5

1.4

279.73

272.51

ug/g

0.65

903

5514

Erysipelas, including avohilmo

1769

8153

1.63

75.49

1.5

1.4

250.23

281.62

ug/g

8.02

1060

4730

5-aminosalicylic acid

563

2455

2.36

75.46

1.5

1.4

287.95

274.90

ug/g

0.72

331

1394

Vascular disorders of the intestines

214

546

4.13

75.05

1.6

1.3

233.52

270.86

ug/g

1.74

142

341

Chronic apical periodontitis

2634

9934

1.50

75.03

1.4

274.65

275.88

ug/g

0.10

1489

5731

Disease of hard tissues of teeth, NOS

1252

3645

1.83

74.53

1.5

1.4

274.86

265.55

ug/g

0.77

733

2182

Substance use, excluding alcohol

532

2279

2.41

74.39

1.5

1.4

261.74

279.58

ug/g

1.02

295

1288

Viral and other specified intestinal infections

501

2031

2.47

74.27

1.6

1.4

283.67

294.07

ug/g

0.50

306

1064

Major coronary heart disease event

2094

8068

1.58

74.21

1.5

1.4

274.94

270.23

ug/g

0.43

1271

4699

Accidents

1813

5591

1.65

74.15

1.4

273.89

280.08

ug/g

0.53

1029

3187

Asthma, hospital admissions , main diagnosis only

1978

11101

1.57

74.04

1.5

1.4

281.82

276.28

ug/g

0.54

1143

6347

Heart failure and antihypertensive medication

618

1765

2.34

73.75

1.5

1.4

245.27

271.21

ug/g

2.23

397

1046

Osteoporosis

805

3733

2.04

73.41

1.5

1.4

257.70

267.97

ug/g

0.78

490

2223

Malignant neoplasm of small intestine

130

227

6.54

73.31

1.5

1.4

208.31

303.74

ug/g

5.78

104

134

Cervicalgia

565

2500

2.33

73.25

1.5

1.4

293.14

268.83

ug/g

2.01

330

1457

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2320

9714

1.53

72.89

1.5

1.4

267.95

273.96

ug/g

0.54

1363

5627

Hypoglycaemia, other or unspecified

250

728

3.65

72.74

1.7

1.4

202.48

288.61

ug/g

7.25

157

425

Asthma-related pneumonia

975

5256

1.89

72.74

1.5

1.4

268.84

269.31

ug/g

0.02

593

3080

Asthma-related pneumonia or sepsis

976

5272

1.89

72.34

1.5

1.4

268.45

269.35

ug/g

0.04

594

3091

Asthma, hospital admissions 3, pneumonia

976

5272

1.89

72.34

1.5

1.4

268.45

269.35

ug/g

0.04

594

3091

STROKE

1321

5162

1.75

72.18

1.5

1.4

269.65

278.20

ug/g

0.53

785

2946

Implicit fungal Sepsis, including avohilmo

270

832

3.46

71.95

1.7

1.4

253.65

281.85

ug/g

1.38

160

484

Cerebrovascular diseases (FINNGEN)

716

2388

2.15

71.65

1.5

1.4

267.23

289.52

ug/g

1.82

411

1315

Specific personality disorders

598

2734

2.25

71.53

1.4

306.19

287.23

ug/g

0.64

319

1490

Disorders of mineral metabolism

303

1004

3.19

71.34

1.5

1.4

247.37

280.85

ug/g

1.68

184

576

Chronic sinusitis

1052

5849

1.83

71.31

1.4

304.11

269.48

ug/g

5.71

610

3368

Inflammatory diseases of female pelvic organs

1533

6368

1.68

71.28

1.4

302.40

287.38

ug/g

1.76

818

3525

Disorders of choroid and retina

2020

9178

1.56

71.28

1.5

1.4

252.41

271.26

ug/g

3.88

1260

5363

Any death

1661

7219

1.64

71.06

1.4

213.41

275.92

ug/g

28.60

1026

4310

Hyperkinetic disorders, excluding more controls

264

738

3.42

70.95

1.3

314.47

334.19

ug/g

0.63

130

361

Arthropathies

1954

6265

1.59

70.73

1.4

287.54

273.46

ug/g

1.85

1100

3513

Vitamin B12 deficiency anaemia

345

1238

2.92

70.17

1.6

1.4

244.54

273.18

ug/g

1.80

230

740

Temporomandibular joint disorders, including avohilmo

1093

5982

1.80

70.04

1.4

301.99

287.01

ug/g

1.40

569

3295

IBD patients in KELA-register

571

2588

2.27

69.77

1.6

1.4

286.15

275.23

ug/g

0.57

324

1465

Diseases of the respiratory system

1425

4196

1.73

69.48

1.4

281.31

271.91

ug/g

0.79

817

2395

Persons encountering health services for specific procedures, not carried out

277

883

3.29

69.35

1.4

254.89

294.36

ug/g

2.08

173

487

Crohn's disease of small intestine

232

666

3.69

68.85

1.5

1.4

290.89

294.16

ug/g

0.07

116

375

Other diseases of hard tissues of teeth

1263

3738

1.78

68.55

1.5

1.4

271.90

265.22

ug/g

0.49

769

2238

Ventral hernia

667

3243

2.12

68.35

1.6

1.4

250.62

264.84

ug/g

0.94

397

1922

Injuries to the shoulder and upper arm

2081

10623

1.53

68.20

1.5

1.4

276.37

272.45

ug/g

0.29

1259

6119

Intracranial injury

1430

8143

1.66

68.17

1.4

275.44

271.15

ug/g

0.31

808

4693

Carpal tunnel syndrome

1514

8114

1.64

68.13

1.5

1.4

276.48

273.32

ug/g

0.18

881

4706

Bipolar affective disorders

462

1936

2.46

67.80

1.5

1.4

291.00

285.23

ug/g

0.21

251

1056

Diseases of pulp and periapical tissues, including avohilmo

2387

8281

1.51

67.74

1.5

1.4

273.39

275.51

ug/g

0.17

1364

4760

Menorrhagia

783

2154

2.07

67.57

1.4

304.43

272.46

ug/g

3.50

410

1202

Panic disorder

372

1416

2.71

66.86

1.5

1.3

296.15

297.81

ug/g

0.04

182

756

Other systemic involvement of connective tissue (FG)

703

3442

2.06

66.78

1.4

300.94

266.22

ug/g

4.06

402

1954

Elevated blood glucose level

292

986

3.13

66.55

1.7

1.4

226.69

281.07

ug/g

3.58

165

591

Gout

704

2994

2.07

66.33

1.5

1.4

259.06

247.54

ug/g

0.76

459

1817

Deforming dorsopathies

700

3506

2.04

65.70

1.5

1.4

293.72

269.15

ug/g

2.38

405

2014

Early onset COPD, excluding more controls

515

2300

2.30

65.15

1.5

1.4

269.44

262.33

ug/g

0.31

309

1371

Type 1 diabetes, definitions combined

258

816

3.28

64.81

1.7

1.3

230.87

326.48

ug/g

10.73

175

418

Visual disturbances and blindness

1333

8144

1.66

64.37

1.5

1.4

287.59

270.54

ug/g

1.47

757

4703

Injuries to the thorax

1169

6909

1.72

64.20

1.5

1.4

253.29

265.76

ug/g

1.21

688

4065

Systemic connective tissue disorders

939

5235

1.84

63.82

1.4

300.88

270.52

ug/g

4.34

530

3044

Poisoning by medicine

549

2544

2.22

63.62

1.5

1.4

286.75

284.84

ug/g

0.04

317

1382

Neuroendocrine tumor and carcinoma of small intestine

126

8.39

62.97

1.5

1.3

212.89

301.16

ug/g

3.49

Disorders of lens

1617

6336

1.61

62.85

1.5

1.4

258.27

269.83

ug/g

1.00

995

3750

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

645

3093

2.08

62.72

1.4

207.59

281.39

ug/g

16.48

433

1847

Hypothyroidism, other/unspecified

2054

9017

1.52

62.68

1.4

286.94

272.55

ug/g

2.13

1145

5162

External causes of morbidity and mortality

1399

4217

1.68

62.63

1.4

277.63

282.98

ug/g

0.37

794

2374

Atrial fibrillation and flutter

699

2224

2.07

62.61

1.5

1.4

286.29

284.40

ug/g

0.08

434

1244

Migraine with aura

585

2790

2.14

62.60

1.4

323.92

284.78

ug/g

3.90

296

1539

Presence of other functional implants

1497

6402

1.63

62.29

1.6

1.4

262.59

267.70

ug/g

0.40

921

3774

Disorders of the thyroid gland

2175

9539

1.50

62.25

1.4

284.21

270.79

ug/g

2.04

1232

5461

Type 1 diabetes, strict (exclude DM2)

256

826

3.21

62.23

1.7

1.4

230.87

320.25

ug/g

9.51

175

424

Chronic rhinitis, nasopharyngitis and pharyngitis

811

4349

1.91

62.22

1.4

307.76

273.02

ug/g

4.52

474

2485

ILD medications: azathioprine

396

1623

2.52

61.30

1.5

1.4

277.33

281.55

ug/g

0.15

230

938

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

1228

7168

1.68

61.19

1.4

294.42

268.21

ug/g

4.19

740

4177

Other diseases of lip and oral mucosa

1095

6456

1.73

61.07

1.5

1.4

275.77

276.25

ug/g

0.02

620

3703

Excessive, frequent and irregular menstruation

830

2307

1.96

60.92

1.4

1.3

298.78

276.24

ug/g

2.00

434

1260

Coxibs

599

1441

2.22

60.85

1.5

1.4

287.01

259.92

ug/g

1.88

343

862

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

2134

11315

1.49

60.79

1.5

1.4

278.41

275.60

ug/g

0.24

1237

6474

Ulcer of lower limb, not elsewhere classified

432

1854

2.42

60.64

1.6

1.4

236.89

262.56

ug/g

1.90

276

1130

Ovarian cyst

766

2236

2.00

60.63

1.4

1.3

295.56

274.85

ug/g

1.65

416

1230

Other and unspecified dermatitis

1305

8060

1.65

60.53

1.5

1.4

283.15

274.00

ug/g

0.77

742

4668

373

1496

2.58

60.42

1.4

280.01

287.66

ug/g

0.27

219

822

Coeliac disease

355

1397

2.65

60.15

1.5

1.3

262.38

296.24

ug/g

2.21

229

771

Hypothyreosis and Thyroxine purchase for inclusion criteria

2126

9451

1.49

59.90

1.4

287.32

273.17

ug/g

2.16

1194

5428

Other symptoms and signs involving cognitive functions and awareness

1182

6301

1.69

59.86

1.5

1.4

269.89

261.30

ug/g

0.71

675

3719

Visual disturbances

1234

7544

1.67

59.81

1.5

1.4

289.00

271.78

ug/g

1.39

706

4378

Diseases of peritoneum

322

1214

2.78

59.72

1.6

1.4

239.90

276.26

ug/g

2.51

215

706

Other diseases of oesophagus

271

934

3.03

59.24

1.5

1.4

261.04

265.16

ug/g

0.12

164

547

Azathioprine

396

1649

2.48

59.23

1.5

1.4

277.33

280.91

ug/g

0.12

230

956

Endometriosis

746

2215

2.00

59.22

1.4

1.3

313.08

274.23

ug/g

4.77

394

1223

Asthma/COPD (KELA code 203)

2184

9991

1.48

59.02

1.5

1.4

274.51

276.10

ug/g

0.12

1282

5700

Diseases of oral cavity, salivary glands and jaws

1234

3766

1.71

58.98

1.4

270.93

264.95

ug/g

0.42

738

2253

Disorders of synovium and tendon

1197

6131

1.68

58.94

1.4

293.29

268.62

ug/g

2.27

705

3541

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

426

1839

2.39

58.71

1.5

1.4

270.86

289.25

ug/g

0.87

235

1002

Hyperkalaemia

205

605

3.59

58.46

1.7

1.5

201.37

265.08

ug/g

4.07

141

365

Arthrosis

1569

5452

1.60

58.28

1.4

291.39

264.80

ug/g

4.96

920

3143

Emotionally unstable personality disorder

317

1196

2.74

58.21

1.4

302.00

309.76

ug/g

0.22

159

599

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

681

3527

1.97

58.12

1.4

278.20

286.48

ug/g

0.42

380

1912

Polyarthrosis

571

2490

2.13

58.07

1.5

1.4

267.47

258.31

ug/g

0.51

322

1484

Hernia of abdominal wall

1140

6893

1.69

57.78

1.5

1.4

272.88

265.53

ug/g

0.38

675

4047

Glucagon-like peptide-1 (GLP-1) analogues

782

4252

1.88

57.69

1.4

279.37

280.43

ug/g

0.05

454

2449

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

782

4252

1.88

57.69

1.4

279.37

280.43

ug/g

0.05

454

2449

Other cataract

1103

4854

1.72

57.52

1.5

1.4

250.22

267.38

ug/g

1.96

668

2893

Cutaneous abscess, furuncle and carbuncle

667

3452

1.98

57.23

1.5

1.4

263.02

276.28

ug/g

0.90

408

1954

Exposure to other specified factors

1886

10926

1.50

57.22

1.4

278.22

277.26

ug/g

0.06

1070

6268

Problems related to lifestyle

284

1023

2.88

57.09

1.6

1.4

255.87

280.08

ug/g

0.88

143

575

Polycystic ovarian syndrome, consortium definition

1659

6167

1.56

56.86

1.4

297.33

288.64

ug/g

0.83

897

3403

Mycoses

735

3940

1.91

56.78

1.5

1.4

271.78

273.07

ug/g

0.06

458

2286

All influenza

659

3408

1.98

56.58

1.5

1.4

282.51

274.56

ug/g

0.38

372

2005

Undetermined asthma, excluding more controls

349

1398

2.57

56.58

1.5

1.4

302.10

276.44

ug/g

1.31

212

818

Migraine without aura

458

2067

2.27

56.47

1.4

1.3

326.22

296.35

ug/g

2.10

240

1098

Disturbances of skin sensation

700

3699

1.94

56.42

1.4

318.41

276.17

ug/g

5.52

376

2073

Undetermined asthma

349

1412

2.55

55.41

1.5

1.4

302.10

276.59

ug/g

1.30

212

837

Caries of dentine, including avohilmo

1726

5772

1.55

55.12

1.4

273.80

271.02

ug/g

0.20

1023

3373

Other enthesopathies

706

3770

1.91

54.91

1.4

286.76

270.68

ug/g

1.18

394

2167

Cervicobrachial syndrome

542

2648

2.10

54.72

1.5

1.4

292.03

273.36

ug/g

1.20

322

1512

Primary Sclerosing Cholangitis, IBD and UDCA required

158

6.53

54.63

1.5

1.3

252.32

320.08

ug/g

2.09

Other dialysis

136

318

4.71

54.58

1.7

1.4

248.54

279.57

ug/g

0.90

194

Suicide or other Intentional self-harm

592

2991

2.03

54.48

1.4

271.69

277.18

ug/g

0.23

335

1656

Erysipelas

1311

7131

1.61

54.37

1.5

1.4

243.37

275.18

ug/g

6.56

797

4172

Benign neoplasm: Caecum

351

1449

2.54

54.18

1.5

258.75

267.22

ug/g

0.34

216

877

Benign neoplasm: Rectum, anus and anal canal

563

2813

2.07

53.87

1.5

275.13

263.23

ug/g

0.64

338

1716

Nonorganic sleeping disorders

548

2706

2.08

53.82

1.4

319.86

284.80

ug/g

1.51

309

1497

Malignant neoplasm of stomach, including Hilmo

193

578

3.52

53.70

1.6

1.5

236.34

289.49

ug/g

3.55

148

366

Other acute lower respiratory infections

1267

7601

1.61

53.70

1.5

1.4

279.03

272.31

ug/g

0.52

712

4381

Oter anti-inflammatory and antirheumatic agents, non-steroids

494

1220

2.27

53.56

1.5

270.20

249.79

ug/g

1.24

303

743

Other symptoms and signs involving the nervous and musculoskeletal systems

1031

6193

1.70

53.56

1.5

1.4

302.25

274.71

ug/g

3.52

609

3535

Soft tissue disorders related to use, overuse and pressure

685

3658

1.92

53.46

1.4

294.16

263.36

ug/g

3.61

408

2165

Symptoms and signs involving speech and voice

865

4963

1.78

53.41

1.5

1.4

277.47

272.62

ug/g

0.27

509

2888

Diseases of the ear and mastoid process

2534

9015

1.42

53.27

1.4

286.61

273.60

ug/g

2.06

1430

5164

Hyperlipidaemia, other/unspecified

936

4913

1.75

53.11

1.5

1.4

268.44

266.44

ug/g

0.10

564

2899

Other sleep disorders

311

1220

2.64

52.96

1.5

1.4

304.57

268.74

ug/g

2.20

197

736

Fracture of rib(s), sternum and thoracic spine

790

4430

1.82

52.74

1.5

1.4

247.78

265.84

ug/g

1.63

466

2654

Paroxysmal tachycardia

503

1984

2.15

52.73

1.4

290.21

288.43

ug/g

0.06

285

1058

Malignant neoplasm of stomach

174

494

3.72

52.62

1.7

1.5

233.06

287.02

ug/g

3.22

136

310

Acute bronchitis

1004

5895

1.70

52.59

1.5

1.4

276.08

269.90

ug/g

0.39

552

3412

Inflammatory bowel disease, strict (require KELA)

571

2887

2.03

52.49

1.6

1.4

286.15

276.84

ug/g

0.47

324

1638

Abnormal findings on diagnostic imaging of other body structures

431

1970

2.27

52.23

1.6

1.4

257.18

276.04

ug/g

1.05

270

1177

Disorders of calcium metabolism

226

759

3.15

52.20

1.5

1.4

247.20

278.34

ug/g

1.25

137

440

Dialysis

154

407

4.08

52.13

1.5

1.4

243.40

275.24

ug/g

1.10

104

248

Candidiasis

408

1824

2.32

52.07

1.6

1.4

277.65

280.42

ug/g

0.09

254

1025

Obesity, other/unspecified

802

4533

1.80

51.94

1.4

280.27

284.82

ug/g

0.24

447

2534

Disorders of vitreous body

1288

7827

1.59

51.76

1.5

1.4

283.49

266.32

ug/g

1.59

796

4619

Postprocedural disorders of digestive system, not elsewhere classified

141

352

4.36

51.75

1.6

1.4

246.10

297.05

ug/g

1.85

199

Ischaemic heart disease, wide definition

1839

7679

1.49

51.70

1.5

1.4

263.24

267.76

ug/g

0.39

1116

4515

Arthropathies in other diseases classified elsewhere

140

348

4.34

51.51

1.7

1.4

217.70

263.83

ug/g

1.82

208

Disorder of pancreatic internal secretion, other and/or unspecified

10.52

51.48

2.2

1.4

141.64

295.13

ug/g

6.13

Acute gastritis

218

721

3.17

51.43

1.6

1.4

270.08

274.35

ug/g

0.11

130

429

Meniscus derangement

1232

5099

1.63

51.24

1.4

286.88

262.77

ug/g

2.27

715

2950

Gonarthrosis

1411

5095

1.58

51.19

1.5

1.4

281.38

262.95

ug/g

1.76

845

2951

Charcot foot

166

6.31

51.19

1.9

1.4

191.50

279.02

ug/g

3.78

Abnormal findings on diagnostic imaging of lung

1193

7109

1.62

51.10

1.5

1.4

269.19

262.42

ug/g

0.36

701

4218

Subjective visual disturbances

670

3609

1.90

51.09

1.5

1.4

300.85

270.99

ug/g

1.57

384

2103

Dental caries, including avohilmo

1597

5349

1.55

51.09

1.4

275.94

269.37

ug/g

0.56

965

3120

Phobic anxiety disorders

301

1176

2.62

51.09

1.5

1.3

289.05

299.87

ug/g

0.34

163

619

Other systemic involvement of connective tissue

724

3997

1.86

51.03

1.4

299.89

270.05

ug/g

3.33

418

2326

Viral hepatitis, IBD co-morbidity

124

281

4.57

50.67

1.4

1.3

255.99

276.67

ug/g

0.48

176

Dental operations

1304

4196

1.62

50.59

1.4

271.89

265.41

ug/g

0.49

793

2504

Superficial injury of head

614

3219

1.95

50.55

1.4

283.70

267.77

ug/g

1.03

368

1886

Urticaria and erythema

876

5120

1.74

50.42

1.4

308.68

279.97

ug/g

3.49

460

2913

Other disorders of ear

2131

9668

1.44

50.29

1.5

1.4

276.32

272.22

ug/g

0.36

1236

5594

Hypothyroidism, strict autoimmune, 3 medication purchases required

1896

8768

1.47

50.12

1.4

287.24

274.61

ug/g

1.65

1066

5024

Disorders of vitreous body and globe

1309

7995

1.58

50.07

1.5

1.4

283.79

266.53

ug/g

1.63

807

4724

Preparatory care for dialysis

168

485

3.74

50.05

1.5

1.4

224.22

270.85

ug/g

2.25

120

290

Dentofacial anomalies [including malocclusion]

1600

8377

1.51

50.02

1.4

305.79

282.07

ug/g

4.08

839

4756

Benign neoplasm: Ascending colon

416

1913

2.26

49.79

1.5

263.25

265.13

ug/g

0.06

246

1171

Acute alcohol intoxication, ICD10

502

2472

2.09

49.78

1.5

1.4

253.89

275.86

ug/g

1.25

278

1423

Alcohol abuse, main dg

403

1827

2.27

49.61

1.5

1.4

254.30

275.20

ug/g

0.97

225

1069

Injuries to the abdomen, lower back, lumbar spine and pelvis

997

5966

1.68

49.59

1.5

1.4

262.70

271.60

ug/g

0.64

577

3451

Lactose intolerance

124

291

4.60

49.21

1.4

288.81

304.21

ug/g

0.30

171

Colectomy operation

467

2254

2.14

49.20

1.5

1.4

242.11

267.02

ug/g

1.65

297

1379

Injury, poisoning and certain other consequences of external causes

1104

3340

1.68

48.97

1.4

279.09

285.07

ug/g

0.37

618

1873

Eating disorder

223

766

3.01

48.78

1.4

1.3

304.23

322.50

ug/g

0.48

103

350

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

137

350

4.19

48.49

1.9

1.4

211.43

317.38

ug/g

8.60

103

191

Benign neoplasm: Sigmoid colon

526

2665

2.04

48.48

1.5

262.77

267.01

ug/g

0.19

324

1622

Voice disturbances

693

3836

1.85

48.48

1.5

1.4

281.28

271.93

ug/g

0.55

407

2202

Venous thromboembolism

1295

8101

1.56

48.27

1.5

1.4

255.06

266.84

ug/g

1.20

780

4745

Other and unspecified effects of external causes

655

3565

1.88

48.16

1.5

1.4

287.37

279.67

ug/g

0.38

357

1994

Acute alcohol intoxication

595

3144

1.93

48.00

1.6

1.4

252.27

271.79

ug/g

1.20

336

1848

Urticaria

721

4046

1.82

47.94

1.4

315.41

284.39

ug/g

3.30

376

2281

Acetic acid derivatives and related substances

560

1421

2.07

47.90

1.5

1.4

274.98

259.12

ug/g

0.84

324

853

Disorders resulting from impaired renal tubular function

147

400

3.98

47.87

1.7

1.4

245.48

277.79

ug/g

0.97

241

Retention of urine

803

3724

1.78

47.78

1.5

1.4

257.98

257.86

ug/g

0.00

471

2275

COPD (mode)

713

3075

1.84

47.64

1.5

1.4

263.48

261.71

ug/g

0.08

433

1838

Benign neoplasm: Rectum

500

2505

2.06

47.62

1.5

271.16

262.30

ug/g

0.40

305

1536

Diabetic neuropathy

400

1847

2.27

47.29

1.8

1.5

207.53

241.94

ug/g

2.80

268

1113

Sequelae of external causes of morbidity and mortality

659

3623

1.86

47.13

1.5

1.4

262.22

270.80

ug/g

0.47

406

2148

Gout, idiopatic and unspecified

631

3426

1.89

47.03

1.5

261.43

256.45

ug/g

0.24

412

2087

Eating disorders

257

971

2.73

46.98

1.4

289.98

311.71

ug/g

0.71

124

474

Atrial fibrillation and flutter with reimbursement

566

1810

2.01

46.85

1.5

1.4

286.59

278.61

ug/g

0.39

359

1037

Portal vein thrombosis

170

6.01

46.81

1.5

194.48

292.62

ug/g

4.33

107

Disorders of conjunctiva

1906

10358

1.44

46.62

1.4

283.38

278.48

ug/g

0.45

1097

5876

Other protozoal intestinal diseases, including avohilmo

203

5.34

46.50

1.5

1.4

292.10

289.04

ug/g

0.05

111

Immunodeficiencies

174

538

3.46

46.44

1.5

1.4

318.36

294.07

ug/g

0.72

101

310

Pruritus

332

1429

2.41

46.39

1.5

1.4

275.06

279.71

ug/g

0.14

189

814

Senile cataract

1435

5754

1.54

46.19

1.5

1.4

261.84

267.75

ug/g

0.36

874

3453

Peripheral artery disease

1032

5051

1.64

45.82

1.5

1.4

229.94

262.72

ug/g

6.22

674

3057

Oxicams

487

1325

2.13

45.66

1.4

275.38

253.66

ug/g

1.34

277

799

Exclusions for E4_PCOS_CONSORTIUM

1606

6789

1.49

45.58

1.4

290.14

286.41

ug/g

0.27

885

3802

Post-traumatic stress disorder

201

678

3.06

45.53

1.5

1.3

301.30

312.45

ug/g

0.24

340

Gout, FINNGEN

704

3962

1.80

45.40

1.5

259.06

255.95

ug/g

0.15

459

2433

Benign neoplasm: Small intestine

156

459

3.67

45.25

1.6

1.5

246.98

274.91

ug/g

0.84

109

286

Coronary atherosclerosis

1506

6372

1.51

45.07

1.5

1.4

258.23

263.87

ug/g

0.46

919

3742

Benign neoplasm: Duodenum

119

293

4.50

44.84

1.7

1.5

225.50

274.46

ug/g

1.58

185

Unspecified haematuria

983

4932

1.65

44.81

1.5

1.4

265.69

262.18

ug/g

0.14

567

2988

Gingivitis and periodontal diseases

2197

8113

1.41

44.81

1.5

1.4

276.51

271.92

ug/g

0.35

1280

4712

Any operation in hilmo

13.03

44.43

1.4

1.3

292.37

364.65

ug/g

0.78

Exclusions for E4_PCOS_BROAD

444

2182

2.09

44.31

1.5

1.4

263.35

283.19

ug/g

1.23

258

1241

Other endocrine disorders

172

517

3.37

44.13

1.4

287.15

304.38

ug/g

0.46

112

286

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

591

3160

1.88

44.13

1.5

1.4

278.88

303.33

ug/g

2.00

332

1671

Other eating disorders

137

372

3.84

44.04

1.4

293.78

315.79

ug/g

0.49

182

Coxarthrosis

1128

4608

1.60

44.00

1.4

271.47

259.24

ug/g

1.09

673

2703

Adhesive capsulitis of shoulder

418

2020

2.13

43.75

1.5

1.4

266.53

265.14

ug/g

0.04

256

1220

Enthesopathies of lower limb, excluding foot

524

2739

1.95

43.73

1.5

1.4

281.73

272.49

ug/g

0.47

288

1569

Gout, unspecified

526

2765

1.95

43.46

1.5

261.12

258.75

ug/g

0.09

347

1687

Other disorders of kidney and ureter

364

1676

2.25

43.43

1.6

1.4

247.17

268.85

ug/g

1.16

224

1009

Other CVD

516

2698

1.96

43.22

1.5

1.4

260.64

260.61

ug/g

0.00

323

1666

Dental pulpitis, including avohilmo

2014

9212

1.41

43.14

1.5

1.4

288.92

276.83

ug/g

1.54

1137

5242

Volvulus

200

5.08

43.00

1.6

1.3

270.63

287.13

ug/g

0.26

129

Fungal Sepsis

150

443

3.61

43.00

1.7

1.4

234.47

283.57

ug/g

2.29

269

Trochanteric bursitis

385

1818

2.18

42.89

1.4

298.49

270.24

ug/g

2.10

234

1087

Carcinoid syndrome

7.96

42.84

1.5

1.4

220.09

294.91

ug/g

1.82

Other abnormal uterine and vaginal bleeding

520

1921

1.99

42.83

1.5

1.4

288.58

272.54

ug/g

0.92

290

1089

Hypotension

459

2314

2.04

42.82

1.5

1.4

262.49

260.54

ug/g

0.07

291

1435

Open wound of head

1236

7657

1.54

42.72

1.5

1.4

263.21

266.32

ug/g

0.19

719

4500

Heart failure,strict

1242

5671

1.55

42.71

1.4

255.36

265.05

ug/g

0.66

803

3340

Cervicocranial syndrome

280

1160

2.49

42.56

1.4

333.48

273.61

ug/g

1.59

171

680

Diseases of pulp and periapical tissues and dental caries

1389

4713

1.53

42.33

1.4

273.09

268.29

ug/g

0.34

836

2758

Internal derangement of knee

813

4833

1.69

42.22

1.5

1.4

280.13

265.64

ug/g

1.10

449

2780

Immunodeficiency with predominantly antibody defects

114

284

4.39

42.14

1.6

1.4

327.64

290.03

ug/g

0.99

170

Psychotic depression

152

456

3.46

42.03

1.5

1.4

275.45

267.92

ug/g

0.17

267

Pain associated with micturition

335

1518

2.28

41.53

1.4

306.53

280.04

ug/g

1.30

167

892

Other neurological diseases

1666

9042

1.45

41.48

1.5

1.4

274.87

267.79

ug/g

0.53

979

5280

Second line medication for Crohn's disease

1319

8885

1.50

41.44

1.5

1.4

285.17

276.66

ug/g

0.77

759

5107

Chronic laryngitis and laryngotracheitis

374

1771

2.18

41.44

1.6

1.4

296.89

263.17

ug/g

2.36

208

1037

Benign neoplasm: Stomach

295

1272

2.42

41.41

1.5

1.4

262.56

272.67

ug/g

0.37

170

756

Mixed and other personality disorders

219

818

2.79

41.39

1.5

1.4

270.80

301.44

ug/g

1.08

113

424

Implicit fungal Sepsis

139

402

3.69

41.19

1.7

1.4

239.89

280.56

ug/g

1.59

246

Other extrapyramidal and movement disorders in other diseases

636

3607

1.81

41.14

1.5

1.4

289.03

267.24

ug/g

1.93

386

2132

Disorders of oesophagus in diseases classified elsewhere

198

5.10

40.92

1.5

1.3

235.57

289.44

ug/g

1.41

114

Periodontitis

2237

10454

1.38

40.91

1.5

1.4

264.85

275.45

ug/g

1.17

1305

6055

Acute peritonitis

198

708

2.94

40.89

1.6

1.4

224.89

275.56

ug/g

3.04

138

420

Spondylolisthesis/Spondylolysis

444

2248

2.03

40.87

1.5

1.4

286.57

268.14

ug/g

1.11

255

1328

Disorders of skin appendages

1105

7162

1.56

40.84

1.5

1.4

284.18

280.62

ug/g

0.21

627

4014

Migraine without aura and triptan purchases

370

1750

2.16

40.84

1.4

329.16

302.80

ug/g

1.42

190

920

Enlarged lymph nodes

351

1631

2.20

40.54

1.5

1.4

310.60

272.96

ug/g

2.54

205

941

Assault

316

1409

2.30

40.51

1.4

282.57

284.00

ug/g

0.03

165

773

Fibroblastic disorders

532

2869

1.89

40.41

1.5

1.4

278.19

255.55

ug/g

1.62

313

1707

Osteomyelitis

199

718

2.91

40.40

1.5

1.4

236.33

266.22

ug/g

1.35

131

443

Injuries to the knee and lower leg

2612

10574

1.35

40.31

1.4

269.04

278.00

ug/g

1.26

1534

6033

Unspecified fall

1197

7809

1.53

40.27

1.5

1.4

272.08

270.70

ug/g

0.06

718

4493

Other protozoal intestinal diseases

123

6.43

40.26

1.6

1.3

288.31

304.66

ug/g

0.27

Other shoulder lesions

251

1017

2.55

40.09

1.4

285.83

270.00

ug/g

0.52

141

602

Benign neoplasm: Endocrine pancreas

9.92

40.08

1.8

1.4

217.70

298.21

ug/g

1.44

Chronic periodontitis, including avohilmo

2229

10458

1.37

40.06

1.5

1.4

264.88

275.36

ug/g

1.14

1299

6060

Hypocalcemia

106

261

4.47

39.90

1.4

242.74

294.67

ug/g

1.53

157

Gonarthrosis [arthrosis of knee](FG)

1656

6644

1.45

39.89

1.5

1.4

275.93

265.46

ug/g

0.90

1001

3858

Conjunctivitis (acute, non atopic), including avohilmo

2225

9867

1.37

39.86

1.4

290.56

270.99

ug/g

3.97

1277

5685

Diabetic retinopathy, excluding more controls

782

2583

1.74

39.69

1.6

1.4

219.69

255.91

ug/g

4.82

519

1513

Duodenal ulcer

256

1053

2.51

39.50

1.6

1.4

233.71

261.72

ug/g

1.16

159

638

Disorders of parathyroid gland

539

2915

1.87

39.25

1.5

1.4

258.05

272.60

ug/g

0.92

313

1745

Conjunctivitis

1681

9591

1.43

39.16

1.4

285.61

280.93

ug/g

0.40

966

5403

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

430

2190

2.01

38.87

1.4

303.73

293.30

ug/g

0.38

218

1151

Other specified/unspecified arthritis

604

3425

1.80

38.86

1.5

1.4

281.58

264.63

ug/g

1.06

337

1969

Other inflammatory liver diseases

202

751

2.82

38.76

1.6

1.4

227.69

285.01

ug/g

3.06

134

448

Artrosis, including avohilmo

1750

6774

1.43

38.61

1.4

290.25

268.62

ug/g

3.74

999

3896

Non-allergic asthma (mode), excluding more controls

415

2070

2.03

38.60

1.5

1.4

269.96

272.12

ug/g

0.08

251

1183

Gout, strict definition

462

2430

1.95

38.22

1.5

257.23

257.18

ug/g

0.00

310

1492

Mental and behavioural disorders due to sedatives or hypnotics

194

711

2.85

38.14

1.5

1.4

263.97

289.19

ug/g

0.74

104

388

Abscess of anal and rectal regions

184

657

2.89

37.70

1.5

1.4

274.35

288.37

ug/g

0.36

115

392

Adverse effects, not elsewhere classified

471

2501

1.93

37.69

1.4

292.82

285.96

ug/g

0.27

250

1388

Statin medication

1364

5209

1.49

37.67

1.5

1.4

286.18

283.62

ug/g

0.16

793

2895

Transport accidents

956

5079

1.58

37.61

1.5

1.4

272.19

279.70

ug/g

0.46

525

2888

Sequelae with surgical and medical care as external cause

517

2833

1.87

37.60

1.5

1.4

254.64

270.42

ug/g

0.95

317

1696

Adrenocortical insufficiency

137

418

3.51

37.50

1.6

1.4

246.54

281.44

ug/g

1.09

249

Misadventures to patients during surgical and medical care

374

1841

2.09

37.44

1.5

1.4

248.29

280.08

ug/g

2.14

227

1074

Atypical facial pain

165

561

3.10

37.42

1.6

1.4

322.47

299.97

ug/g

0.56

308

Infections with a predominantly sexual mode of transmission, including avohilmo

798

4486

1.65

37.41

1.4

291.44

292.31

ug/g

0.04

462

2377

Stomatitis and related lesions

487

2623

1.90

37.32

1.5

1.4

284.95

277.19

ug/g

0.32

278

1501

Other and unspecified urticaria

472

2518

1.92

37.25

1.4

315.96

282.45

ug/g

2.52

232

1410

Fenamates

318

971

2.28

36.94

1.4

268.78

258.54

ug/g

0.36

181

573

Certain disorders involving the immune mechanism

468

2503

1.92

36.76

1.5

1.4

297.09

269.28

ug/g

1.99

279

1459

DVT of lower extremities and pulmonary embolism

977

6328

1.56

36.63

1.5

1.4

261.44

266.03

ug/g

0.27

584

3758

Non-allergic asthma (mode)

415

2110

1.99

36.57

1.5

1.4

269.96

273.45

ug/g

0.13

251

1220

Angina pectoris

1289

5817

1.49

36.53

1.5

1.4

261.84

262.34

ug/g

0.03

799

3432

Type 1 diabetes, strict definition, subgroup 1

161

543

3.05

36.42

1.6

1.2

243.69

350.93

ug/g

9.38

118

257

Other diseases of blood and blood-forming organs, wide

542

3042

1.82

36.40

1.4

270.31

271.46

ug/g

0.04

342

1799

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

395

1727

2.03

36.18

1.4

1.3

314.79

319.12

ug/g

0.13

181

840

Injuries to the ankle and foot

1566

9515

1.42

36.06

1.4

279.19

279.85

ug/g

0.04

873

5391

Oesophagitis

156

524

3.12

36.04

1.5

1.3

273.67

279.14

ug/g

0.11

307

Migraine with aura and triptan purchases

353

1723

2.10

35.94

1.4

330.66

302.09

ug/g

1.39

170

912

Special screening examination for other diseases and disorders

256

1097

2.39

35.88

1.4

263.84

266.48

ug/g

0.06

168

632

Paracetamol or NSAID medication

276

569

2.48

35.86

1.4

294.42

290.01

ug/g

0.11

161

338

Diabetic nephropathy, excluding more controls

461

1998

1.94

35.86

1.6

1.4

213.23

251.19

ug/g

3.88

329

1180

Infections with a predominantly sexual mode of transmission

629

3681

1.73

35.86

1.5

1.4

285.41

292.38

ug/g

0.33

373

1955

Lactose intolerance, other/unspecified

102

264

4.14

35.60

1.4

282.57

300.30

ug/g

0.34

153

Crohn disease (strict definition, require KELA, min 2 HDR)

181

666

2.84

35.37

1.5

1.4

299.02

292.50

ug/g

0.14

373

Benign neoplasm: Transverse colon

305

1424

2.22

35.35

1.4

256.99

267.21

ug/g

0.35

182

863

Unspecified kidney failure

273

1216

2.32

35.34

1.6

1.4

234.84

263.00

ug/g

1.65

195

740

Crohn disease (strict definition, require KELA)

182

672

2.83

35.33

1.5

1.4

299.02

291.52

ug/g

0.16

377

Vasomotor and allergic rhinitis

774

4695

1.63

35.24

1.4

304.43

277.38

ug/g

2.81

405

2611

Other metabolic disorders

331

1592

2.14

35.23

1.5

1.4

283.77

289.01

ug/g

0.16

191

877

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

191

724

2.75

35.21

1.5

1.4

297.47

291.78

ug/g

0.12

404

Papulosquamous disorders

923

5987

1.57

35.17

1.4

274.28

272.00

ug/g

0.12

530

3462

Other and unspecified mood [affective] disorders

167

589

2.93

35.08

1.4

279.66

291.43

ug/g

0.27

309

Thiazolidinediones

293

1350

2.25

35.01

1.4

255.81

270.28

ug/g

0.59

179

819

L04AX Other immunosuppressants

1255

8669

1.47

34.87

1.5

1.4

285.37

276.65

ug/g

0.77

721

4999

Colonic or urogenital fistula

626

3703

1.72

34.84

1.5

1.4

286.62

270.46

ug/g

1.06

349

2150

Diseases of male genital organs

973

3130

1.58

34.71

1.5

276.53

256.75

ug/g

1.88

585

1903

Monoamine oxidase A inhibitors

275

1238

2.29

34.62

1.4

289.40

268.02

ug/g

0.36

162

739

Coxarthrosis [arthrosis of hip](FG)

1238

5822

1.48

34.43

1.4

271.19

261.72

ug/g

0.82

738

3435

Crohn's disease NAS

174

636

2.85

34.41

1.5

1.4

302.10

292.30

ug/g

0.23

365

Crohn disease (strict definition, all UC cases excluded)

155

534

3.05

34.32

1.5

1.4

310.62

292.36

ug/g

0.41

304

Iron deficiency anaemia secondary to blood loss (chronic)

400

2079

1.97

34.29

1.6

1.4

247.67

272.87

ug/g

1.58

230

1250

Hypermobility syndrome

153

524

3.05

34.17

1.3

335.54

317.77

ug/g

0.37

257

Nonhereditary hypogammaglobulinemia

115

6.29

34.15

1.5

1.4

339.52

298.29

ug/g

0.78

Impingement syndrome of shoulder

536

3057

1.79

34.01

1.5

1.4

276.29

260.35

ug/g

0.52

323

1814

Alcoholic gastritis

105

6.28

33.58

1.5

1.4

246.41

257.47

ug/g

0.11

Hypertensive heart and/or renal disease

577

2424

1.77

33.57

1.4

239.86

270.85

ug/g

3.38

379

1443

Alcohol withdrawal state with delirium

192

749

2.68

33.52

1.5

1.4

248.36

264.53

ug/g

0.40

103

468

Type 1 diabetes, strict definition

169

613

2.83

33.49

1.7

1.3

244.09

338.13

ug/g

8.14

125

302

Other symptoms and signs involving the circulatory and respiratory systems

176

656

2.78

33.45

1.5

1.4

275.96

264.72

ug/g

0.27

106

390

Other disorders of bladder

296

1393

2.19

33.44

1.5

273.48

264.84

ug/g

0.28

190

851

Disturbance of activity and attention

261

1133

2.30

33.44

1.3

318.77

331.63

ug/g

0.38

128

528

Cellulitis

518

2942

1.80

33.36

1.5

1.4

248.21

275.79

ug/g

2.38

322

1701

Diabetic retinopathy, strict definition

511

2565

1.83

33.33

1.7

1.5

216.46

248.84

ug/g

3.32

358

1528

Paralytic ileus

101

272

3.90

33.09

1.5

1.4

276.82

271.95

ug/g

0.08

181

Other diseases of gallbladder

123

378

3.41

33.01

1.4

1.3

310.79

305.54

ug/g

0.08

217

Extrapyramidal and movement disorders

912

5985

1.55

33.01

1.4

288.16

264.53

ug/g

2.93

559

3544

Other disorders of skin and subcutaneous tissue, not elsewhere classified

359

1823

2.02

32.99

1.5

1.4

255.90

273.20

ug/g

0.90

201

1080

Adenomyosis (Endometriosis of uterus)

304

1450

2.15

32.91

1.4

1.3

310.56

270.00

ug/g

2.53

164

826

Other disorders of eyelid

1024

6490

1.51

32.77

1.4

285.92

263.58

ug/g

2.95

628

3829

Injuries to the wrist and hand

2196

11028

1.33

32.67

1.4

274.85

276.04

ug/g

0.09

1258

6333

Cluster headache, wide

120

366

3.45

32.66

1.5

1.3

300.86

295.52

ug/g

0.08

208

Cluster headache, strict

114

337

3.57

32.62

1.5

1.3

300.65

298.02

ug/g

0.04

191

Other disorders of adrenal gland

147

507

3.06

32.61

1.7

1.4

250.82

290.92

ug/g

1.48

303

Acidosis

202

4.51

32.53

1.5

228.28

256.18

ug/g

0.49

124

Migraine, single triptan purchase ok & required. ICD-code if available is included

1586

7759

1.40

32.33

1.4

301.27

280.18

ug/g

3.34

862

4384

Triptan medication for migraine, single purchase ok

1586

7759

1.40

32.33

1.4

301.27

280.18

ug/g

3.34

862

4384

Other and unspecified disorders of vitreous body

1015

6686

1.51

32.32

1.4

301.11

266.64

ug/g

3.73

615

3976

Other chronic obstructive pulmonary disease, including avohilmo

1221

6964

1.46

32.25

1.5

1.4

262.14

262.84

ug/g

0.04

718

4199

Irregular menses

988

4926

1.52

32.20

1.4

312.23

295.10

ug/g

1.60

518

2645

Amputation

258

1168

2.28

32.14

1.5

1.4

233.29

267.82

ug/g

2.22

169

721

Viral infections characterized by skin and mucous membrane lesions

948

6303

1.52

32.03

1.5

1.4

274.78

274.62

ug/g

0.01

547

3620

Valvular heart disease excluding rheumatic fever

1030

4930

1.51

31.86

1.4

259.98

268.35

ug/g

0.65

635

2877

Lesion of ulnar nerve

333

1669

2.05

31.75

1.5

1.4

307.33

274.63

ug/g

0.69

183

966

Non-rheumatic valve diseases

1024

4897

1.51

31.69

1.4

260.31

267.86

ug/g

0.56

631

2855

Other inflammation of eyelid, including avohilmo

949

6330

1.52

31.61

1.4

293.70

279.45

ug/g

1.26

527

3556

Oesophageal varices

134

447

3.17

31.59

1.4

271.79

277.05

ug/g

0.09

271

Amenorrhoea

148

518

2.94

31.54

1.4

1.3

295.90

296.03

ug/g

0.00

243

Other noninflammatory disorders of vulva and perineum

231

1008

2.36

31.35

1.4

1.3

301.46

279.20

ug/g

0.77

129

547

Obsessive-compulsive disorder

147

514

2.94

31.35

1.4

1.3

315.73

306.46

ug/g

0.18

267

Unspecified/other endometriosis

198

788

2.53

31.28

1.4

1.3

339.61

288.13

ug/g

2.10

392

Radiculopathy

357

1841

1.98

31.27

1.4

290.00

265.17

ug/g

1.39

231

1120

Coagulation defects, purpura and other haemorrhagic conditions

457

2553

1.83

31.22

1.5

1.4

285.23

272.24

ug/g

0.65

261

1478

Vascular diseases of the intestine

131

434

3.19

31.21

1.7

1.5

235.33

280.50

ug/g

1.76

265

Other postsurgical states

187

746

2.61

31.17

1.5

1.4

247.66

274.92

ug/g

1.17

133

445

Amputation of toe

199

818

2.53

31.15

1.5

1.4

230.27

264.66

ug/g

1.78

126

509

Right hemicolectomy

172

660

2.73

31.15

1.5

235.48

270.45

ug/g

1.34

112

402

Other ulcerative colitis

153

552

2.89

31.07

1.5

1.4

294.18

294.59

ug/g

0.01

313

Liquid cancers, including Hilmo

768

4318

1.59

30.94

1.4

263.85

283.32

ug/g

1.88

464

2539

Peripheral artery operations in Hilmo

307

1508

2.09

30.91

1.4

234.54

263.74

ug/g

1.92

194

932

Otitis externa

526

3069

1.75

30.86

1.5

1.4

295.80

273.99

ug/g

1.53

290

1771

Adjustment and management of implanted device

393

2104

1.91

30.75

1.5

1.4

248.23

267.21

ug/g

1.18

239

1273

Disorders of magnesium metabolism

7.67

30.73

1.7

1.4

199.01

260.93

ug/g

0.96

Restless leg syndrome

372

1962

1.95

30.69

1.5

1.4

301.38

279.79

ug/g

1.18

227

1149

ILD, hospital admission 2, with pulmonary infections

251

1146

2.26

30.69

1.4

1.5

269.00

258.38

ug/g

0.33

151

718

Other disorders of eye and adnexa

350

1807

1.99

30.68

1.5

1.4

286.35

287.22

ug/g

0.03

212

1014

Autoimmune hepatitis, wide definition

133

448

3.11

30.67

1.7

1.4

252.66

309.27

ug/g

2.15

250

Diseases of external ear

812

5281

1.56

30.65

1.5

1.4

284.74

269.52

ug/g

1.22

450

3074

Heart failure, strict

1333

6569

1.43

30.64

1.5

1.4

254.65

261.12

ug/g

0.42

866

3911

Dermatophytosis, including avohilmo

1411

9980

1.40

30.55

1.5

1.4

269.70

275.10

ug/g

0.43

815

5747

Rheumatoid arthritis

682

3758

1.63

30.47

1.4

281.99

263.11

ug/g

1.57

388

2196

All-cause Heart Failure

1318

6495

1.43

30.45

1.5

1.4

254.59

261.06

ug/g

0.41

855

3861

Early onset COPD

515

3004

1.75

30.34

1.5

1.4

269.44

266.59

ug/g

0.11

309

1797

Hyperkinetic disorders

270

1237

2.17

30.26

1.3

318.83

330.18

ug/g

0.33

133

581

Conductive and sensorineural hearing loss

1738

8549

1.36

30.21

1.5

1.4

277.14

268.44

ug/g

0.89

1027

5007

Atherosclerosis, excluding cerebral and coronary sclerosis

903

4697

1.53

30.19

1.5

1.4

232.66

262.18

ug/g

4.59

584

2862

Diseases of tongue

161

606

2.76

30.09

1.5

1.4

302.19

275.37

ug/g

0.76

358

Female genital prolapse

594

1947

1.72

29.97

1.4

297.79

269.72

ug/g

2.48

333

1114

Sensorineural hearing loss

1671

8222

1.37

29.82

1.5

1.4

274.19

267.18

ug/g

0.64

994

4832

Brachial plexus disorders

222

974

2.35

29.82

1.4

318.94

299.18

ug/g

0.57

125

516

Hyperparathyroidism

453

2534

1.81

29.72

1.4

257.38

271.11

ug/g

0.73

268

1528

Ocular pain

229

1023

2.32

29.59

1.4

304.65

293.54

ug/g

0.34

133

552

Use of disulfiram, acamprosate or naltrexone

223

986

2.34

29.53

1.5

1.4

247.60

275.53

ug/g

1.03

121

585

Anaemia in chronic diseases classified elsewhere

260

3.86

29.27

1.7

1.5

223.96

272.71

ug/g

1.39

157

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

134

466

3.00

29.17

1.5

224.49

286.72

ug/g

2.61

298

COPD

992

5484

1.49

29.14

1.5

1.4

262.65

263.27

ug/g

0.03

594

3308

Mucosal proctocolitis

272

1309

2.13

28.94

1.5

1.4

281.29

283.36

ug/g

0.05

165

740

Otalgia

227

1024

2.29

28.67

1.5

1.4

270.47

285.09

ug/g

0.44

126

567

Combinations of oral blood glucose lowering drugs

617

3830

1.64

28.57

1.4

257.06

273.13

ug/g

1.13

380

2305

Fracture of shoulder and upper arm

811

5350

1.54

28.47

1.4

267.72

270.23

ug/g

0.13

504

3093

Recurrent aphthous stomatitis , including avohilmo

353

1878

1.93

28.34

1.5

1.4

281.75

280.48

ug/g

0.04

200

1082

Postmenopausal bleeding

572

1770

1.72

28.29

1.4

274.21

267.06

ug/g

0.32

321

1044

Other arthritis (FG)

677

4306

1.60

28.22

1.5

1.4

281.35

266.35

ug/g

0.98

382

2460

Fibrosis and cirrhosis of liver

211

931

2.35

28.19

1.4

1.5

283.54

274.98

ug/g

0.20

122

564

Superficial injury of lower leg

585

3596

1.65

28.13

1.5

1.4

272.61

278.66

ug/g

0.28

332

2023

Adenocarcinoma and papillary adenocarcinoma of stomach

233

3.89

28.07

1.7

1.4

241.16

294.90

ug/g

1.88

146

Pulmonary heart disease, diseases of pulmonary circulation

728

4717

1.57

28.01

1.5

1.4

255.67

268.34

ug/g

0.89

438

2839

Vitreous haemorrhage

256

1224

2.16

27.93

1.7

1.4

214.81

272.60

ug/g

5.77

171

744

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1151

7805

1.43

27.90

1.4

280.89

284.34

ug/g

0.22

667

4341

Excessive attrition of teeth

1289

9219

1.40

27.85

1.4

289.76

276.94

ug/g

1.35

752

5206

Zoster [herpes zoster], including avohilmo

1178

8093

1.42

27.84

1.4

277.44

270.05

ug/g

0.56

691

4708

Personal history of other diseases and conditions

246

1152

2.18

27.74

1.5

1.3

293.23

309.46

ug/g

0.46

119

567

Other chronic obstructive pulmonary disease

949

5297

1.49

27.68

1.5

1.4

264.35

263.00

ug/g

0.07

569

3189

Allergic asthma (mode), excluding more controls

416

2280

1.80

27.58

1.4

296.33

287.20

ug/g

0.36

224

1262

Diseases of salivary glands

742

4847

1.56

27.54

1.5

1.4

284.44

273.58

ug/g

0.71

423

2784

Trigger finger

328

1719

1.95

27.49

1.5

1.4

281.16

266.26

ug/g

0.28

198

1023

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

765

5035

1.54

27.43

1.4

281.78

278.93

ug/g

0.14

444

2899

Noninflammatory disorders of female genital tract

729

2311

1.60

27.40

1.4

1.3

304.00

276.22

ug/g

2.51

378

1261

Pulmonary embolism

671

4291

1.59

27.40

1.5

1.4

253.99

269.59

ug/g

1.13

403

2600

Neuralgia and neuritis, unspecified

138

505

2.84

27.34

1.6

1.4

299.29

284.05

ug/g

0.28

292

Pulmonary heart disease

671

4293

1.59

27.34

1.5

1.4

253.99

269.90

ug/g

1.17

403

2601

Fracture of skull and facial bones

460

2675

1.75

27.33

1.4

1.5

267.26

268.77

ug/g

0.05

255

1565

Allergic asthma (mode)

416

2287

1.80

27.31

1.4

296.33

287.13

ug/g

0.36

224

1268

Malnutrition

230

3.94

27.28

1.4

262.91

298.64

ug/g

0.66

138

Other specified/unspecified bacterial intestinal infections

184

777

2.46

27.22

1.5

1.4

273.33

279.89

ug/g

0.16

114

462

Asthma and allergy

242

1122

2.17

27.22

1.4

300.05

295.63

ug/g

0.11

134

593

Postprocedural endocrine and metabolic disorders, not elsewhere classified

291

1472

2.03

27.11

1.5

1.4

283.18

290.15

ug/g

0.21

170

807

Asthma and allergy, excluding more controls

243

1132

2.16

27.04

1.4

301.15

295.70

ug/g

0.14

135

599

Vitamin deficiency

142

533

2.79

26.89

1.5

259.14

284.31

ug/g

0.58

317

Vitamin deficiency, wide

142

533

2.79

26.89

1.5

259.14

284.31

ug/g

0.58

317

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

228

1060

2.22

26.74

1.5

1.4

275.03

285.34

ug/g

0.31

133

597

Fall on same level involving ice and snow

1272

9241

1.39

26.66

1.4

279.52

272.93

ug/g

0.53

730

5340

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1305

8656

1.39

26.60

1.5

1.4

295.54

281.88

ug/g

1.45

726

4864

Chronic periodontitis, complicated

1263

8939

1.39

26.58

1.5

1.4

256.78

270.60

ug/g

1.49

748

5285

Disorders of tooth development and eruption

318

1339

1.96

26.53

1.5

1.4

285.78

278.04

ug/g

0.24

187

765

Peripheral arterial reconstruction

386

2161

1.83

26.32

1.5

230.87

261.62

ug/g

2.29

243

1343

Necrosis of pulp, including avohilmo

1218

8707

1.40

26.19

1.4

272.28

277.69

ug/g

0.37

707

4951

Allergic conjunctivitis

1198

8312

1.40

26.14

1.4

280.77

285.79

ug/g

0.36

692

4640

Hyperplasia of prostate

697

2500

1.59

26.10

1.5

266.17

246.15

ug/g

1.51

444

1535

Lateral epicondylitis

292

1498

1.99

26.10

1.4

300.23

266.13

ug/g

1.90

167

884

Superficial injury of abdomen, lower back and pelvis

356

1950

1.86

26.03

1.5

1.4

276.04

280.33

ug/g

0.13

206

1088

Hypertensive Heart Disease

501

2269

1.70

25.80

1.4

236.04

270.55

ug/g

3.65

324

1353

Chronic diseases of tonsils and adenoids

1567

7379

1.35

25.70

1.4

303.80

271.95

ug/g

6.48

836

4248

Use of pramipexole

515

3145

1.67

25.64

1.5

1.4

270.82

269.12

ug/g

0.07

314

1899

Anorexia (incl.atypical)

131

481

2.81

25.64

1.4

270.61

295.25

ug/g

0.51

241

Other Crohn's disease

162

662

2.53

25.63

1.6

1.4

278.73

298.44

ug/g

0.53

372

Other diseases of pleura

974

5899

1.45

25.61

1.5

1.4

250.15

263.77

ug/g

1.21

602

3567

Postmenopausal atrophic vaginitis

546

1791

1.69

25.57

1.4

301.41

267.15

ug/g

3.02

325

1049

Deviated nasal septum

678

4407

1.56

25.57

1.4

1.5

280.05

259.60

ug/g

1.57

398

2590

Other diseases of arteries and capillaries

230

1093

2.17

25.54

1.5

1.4

240.73

276.35

ug/g

1.71

138

646

Purpura and other haemorrhagic conditions

317

1686

1.93

25.52

1.5

1.4

281.71

275.81

ug/g

0.19

180

990

Other problems related to primary support group, including family circumstances

248

1175

2.10

25.51

1.5

1.4

263.48

315.06

ug/g

3.37

149

597

Osteoporosis with pathological fracture (FG)

209

959

2.26

25.50

1.5

1.4

254.46

270.43

ug/g

0.53

131

565

Diabetic nephropathy

464

2739

1.72

25.35

1.7

1.5

212.76

241.45

ug/g

2.74

331

1650

Convalescence

142

550

2.69

25.23

1.6

1.4

320.89

287.15

ug/g

0.27

309

Endometriosis of pelvic peritoneum

307

1464

1.94

25.19

1.4

338.82

275.56

ug/g

4.98

148

787

Gonarthrosis,primary

1942

9034

1.31

25.16

1.5

1.4

277.24

266.61

ug/g

1.09

1161

5326

Other viral diseases

581

3650

1.61

25.15

1.4

295.28

282.85

ug/g

0.73

349

2010

Mental and behavioural disorders due to tobacco

218

1022

2.20

25.09

1.5

1.4

257.91

276.51

ug/g

0.60

119

601

Striking against or struck by other objects

683

4463

1.55

25.07

1.5

1.4

273.58

279.22

ug/g

0.28

394

2527

Erosion of teeth , including avohilmo

555

3467

1.63

25.04

1.5

1.4

283.05

281.32

ug/g

0.07

317

1915

Covid-19 suspected case

450

2666

1.72

25.03

1.5

1.4

298.61

284.52

ug/g

0.72

259

1456

Abnormal results of function studies

222

1050

2.18

24.96

1.6

1.4

313.45

285.04

ug/g

1.07

130

594

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

349

1926

1.85

24.93

1.6

1.4

281.72

284.77

ug/g

0.10

209

1088

Hepatic failure, not elsewhere classified

118

420

2.96

24.87

1.6

1.5

231.91

281.35

ug/g

1.44

259

Unspecified privation

253

1258

2.07

24.85

1.5

1.4

240.58

282.34

ug/g

2.34

155

734

Hallux valgus (acquired)

695

3241

1.55

24.64

1.4

290.67

268.85

ug/g

1.03

412

1882

Reimbursement for rheumatic diseases

1222

8885

1.38

24.64

1.4

282.82

275.49

ug/g

0.58

707

5135

Congenital malformations, deformations and chromosomal abnormalities

1162

7980

1.39

24.62

1.5

1.4

292.79

282.77

ug/g

0.85

647

4448

Injuries to the hip and thigh

1065

6815

1.42

24.60

1.4

260.48

265.78

ug/g

0.37

647

4018

Flatulence and related conditions

6.66

24.56

1.8

1.3

266.99

314.26

ug/g

0.52

Other and unspecified nerve root and plexus disorders, also in other diseases

452

2699

1.71

24.47

1.5

1.4

266.72

275.34

ug/g

0.38

258

1533

Propionic acid derivatives

500

1486

1.71

24.39

1.5

1.4

293.62

262.89

ug/g

2.33

300

888

Other complications of surgical and medical care, not elsewhere classified

237

1159

2.10

24.38

1.5

1.4

277.54

283.89

ug/g

0.17

139

649

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

381

2173

1.79

24.36

1.6

1.4

280.22

281.84

ug/g

0.05

230

1240

Smoking dependency

218

1035

2.17

24.31

1.5

1.4

257.91

279.12

ug/g

0.72

119

611

Fracture of foot, except ankle

528

3284

1.63

24.30

1.4

256.55

275.02

ug/g

1.28

318

1845

Abnormal involuntary movements

320

1736

1.89

24.27

1.5

1.4

280.86

272.05

ug/g

0.31

202

1022

Explicit bacterial Sepsis, including avohilmo

241

1186

2.08

24.27

1.5

1.4

236.80

278.27

ug/g

2.03

135

713

Other blood glucose lowering drugs, excl. Insulins

360

2026

1.82

24.20

1.5

1.4

246.01

272.07

ug/g

1.82

235

1224

Triptan medication for migraine, min. 3 purchases

1106

5924

1.41

24.19

1.3

1.4

316.17

287.80

ug/g

3.79

576

3237

Gastrojejunal ulcer

5.72

24.19

1.7

1.3

222.60

287.70

ug/g

1.23

Ulcerative colitis (strict definition, require KELA)

356

1995

1.82

24.18

1.6

1.4

283.96

284.44

ug/g

0.01

213

1136

Other disorders of veins

908

6236

1.45

24.18

1.4

270.62

276.16

ug/g

0.36

540

3611

Other symptoms and signs involving the urinary system

237

1165

2.09

24.01

1.4

1.5

269.28

270.50

ug/g

0.03

138

717

Palmar fascial fibromatosis [Dupuytren]

319

1734

1.88

23.95

1.5

1.4

268.50

248.50

ug/g

0.92

197

1073

Total colectomy operation

119

434

2.87

23.91

1.6

1.5

265.21

275.49

ug/g

0.18

253

Total colectomy

119

434

2.87

23.91

1.6

1.5

265.21

275.49

ug/g

0.18

253

Barrett oesophagus

129

490

2.74

23.88

1.7

1.4

289.26

265.50

ug/g

0.62

297

Other and unspecified visual disturbances

265

1360

2.00

23.86

1.4

288.10

280.07

ug/g

0.25

146

781

Other viral diseases, including avohilmo

738

4910

1.51

23.85

1.4

300.75

284.90

ug/g

1.21

424

2706

Neuromuscular dysfunction of bladder

216

1029

2.16

23.84

1.5

1.4

266.23

272.65

ug/g

0.16

120

606

Explicit bacterial Sepsis

235

1155

2.08

23.76

1.5

1.4

237.21

277.61

ug/g

1.86

131

696

Artificial opening status

149

609

2.55

23.76

1.6

1.5

224.58

266.01

ug/g

1.51

109

374

Fracture of lumbar spine and pelvis

512

3173

1.64

23.74

1.5

1.4

248.64

269.55

ug/g

1.46

299

1907

Sequelae of injuries, of poisoning and of other consequences of external causes

509

3161

1.64

23.64

1.6

1.4

241.24

273.02

ug/g

2.79

300

1839

Bacterial pneumoniae

845

5114

1.47

23.60

1.5

1.4

254.90

269.58

ug/g

1.23

531

3003

Assault by bodily force

178

788

2.32

23.52

1.4

289.34

301.54

ug/g

0.26

425

COPD related to multimorbidity

852

4974

1.47

23.51

1.5

1.4

264.88

257.88

ug/g

0.43

512

3041

Other/unspecified enthesopathies of lower limb, excluding foot

167

720

2.39

23.48

1.4

292.69

290.02

ug/g

0.05

416

Other disorders of bone

418

2479

1.72

23.25

1.5

1.4

302.59

274.62

ug/g

0.76

232

1381

Inflammatory diseases of prostate (prostatitis)

269

1398

1.97

23.23

1.5

287.89

248.75

ug/g

2.07

151

861

Drug-induced adrenocortical insufficiency

213

3.82

23.22

1.6

1.4

264.84

299.84

ug/g

0.68

129

Complications of internal orthopaedic prosthetic devices, implants and grafts

506

3158

1.63

23.09

1.5

1.4

265.93

268.58

ug/g

0.11

312

1892

Other disorders of penis

213

1021

2.14

23.01

1.6

1.5

282.54

250.59

ug/g

1.21

118

630

Social phobias

162

696

2.38

22.81

1.4

295.82

299.79

ug/g

0.07

360

Late syphilis, including avohilmo

169

4.17

22.81

1.7

1.4

200.21

275.55

ug/g

2.50

100

Cluster headache, strict, including avohilmo

134

531

2.62

22.79

1.5

1.4

294.45

301.51

ug/g

0.12

290

Supplementary factors related to causes of morbidity and mortality classified elsewhere

660

4384

1.53

22.73

1.5

1.4

277.79

271.88

ug/g

0.27

373

2524

Liquid cancers

598

3681

1.56

22.51

1.5

1.4

270.46

281.85

ug/g

0.72

366

2173

Cluster headache, wide,, including avohilmo

140

571

2.55

22.42

1.5

1.4

294.97

301.58

ug/g

0.11

313

Umbilical hernia

554

3555

1.58

22.38

1.5

1.4

294.97

264.02

ug/g

1.29

314

2082

Lichen ruber planus, wide definition including periferal and oral lichen planus

525

3333

1.60

22.36

1.4

278.64

273.11

ug/g

0.24

297

1982

DVT of lower extremities

416

2492

1.70

22.35

1.4

271.82

269.54

ug/g

0.07

246

1507

Injuries to the neck

475

2942

1.64

22.29

1.4

278.61

275.73

ug/g

0.10

253

1656

Invasive ventilation

186

860

2.24

22.28

1.7

1.4

253.90

273.54

ug/g

0.60

119

522

All influenza (not pneumonia)

310

1709

1.85

22.25

1.5

1.4

294.60

274.45

ug/g

0.80

162

1004

Agoraphobia

251

3.40

22.24

1.6

1.3

288.08

309.15

ug/g

0.29

139

Disorder of lipoprotein metabolism, unspecified

294

1597

1.88

22.24

1.6

1.4

255.58

265.54

ug/g

0.34

180

961

Fitting and adjustment of other devices

746

4475

1.49

22.24

1.5

1.4

276.38

270.25

ug/g

0.33

452

2622

Diseases of the myoneural junction and muscle

288

1556

1.90

22.21

1.4

264.32

275.48

ug/g

0.40

160

942

Other/unspecified synovitis and tenosynovitis

246

1260

2.00

22.19

1.5

1.4

297.67

266.37

ug/g

0.54

152

745

Major coronary heart disease event excluding revascularizations

1268

6205

1.36

22.15

1.5

1.4

255.72

262.21

ug/g

0.52

797

3656

Degeneration of macula and posterior pole

1061

5930

1.40

22.12

1.5

1.4

260.75

264.12

ug/g

0.21

633

3563

Presence of cardiac and vascular implants and grafts

912

4733

1.43

21.93

1.5

1.4

255.17

260.75

ug/g

0.36

558

2855

Heart failure and coronary heart disease

905

4465

1.44

21.83

1.5

1.4

251.90

258.83

ug/g

0.46

597

2679

Localized swelling, mass and lump of skin and subcutaneous tissue

691

4676

1.50

21.78

1.4

286.45

269.32

ug/g

1.22

407

2718

Kela reimbursement Agammaglobulinemia (D80-84)

5.74

21.64

1.5

1.4

388.32

295.27

ug/g

2.11

Unspecified urinary incontinence

229

1159

2.04

21.57

1.4

297.74

281.92

ug/g

0.45

101

686

Diabetic retinopathy

927

4075

1.44

21.56

1.6

1.5

217.04

249.86

ug/g

5.32

603

2421

Other diseases of peritoneum

129

517

2.61

21.56

1.6

1.4

267.81

291.81

ug/g

0.63

301

Bulimia nervosa (incl. atypical)

256

3.33

21.54

1.3

310.77

337.85

ug/g

0.45

119

Dislocation, sprain and strain of joints and ligaments at neck level

319

1793

1.81

21.51

1.4

297.70

289.02

ug/g

0.26

169

962

Ptosis of eyelid

267

1424

1.93

21.49

1.5

1.4

277.76

267.75

ug/g

0.35

173

883

Other and unspecified drugs and medicaments

212

1045

2.09

21.47

1.5

1.4

271.20

284.72

ug/g

0.42

124

587

Atopic dermatitis

1153

6773

1.37

21.38

1.4

299.55

284.39

ug/g

1.41

605

3789

Inflammatory disease of uterus

287

1566

1.87

21.35

1.4

1.3

322.12

295.86

ug/g

1.20

149

820

Glomerulonephritis

226

1142

2.03

21.33

1.6

1.4

243.85

282.92

ug/g

2.18

151

688

Anogenital herpesviral [herpes simplex] infection, including avohilmo

223

1120

2.03

21.26

1.4

293.60

307.35

ug/g

0.37

114

547

Other enthesopathy of foot (+metatarsalgia)

224

1128

2.03

21.24

1.4

271.19

274.02

ug/g

0.07

120

663

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

373

2198

1.72

21.20

1.4

322.10

300.62

ug/g

1.04

218

1118

Other specified and unspecified personality disorders

191

911

2.15

21.02

1.4

331.27

294.63

ug/g

0.41

101

487

Disorders of breast

1033

6634

1.38

20.95

1.4

290.98

288.19

ug/g

0.17

591

3658

Other disorders of nervous system

172

791

2.25

20.93

1.6

1.4

259.48

275.79

ug/g

0.43

481

Metatarsalgia

211

1046

2.07

20.93

1.4

275.72

276.99

ug/g

0.03

112

620

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

195

942

2.14

20.88

1.4

1.5

271.00

270.14

ug/g

0.02

112

565

Cholangitis (primary sclerosing, PSC), with reimbursement 202

199

3.72

20.83

1.6

1.5

228.45

290.04

ug/g

1.34

123

Disorders of sclera, cornea, iris and ciliary body

1145

8523

1.36

20.80

1.5

1.4

273.95

273.66

ug/g

0.01

687

4924

Lichen planus, including avohilmo

446

2774

1.64

20.78

1.4

275.33

274.73

ug/g

0.02

257

1653

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

124

496

2.60

20.75

1.5

1.4

268.06

291.75

ug/g

0.60

314

Conduction disorders

622

3311

1.52

20.74

1.5

1.4

252.67

264.09

ug/g

0.74

369

1965

Hyperhidrosis

248

3.31

20.58

1.4

327.50

298.17

ug/g

0.51

135

Cerebrovascular diseases

1574

8445

1.30

20.58

1.5

1.4

256.76

266.57

ug/g

1.08

967

4956

Streptococcal septicaemia, including avohilmo

207

1031

2.06

20.33

1.5

234.10

282.99

ug/g

2.33

113

628

Blepharochalasis

655

4452

1.49

20.33

1.4

282.96

265.06

ug/g

1.40

390

2672

Diseases of inner ear

1172

8398

1.35

20.31

1.4

280.49

268.76

ug/g

1.06

647

4927

Delirium, not induced by alcohol and other psychoactive substances

286

1584

1.84

20.21

1.5

238.71

260.86

ug/g

1.00

168

999

Psoriasis

603

4039

1.51

20.07

1.5

1.4

277.53

273.42

ug/g

0.19

347

2341

Other infectious diseases, including avohilmo

211

1064

2.04

20.05

1.4

269.29

278.23

ug/g

0.24

126

632

Disorders of vestibular function (Vertigo)

1026

7356

1.37

20.04

1.4

279.24

268.55

ug/g

0.84

562

4329

Colorectal cancer, including Hilmo

544

3317

1.55

20.01

1.4

242.82

279.30

ug/g

3.79

340

1990

Late syphilis

131

4.40

19.96

1.7

1.4

194.55

271.26

ug/g

2.00

Lichen planus

313

1794

1.79

19.94

1.4

269.72

277.15

ug/g

0.26

179

1068

COPD, early/later onset

954

5816

1.39

19.85

1.5

1.4

264.92

259.65

ug/g

0.33

573

3518

Fall on and from stairs and steps

565

3743

1.53

19.84

1.5

1.4

257.06

273.05

ug/g

1.05

339

2180

Primary biliary cholangitis, wide definition

235

3.39

19.83

1.3

1.4

309.90

303.57

ug/g

0.08

133

Other embolism and thrombosis

281

1561

1.84

19.83

1.4

273.44

274.27

ug/g

0.01

163

936

Streptococcal septicaemia

202

1007

2.06

19.80

1.5

1.4

234.77

282.39

ug/g

2.15

110

617

Benign neoplasm: Descending colon

185

896

2.14

19.78

1.5

246.18

268.60

ug/g

0.86

118

545

ILD, hospital admissions 3, with pneumonia sepsis

206

1036

2.05

19.76

1.5

269.29

265.68

ug/g

0.08

122

641

Abnormal serum enzyme levels

614

3992

1.50

19.73

1.5

259.04

258.00

ug/g

0.04

381

2433

Other and unspecified tonsillitis

567

3106

1.53

19.65

1.4

307.94

285.93

ug/g

1.24

265

1730

Cirrhosis of liver, NAS

144

633

2.36

19.62

1.5

269.89

272.42

ug/g

0.04

401

Phlebitis and thrombophlebitis (not including DVT)

478

3066

1.58

19.48

1.4

259.08

272.62

ug/g

0.70

279

1817

Follow-up examination after treatment for malignant neoplasms

202

1012

2.04

19.45

1.4

271.69

258.14

ug/g

0.37

121

610

Other disorders of patella

327

1906

1.74

19.44

1.4

297.16

270.99

ug/g

1.26

171

1079

Abnormalities of gait and mobility

280

1566

1.83

19.39

1.5

274.93

265.56

ug/g

0.36

194

958

Fracture of femur

581

3494

1.52

19.39

1.5

1.4

247.13

261.88

ug/g

1.03

357

2133

Conjunctivitis (acute, non atopic)

575

3824

1.52

19.35

1.4

294.71

278.43

ug/g

1.10

333

2144

Other noninflammatory disorders of uterus, except cervix

428

1758

1.65

19.35

1.4

281.01

266.37

ug/g

0.78

257

1028

Transient ischemic attack

1115

6630

1.35

19.32

1.4

265.22

264.34

ug/g

0.04

683

3954

Plantar fascial fibromatosis

211

1077

2.00

19.32

1.5

1.4

291.24

273.56

ug/g

0.57

118

642

Other female pelvic inflammatory diseases

350

2087

1.71

19.28

1.4

300.11

281.31

ug/g

0.88

185

1166

Other and unspecified local infections of skin and subcutaneous tissue

222

1155

1.97

19.28

1.4

246.08

279.72

ug/g

1.47

130

673

Non-ischemic cardiomyopathy

677

3688

1.48

19.22

1.4

253.45

260.29

ug/g

0.39

434

2210

Mouth breathing

805

5731

1.42

19.21

1.4

1.5

295.38

268.37

ug/g

2.72

466

3347

Other/unspecified cytomegaloviral diseases

210

3.52

19.20

1.5

1.4

273.87

298.85

ug/g

0.44

127

Other local infections of skin and subcutaneous tissue

233

1234

1.93

19.17

1.4

254.94

281.36

ug/g

1.01

135

715

Anti-inflammatory and antirheumatic products, non-steroids

475

1487

1.62

19.15

1.5

1.4

286.77

262.89

ug/g

1.53

284

888

Urolithiasis

655

4502

1.47

19.15

1.5

1.4

261.06

263.33

ug/g

0.10

358

2686

898

5857

1.40

19.14

1.4

284.52

258.45

ug/g

1.98

541

3556

Ulcerative colitis (strict definition, all Crohn cases excluded)

293

1666

1.79

19.08

1.6

1.4

288.03

286.17

ug/g

0.05

172

946

Other disorders of the musculoskeletal system and connective tissue

336

1988

1.73

19.08

1.5

1.4

254.35

273.54

ug/g

1.09

218

1187

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

724

5001

1.44

19.06

1.4

294.85

287.01

ug/g

0.43

374

2724

Disorders of muscles

213

1096

1.99

19.04

1.5

1.4

278.22

270.29

ug/g

0.21

125

656

Other respiratory diseases principally affecting the interstitium

389

2391

1.66

19.02

1.5

1.4

275.75

261.31

ug/g

0.33

239

1467

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

228

1204

1.94

18.98

1.5

1.4

243.60

276.52

ug/g

1.49

142

709

Sulfonylureas

669

3650

1.47

18.97

1.5

1.4

234.55

267.85

ug/g

3.89

415

2206

Type of accident

599

4053

1.50

18.97

1.5

1.4

276.88

272.72

ug/g

0.17

346

2339

Chronic ulcer of skin, not elsewhere classified

168

796

2.18

18.96

1.6

1.4

231.18

268.62

ug/g

1.72

475

COPD, hospital admissions

937

5765

1.38

18.89

1.5

1.4

266.13

259.58

ug/g

0.42

563

3484

Fracture at wrist and hand level

686

4750

1.46

18.88

1.4

264.65

273.19

ug/g

0.51

405

2728

Other specified/unspecified soft tissue disorders

119

488

2.52

18.87

1.6

1.4

270.33

283.13

ug/g

0.26

283

Bacterial pneumonia, not elsewhere classified

778

4841

1.43

18.83

1.5

1.4

250.64

269.52

ug/g

1.73

496

2852

Unspecified misadventure during surgical and medical care

149

676

2.29

18.83

1.4

226.44

277.12

ug/g

2.42

403

Heart failure and bmi 25plus

712

3289

1.46

18.78

1.4

262.31

260.09

ug/g

0.07

459

1890

SLE (Finngen)

339

2.86

18.77

1.4

341.46

319.06

ug/g

0.46

195

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

600

4076

1.49

18.62

1.4

286.84

269.17

ug/g

1.14

350

2332

Caries of enamel

1983

10434

1.25

18.61

1.4

296.65

273.49

ug/g

3.76

1156

5975

Cytomegalovirus infection, IBD co-morbidity

245

3.25

18.56

1.5

1.4

271.72

287.71

ug/g

0.26

143

Need for other prophylactic measures

146

661

2.29

18.53

1.6

1.5

233.99

282.83

ug/g

2.17

392

Allergic rhinitis

580

3864

1.50

18.52

1.4

310.83

286.22

ug/g

1.86

291

2117

Malignant neoplasm of skin, including Hilmo

1054

5238

1.36

18.50

1.5

1.4

276.64

285.20

ug/g

0.48

673

3049

Anosmia

109

4.36

18.49

1.4

1.3

296.02

320.82

ug/g

0.30

Persons with potential health hazards related to communicable diseases

672

4624

1.45

18.48

1.4

286.38

290.29

ug/g

0.17

408

2466

Other degenerative diseases of the nervous system

529

2532

1.54

18.39

1.4

256.80

252.53

ug/g

0.17

294

1504

Acute pharyngitis

274

1527

1.80

18.36

1.4

279.41

282.74

ug/g

0.08

149

844

Ulcer of oesophagus

142

637

2.29

18.33

1.4

269.55

264.69

ug/g

0.10

387

Herpesviral [herpes simplex] infections, including avohilmo

521

3451

1.53

18.32

1.5

1.4

276.21

284.79

ug/g

0.41

290

1916

Uterine polyps

521

1980

1.56

18.18

1.5

1.4

272.90

270.47

ug/g

0.09

295

1124

Mental and behavioural disorders due to opioids

328

2.84

18.11

1.7

1.4

245.75

309.94

ug/g

1.84

174

Benign neoplasm of other and unspecified endocrine glands

302

1762

1.75

18.10

1.5

1.4

249.81

275.62

ug/g

1.41

169

1049

Pollen allergy

344

2042

1.68

18.09

1.4

314.73

308.64

ug/g

0.18

156

1058

Other viral diseases, not elsewhere classified

367

2247

1.65

17.94

1.5

1.4

298.73

285.55

ug/g

0.59

228

1251

Skin changes due to chronic exposure to nonionizing radiation

851

5600

1.39

17.93

1.4

284.00

257.41

ug/g

1.92

512

3408

Seborrhoeic keratosis

557

3764

1.50

17.88

1.5

1.4

289.70

268.19

ug/g

1.74

334

2261

Unspecified mental disorder

772

5532

1.41

17.85

1.4

293.39

277.44

ug/g

1.34

449

3131

Cachexia

7.57

17.85

1.7

1.2

254.88

315.82

ug/g

0.51

Appendectomy

1276

9372

1.31

17.83

1.4

285.90

278.62

ug/g

0.55

714

5328

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

570

3866

1.49

17.83

1.4

280.02

278.87

ug/g

0.04

336

2171

Ehlers-Danlos syndrome, including avohilmo

120

4.31

17.79

1.7

1.4

314.57

324.41

ug/g

0.10

Cytomegaloviral disease

262

3.12

17.78

1.5

278.76

288.29

ug/g

0.14

150

ILD, hospital admissions

333

2005

1.70

17.74

1.4

1.5

284.02

262.01

ug/g

0.49

207

1231

Polyp of the female genital tract

543

2027

1.53

17.70

1.5

1.4

273.33

271.53

ug/g

0.06

299

1150

Viral pneumonia

274

1564

1.79

17.67

1.4

259.21

276.09

ug/g

0.61

147

922

Tinnitus

507

3369

1.53

17.66

1.5

1.4

295.61

269.62

ug/g

1.74

282

1970

Superficial injury of thorax

321

1916

1.71

17.61

1.4

266.15

275.74

ug/g

0.32

188

1128

Dermatophytosis

298

1747

1.74

17.53

1.6

1.4

263.24

270.50

ug/g

0.23

183

1032

Superficial injury of wrist and hand

414

2633

1.59

17.52

1.4

284.40

276.73

ug/g

0.28

228

1467

Bacterial pneumonia (organism specified)

898

5979

1.37

17.52

1.5

1.4

254.46

266.66

ug/g

0.99

560

3490

Other follicular disorders

165

800

2.12

17.51

1.6

1.4

282.25

291.41

ug/g

0.20

443

Other inflammation of eyelid

312

1853

1.72

17.48

1.5

1.4

273.34

275.09

ug/g

0.05

183

1107

Other predominantly sexually transmitted diseases, not elsewhere classified

316

1881

1.71

17.46

1.4

316.51

302.30

ug/g

0.56

192

968

Thrombocytopenia, unspecified

174

863

2.08

17.44

1.5

1.4

263.48

275.87

ug/g

0.33

521

Cytomegaloviral disease, including avohilmo

265

3.08

17.43

1.5

278.76

286.63

ug/g

0.12

152

Speech and linguistic disorders, excluding more controls

134

558

2.29

17.39

1.4

314.34

315.67

ug/g

0.02

305

Diabetic maculopathy

330

1885

1.70

17.31

1.6

1.5

214.40

253.77

ug/g

3.12

230

1119

Sacrococcygeal disorders, not elsewhere classified

282

2.95

17.19

1.4

1.3

309.57

298.65

ug/g

0.17

166

Disorders of ocular muscles, binocular movement, accommodation and refraction

948

7000

1.35

17.19

1.5

1.4

276.18

281.89

ug/g

0.34

525

3935

Sicca syndrome [Sjögren]

212

1132

1.93

17.19

1.4

311.22

288.99

ug/g

0.83

112

654

Artificial joint operation, meniscal resection

1893

9775

1.25

17.18

1.5

1.4

275.15

267.89

ug/g

0.61

1142

5718

Calculus of kidney and ureter

603

4171

1.46

17.13

1.5

1.4

258.11

264.29

ug/g

0.29

334

2490

Injury of muscle and tendon at shoulder and upper arm level

743

5336

1.41

17.11

1.5

1.4

275.33

261.30

ug/g

0.66

471

3162

Other and unspecified immunodeficiencies with predominantly antibody defects

138

4.03

17.06

1.6

1.4

370.89

320.44

ug/g

0.77

Type1 diabetes, definitions combined, early onset

130

577

2.30

17.02

1.7

1.4

249.46

327.87

ug/g

4.91

293

Actinic keratosis

822

5453

1.39

17.02

1.4

284.52

257.22

ug/g

1.91

493

3330

Drug-induced hypoglycaemia without coma

142

3.89

17.00

1.8

1.3

194.17

297.00

ug/g

2.28

Decubitus ulcer and pressure area

149

704

2.18

16.99

1.5

261.63

264.67

ug/g

0.07

434

Cystic fibrosis

21.00

16.94

1.4

1.3

250.66

363.16

ug/g

—

Iron deficiency

285

2.92

16.85

1.3

1.4

351.06

332.34

ug/g

0.27

144

Open wound of lower leg

322

1949

1.68

16.78

1.5

1.4

259.43

274.46

ug/g

0.65

204

1122

Other and unspecified injuries of head

173

868

2.05

16.77

1.4

265.32

276.19

ug/g

0.25

103

498

Malignant neoplasm of skin

992

5015

1.35

16.76

1.4

267.42

284.45

ug/g

1.91

627

2929

Interstitial lung disease

333

2036

1.67

16.74

1.4

1.5

284.02

261.93

ug/g

0.49

207

1251

Interstitial lung disease endpoints

333

2036

1.67

16.74

1.4

1.5

284.02

261.93

ug/g

0.49

207

1251

Selective deficiency of immunoglobulin G [IgG] subclasses

5.61

16.72

2.0

1.5

331.85

286.85

ug/g

0.50

Other interstitial pulmonary diseases

333

2037

1.67

16.71

1.4

1.5

284.02

262.22

ug/g

0.48

207

1252

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

945

4733

1.36

16.65

1.5

1.4

273.85

282.13

ug/g

0.41

594

2789

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

160

786

2.11

16.61

1.5

1.4

259.69

284.50

ug/g

0.84

451

Bronchiectasis

189

983

1.98

16.59

1.3

1.4

282.14

271.12

ug/g

0.33

110

592

Zoster [herpes zoster]

407

2616

1.58

16.58

1.5

1.4

270.36

270.42

ug/g

0.00

234

1580

Nephrotic syndrome

328

2.78

16.57

1.4

257.79

282.55

ug/g

0.64

200

Injuries to the elbow and forearm

1460

9903

1.27

16.51

1.4

267.17

278.39

ug/g

1.17

812

5695

Kela-code for severe mental illness

687

4904

1.42

16.35

1.4

297.57

275.71

ug/g

1.97

399

2786

Oesophageal obstruction

324

2.76

16.33

1.5

1.4

256.81

272.35

ug/g

0.31

193

Abrasion of teeth

760

5532

1.39

16.17

1.5

1.4

287.04

278.67

ug/g

0.51

463

3166

Varicose veins

1242

7283

1.30

16.17

1.4

273.84

270.94

ug/g

0.20

761

4293

Basal cell carcinoma, including Hilmo

914

4595

1.36

16.11

1.5

1.4

272.91

282.37

ug/g

0.47

571

2711

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

140

659

2.18

16.06

1.7

1.4

240.75

298.99

ug/g

2.13

353

Gluteal tendinitis

106

445

2.46

16.06

1.5

1.4

298.81

294.92

ug/g

0.07

261

Other necrotizing vasculopathies (FG)

142

674

2.17

16.06

1.5

1.4

291.95

261.36

ug/g

0.90

401

Ethmoidectomy

270

1580

1.74

16.03

1.5

1.4

297.78

276.95

ug/g

0.78

142

907

Cerebral palsy and other paralytic syndromes

233

1307

1.82

16.02

1.5

1.4

270.96

282.82

ug/g

0.40

149

756

Secondary malignant neoplasm of respiratory and digestive organs

148

3.72

16.00

1.6

1.4

237.17

294.49

ug/g

0.94

Other hammer toe(s) (acquired)

360

2056

1.62

15.97

1.5

1.4

285.59

259.21

ug/g

1.53

226

1234

Other viral diseases, not elsewhere classified, including avohilmo

503

3384

1.49

15.93

1.5

1.4

304.18

285.73

ug/g

1.12

291

1870

Fracture of lower leg, including ankle

1122

8497

1.31

15.90

1.5

1.4

258.44

275.90

ug/g

2.10

656

4908

Thyrotoxicosis, other and/or unspecified

415

2706

1.56

15.83

1.4

282.15

279.59

ug/g

0.09

252

1541

Colorectal cancer

467

2990

1.52

15.83

1.4

235.36

279.33

ug/g

4.49

289

1793

Open wound of ankle and foot

213

1167

1.86

15.83

1.4

261.59

276.49

ug/g

0.47

135

676

Hypopituitarism

158

784

2.07

15.80

1.5

1.4

311.71

287.37

ug/g

0.78

474

Later onset COPD, excluding more controls

415

2048

1.57

15.68

1.4

262.17

257.13

ug/g

0.19

250

1249

Malignant neoplasm of liver and intrahepatic bile ducts

269

2.90

15.64

1.3

1.5

250.00

285.26

ug/g

0.69

174

Small fibre neuropathy

321

2.74

15.62

1.6

1.5

286.71

273.00

ug/g

0.20

202

Acute suppurative otitis media

440

2706

1.53

15.59

1.4

308.64

297.54

ug/g

0.43

236

1407

Emotional disorders starting during childhood or adolecense, excluding more controls

222

3.03

15.57

1.4

282.61

358.45

ug/g

1.49

115

Idiopathic gout

205

1118

1.88

15.54

1.4

1.5

255.35

255.91

ug/g

0.01

131

686

Benign neoplasm: Adrenal gland

188

1000

1.94

15.48

1.5

1.4

244.81

276.31

ug/g

1.26

108

604

Cramp and spasm

117

522

2.32

15.47

1.6

1.4

272.31

278.91

ug/g

0.12

302

COPD, hospital admission 2, with asthma infections

646

3959

1.42

15.37

1.5

1.4

271.00

257.32

ug/g

0.90

392

2436

Seronegative rheumatoid arthritis

252

1465

1.76

15.36

1.4

276.35

267.89

ug/g

0.27

144

866

Crohn's disease of large intestine

111

485

2.36

15.35

1.5

1.4

275.27

293.99

ug/g

0.38

279

Leisure time condition

367

2346

1.59

15.32

1.5

1.4

289.82

275.55

ug/g

0.56

220

1348

Other skin changes

420

2771

1.54

15.23

1.5

1.4

273.16

266.53

ug/g

0.25

240

1660

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

173

3.42

15.22

1.6

1.4

322.12

317.71

ug/g

0.05

Thyroiditis, ILD-related definition

241

1387

1.77

15.21

1.4

302.96

289.23

ug/g

0.45

148

773

Childhood asthma (age<16)

172

684

1.98

15.11

1.3

344.41

316.05

ug/g

0.82

330

Corticotropin deficiency

4.60

15.05

1.8

1.4

283.08

307.99

ug/g

0.34

Psoriatic and enteropathic arthropathies

238

1369

1.77

15.04

1.6

1.4

272.63

266.41

ug/g

0.18

143

802

Traumatic subdural haemorrhage

256

1400

1.74

15.03

1.4

253.08

249.81

ug/g

0.08

153

857

Other and unspecified disorders of skin and subcutaneous tissue

148

732

2.08

15.03

1.5

1.4

278.03

282.85

ug/g

0.10

429

Colitis, primary sclerosing

126

3.89

15.03

1.5

1.4

215.79

313.00

ug/g

2.03

Unknown and unspecified causes of morbidity

131

617

2.17

15.02

1.5

1.4

281.52

280.05

ug/g

0.02

341

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

176

925

1.95

15.01

1.5

1.4

259.75

286.20

ug/g

0.88

112

534

Intussusception

164

3.44

15.00

1.7

1.3

245.97

295.47

ug/g

1.03

102

Other necrotizing vasculopathies

170

885

1.98

14.95

1.5

1.4

289.78

271.19

ug/g

0.52

521

Diagnoses used for exclusion with ILD

504

3463

1.47

14.91

1.5

1.4

253.34

266.86

ug/g

0.78

302

2081

Malignant neoplasm of colon, including Hilmo

362

2311

1.58

14.91

1.4

232.90

277.02

ug/g

4.03

234

1405

Atrophic disorders of skin

347

2206

1.60

14.91

1.4

293.80

283.26

ug/g

0.41

199

1264

Childhood asthma (age<16), excluding more controls

171

682

1.98

14.90

1.3

344.41

313.14

ug/g

0.95

328

Primary biliary cholangitis (PBC)

212

3.13

14.84

1.3

1.4

294.26

304.98

ug/g

0.13

123

Polycystic kidney disease

290

2.79

14.78

1.4

1.5

299.94

285.64

ug/g

0.22

174

Scoliosis

162

832

1.99

14.68

1.4

278.38

283.51

ug/g

0.11

468

Hypercalcemia

116

529

2.28

14.64

1.6

1.5

246.43

271.83

ug/g

0.57

313

Schizophrenia or delusion, excluding more controls

479

3225

1.48

14.61

1.4

287.90

277.36

ug/g

0.49

274

1872

Amputation of foot

269

2.85

14.60

1.5

214.52

261.22

ug/g

1.16

163

Other malignant neoplasms of skin (=non-melanoma skin cancer)

895

4569

1.34

14.53

1.5

1.4

266.02

281.99

ug/g

1.58

558

2697

Other infectious diseases

168

879

1.96

14.51

1.4

1.5

270.79

279.27

ug/g

0.21

102

528

Enteropathic arthropathies

204

3.13

14.48

1.6

1.4

269.86

296.83

ug/g

0.45

117

Atopic dermatitis, strict definition with reimbursement

517

3441

1.46

14.47

1.4

306.57

293.23

ug/g

0.69

278

1855

Nonsuppurative otitis media

395

2243

1.54

14.44

1.4

320.70

296.07

ug/g

1.31

213

1172

Other otitis externa (chronic)

155

791

2.01

14.43

1.5

1.4

293.70

287.25

ug/g

0.13

454

Redundant prepuce, phimosis and paraphimosis

348

2190

1.58

14.41

1.5

259.02

256.84

ug/g

0.07

199

1328

FESS (DNB20)

257

1530

1.71

14.39

1.5

1.4

299.33

278.64

ug/g

0.74

136

880

Diplopia

274

1659

1.68

14.38

1.5

1.4

273.38

272.23

ug/g

0.03

159

959

Deficiency of other B group vitamins

216

3.07

14.38

1.4

1.5

287.45

279.23

ug/g

0.10

129

Failure and rejection of transplanted organs and tissues

135

3.73

14.37

1.8

1.3

305.87

304.33

ug/g

0.01

Injury of eye and orbit

267

1604

1.69

14.37

1.5

1.4

269.30

270.12

ug/g

0.02

153

910

Impotence

120

558

2.21

14.32

1.6

255.31

238.39

ug/g

0.38

352

Basal cell carcinoma

872

4466

1.34

14.31

1.4

262.29

282.81

ug/g

2.35

544

2636

Familial hypercholesterolemia

300

1860

1.64

14.31

1.4

243.21

264.23

ug/g

1.06

177

1119

Other menopausal disorders

487

1832

1.50

14.30

1.4

292.57

270.47

ug/g

1.39

278

1045

Nonsuppurative otitis media, including avohilmo

559

3397

1.44

14.27

1.4

302.16

284.74

ug/g

1.10

311

1840

Other disorders starting during childhood or adolecense, excluding more controls

256

2.77

14.26

1.2

1.4

350.03

357.38

ug/g

0.08

127

Disorders of phosphorus metabolism and phosphatases

6.72

14.24

1.7

1.4

207.24

272.02

ug/g

0.66

Disorder of the sleep-wake schedule

170

3.35

14.24

1.4

291.34

289.76

ug/g

0.02

Speech therapy

529

3705

1.45

14.20

1.5

1.4

280.78

272.65

ug/g

0.42

358

2173

Benign thyroid growths and nodules

672

4549

1.39

14.15

1.4

294.39

273.89

ug/g

1.83

399

2633

Biological medication for rheuma

342

2193

1.58

14.12

1.5

1.4

292.58

283.29

ug/g

0.34

186

1220

Benign neoplasm: Ill-defined sites within the digestive system

5.11

14.06

1.3

1.4

300.15

298.81

ug/g

0.01

Superficial injury of ankle and foot

237

1389

1.73

14.01

1.5

1.4

291.05

292.59

ug/g

0.03

123

763

6-mercaptopurine

314

2.63

14.01

1.7

1.4

286.74

296.69

ug/g

0.14

175

Cystic kidney disease

351

2.56

14.00

1.4

297.57

292.93

ug/g

0.07

212

Bruxism

193

3.17

13.98

1.2

1.4

371.40

309.27

ug/g

1.08

106

Appendicitis, broad definition

1426

10307

1.25

13.96

1.4

287.07

275.62

ug/g

1.17

813

5884

Cerebral cysts

124

590

2.16

13.96

1.5

1.4

318.66

297.09

ug/g

0.46

324

Magnesium deficiency

7.20

13.95

1.8

1.3

225.00

282.41

ug/g

0.76

Hallux rigidus

282

1734

1.65

13.93

1.4

283.40

257.91

ug/g

1.28

162

1044

Cystic kidney disease, including avohilmo

382

2.48

13.93

1.5

1.4

295.73

289.66

ug/g

0.10

233

Other disorders involving the immune mechanism, not elsewhere classified

328

2.60

13.91

1.6

1.5

262.48

285.17

ug/g

0.43

190

Anogenital herpesviral [herpes simplex] infection

128

617

2.12

13.89

1.5

1.4

278.04

306.13

ug/g

0.68

308

Vitamin D deficiency

183

3.22

13.89

1.7

1.5

238.28

302.84

ug/g

1.24

108

Tongue abnormality

148

755

2.02

13.87

1.5

1.4

313.46

278.22

ug/g

1.14

443

Trigeminal neuralgia

135

666

2.08

13.83

1.4

286.52

291.54

ug/g

0.09

374

Follow-up care involving plastic surgery

395

2.44

13.82

1.4

291.76

305.01

ug/g

0.21

211

Diseases of appendix

1437

10373

1.25

13.78

1.4

285.56

275.05

ug/g

1.04

820

5927

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

205

1163

1.81

13.74

1.5

1.4

252.84

273.20

ug/g

0.77

118

689

Psoriasis vulgaris

368

2420

1.54

13.60

1.4

277.31

275.48

ug/g

0.06

208

1426

Diseases of spleen

187

3.17

13.45

1.5

1.4

265.42

283.56

ug/g

0.26

112

Primary gonarthrosis, bilateral

1087

7136

1.29

13.44

1.5

1.4

271.88

265.18

ug/g

0.53

677

4270

Systemic sclerosis (FG)

264

2.78

13.44

1.5

1.4

314.91

282.23

ug/g

0.62

153

Nail disorders

183

1010

1.85

13.41

1.7

1.4

256.45

289.22

ug/g

1.48

118

580

Unspecified protein-energy malnutrition

5.99

13.39

1.3

1.4

225.29

312.39

ug/g

1.09

Drug-induced cataract

265

2.78

13.36

1.5

1.4

291.49

294.80

ug/g

0.04

158

Other and unspecified myopathies

188

1049

1.83

13.30

1.4

255.45

271.03

ug/g

0.48

102

639

Diseases of middle ear and mastoid

1057

6747

1.29

13.27

1.4

296.72

281.74

ug/g

1.30

577

3799

Algoneurodystrophy

348

2.51

13.23

1.6

1.5

310.34

305.86

ug/g

0.05

200

Visual impairment including blindness (binocular or monocular)

153

803

1.95

13.14

1.5

1.4

277.29

278.46

ug/g

0.02

474

Oligomenorrhoea

283

2.66

13.12

1.4

1.3

327.28

290.17

ug/g

0.74

137

Secondary uncertain malignant neoplasm

255

1554

1.67

13.07

1.5

1.4

249.67

284.26

ug/g

1.85

156

939

Protein-energy malnutrition of moderate and mild degree

4.24

13.06

1.4

1.5

269.63

289.69

ug/g

0.19

Disorders of continuity of bone

215

1254

1.75

13.05

1.3

1.4

270.40

284.52

ug/g

0.43

131

702

Adenocarcinoma of small intestine

12.92

13.03

1.5

1.3

150.73

324.00

ug/g

2.38

Agranulocytosis

241

1451

1.70

13.02

1.4

257.62

276.85

ug/g

0.74

158

856

Spinal instabilities

262

2.74

13.01

1.4

240.54

273.91

ug/g

0.73

157

Suppurative and unspecified otitis media

609

3914

1.39

13.00

1.4

299.93

286.83

ug/g

0.68

331

2128

Haemorrhage, not elsewhere classified

338

2.50

12.99

1.8

1.4

220.70

270.60

ug/g

1.39

201

Sulfasalazine

523

3715

1.42

12.95

1.5

1.4

267.60

273.21

ug/g

0.24

304

2131

Early lumbar disc prolapse, operated

160

854

1.90

12.94

1.4

288.46

286.57

ug/g

0.03

463

Malignant neoplasm of urinary organs, including Hilmo

215

1256

1.74

12.94

1.4

240.06

279.87

ug/g

2.03

131

779

Acne, including avohilmo

322

1668

1.58

12.90

1.4

1.3

287.99

316.57

ug/g

1.35

160

784

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

192

1088

1.80

12.87

1.4

245.86

283.64

ug/g

1.65

115

672

Other pleural conditions

211

1229

1.75

12.87

1.4

1.5

245.25

269.45

ug/g

0.90

131

744

Other specified/unspecified systemic involvement of connective tissue

135

685

2.03

12.87

1.3

1.4

317.16

296.01

ug/g

0.51

380

ILD, hospital admissions 1, main diag only

285

1795

1.62

12.85

1.5

286.97

262.40

ug/g

0.46

172

1102

Viral warts, including avohilmo

417

2847

1.48

12.83

1.5

1.4

270.43

280.71

ug/g

0.48

254

1600

Acute appendicitis, no complications

1032

8058

1.28

12.82

1.4

287.77

277.71

ug/g

0.79

593

4569

CR(E)ST syndrome

177

3.19

12.80

1.5

1.3

308.85

307.52

ug/g

0.01

101

Other bursitis of hip

214

2.94

12.79

1.5

265.69

297.53

ug/g

0.62

127

Myocardial infarction

960

5195

1.30

12.78

1.5

1.4

254.86

260.72

ug/g

0.38

616

3070

Excessive earwax

1297

9473

1.25

12.77

1.5

1.4

271.02

268.43

ug/g

0.17

781

5505

Pure hyperglyceridaemia

214

2.93

12.76

1.7

1.4

279.15

268.42

ug/g

0.13

124

Postmenopausal osteoporosis with pathological fracture

166

906

1.89

12.76

1.4

246.26

275.70

ug/g

0.95

533

Otitis externa, unspecified

229

1368

1.70

12.71

1.4

301.81

286.05

ug/g

0.53

127

765

Systemic lupus erythematosus

411

2.35

12.71

1.4

341.46

296.91

ug/g

1.25

241

Endometriosis of ovary

284

1681

1.61

12.67

1.5

1.3

289.54

271.95

ug/g

0.66

143

928

Special screening examination for neoplasms

120

585

2.09

12.65

1.4

300.17

261.28

ug/g

1.01

348

Benign paroxysmal vertigo

614

4505

1.38

12.61

1.4

282.29

270.85

ug/g

0.68

329

2688

Chondrocostal junction syndrome [Tietze]

425

2.32

12.59

1.6

1.4

290.86

293.46

ug/g

0.04

246

Rash and other nonspecific skin eruption

206

1200

1.75

12.59

1.3

1.4

278.28

285.16

ug/g

0.18

125

696

COPD-related respiratory insufficiency

234

1410

1.69

12.59

1.5

1.4

287.13

259.76

ug/g

1.31

155

866

therapeutic use

357

2.45

12.58

1.5

261.84

287.93

ug/g

0.51

218

Other (seronegative) rheumatoid arthritis, wide

390

2642

1.50

12.57

1.5

1.4

283.27

272.72

ug/g

0.48

230

1567

Spondyloarthritis

325

2116

1.56

12.57

1.5

1.4

255.81

274.42

ug/g

0.83

180

1224

Glaucoma

1159

7845

1.26

12.55

1.5

1.4

261.83

264.78

ug/g

0.19

712

4646

Systemic sclerosis, icd10

274

2.68

12.52

1.5

1.4

314.91

293.12

ug/g

0.37

157

Other peripheral vascular diseases

178

997

1.83

12.48

1.4

301.10

287.88

ug/g

0.37

113

568

Postviral fatigue syndrome

4.66

12.42

1.4

341.50

354.22

ug/g

0.08

Acute appendicitis

1323

9957

1.24

12.32

1.4

289.71

275.60

ug/g

1.52

755

5678

Superficial injury of hip and thigh

306

1978

1.57

12.27

1.5

1.4

269.64

275.02

ug/g

0.17

182

1169

Epilepsy

543

3906

1.40

12.26

1.5

1.4

259.14

266.48

ug/g

0.35

327

2286

Chronic hepatitis, not elsewhere classified

367

2.40

12.25

1.4

286.74

301.01

ug/g

0.24

220

Seborrhoeic dermatitis

199

1157

1.75

12.23

1.6

1.4

264.53

274.27

ug/g

0.25

121

666

Superficial injury of shoulder and upper arm

238

1451

1.67

12.22

1.5

1.4

273.68

282.99

ug/g

0.29

138

811

Lichen simplex chronicus and prurigo

139

725

1.97

12.22

1.5

1.4

271.43

281.29

ug/g

0.22

426

Extreme obesity with alveolar hypoventilation

102

476

2.22

12.22

1.6

1.5

279.29

287.46

ug/g

0.14

291

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

294

1887

1.58

12.20

1.5

1.4

255.94

284.68

ug/g

1.60

173

1142

Pneumonitis due to solids and liquids

164

902

1.85

12.18

1.5

225.29

268.22

ug/g

1.96

549

Salpingitis and oophoritis

354

2368

1.52

12.17

1.4

293.37

285.00

ug/g

0.28

197

1331

Other disorders of conjunctiva

293

1882

1.58

12.16

1.6

1.5

267.77

269.36

ug/g

0.04

171

1140

Eosinophilic disease (BM)

120

3.59

12.15

1.7

1.4

300.52

292.91

ug/g

0.06

608

3836

1.38

12.14

1.5

1.4

256.90

261.04

ug/g

0.19

362

2339

Syphilis, including avohilmo

278

2.63

12.13

1.7

1.4

191.75

269.94

ug/g

2.77

160

Syphilis

278

2.63

12.13

1.7

1.4

191.75

269.94

ug/g

2.77

160

Hepatocellular carcinoma, including Hilmo

254

2.69

12.12

1.2

1.4

287.86

284.10

ug/g

0.05

162

Malignant neoplasm of colon

290

1859

1.58

12.08

1.4

231.10

278.08

ug/g

3.48

182

1128

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

208

1220

1.72

12.08

1.4

314.30

304.62

ug/g

0.27

111

640

Other disorders of breast

285

1822

1.59

12.07

1.4

293.84

285.50

ug/g

0.29

156

978

Systemic sclerosis

280

2.62

11.99

1.5

1.4

314.91

296.47

ug/g

0.30

158

Emotional disorders and disorders of social functioning with onset specific to childhood

348

2.38

11.98

1.3

1.4

306.74

348.03

ug/g

0.68

169

In situ neoplasms

807

6207

1.31

11.97

1.4

281.02

270.04

ug/g

0.72

455

3620

Flat foot [pes planus] (acquired)

194

1127

1.75

11.97

1.4

285.73

269.11

ug/g

0.48

111

667

Giant cell arteritis

103

487

2.19

11.95

1.4

279.16

279.49

ug/g

0.00

296

Raynaud syndrome

187

1078

1.77

11.90

1.4

323.10

284.75

ug/g

1.71

106

585

Hypertrophy of breast in women and men

383

2614

1.48

11.88

1.4

293.15

286.39

ug/g

0.24

201

1423

Endocrine disorders, other/unspecified

201

2.93

11.85

1.3

1.4

242.67

291.70

ug/g

0.95

126

Other hearing loss

562

3974

1.38

11.84

1.5

1.4

267.89

261.46

ug/g

0.29

331

2394

444

2905

1.44

11.83

1.4

258.47

261.21

ug/g

0.10

269

1778

Other bursopathies

247

1533

1.64

11.82

1.4

285.75

263.89

ug/g

0.82

129

942

SLE, ICD10

386

2.34

11.82

1.4

350.84

298.11

ug/g

1.59

224

SLE, strict definition

386

2.34

11.82

1.4

350.84

298.11

ug/g

1.59

224

Family history of malignant neoplasm

223

1350

1.68

11.80

1.5

1.4

266.62

283.55

ug/g

0.51

132

729

Amputation of ankle bones

218

2.83

11.80

1.4

242.68

270.44

ug/g

0.48

132

Pacemaker

706

4958

1.34

11.78

1.5

1.4

255.46

259.56

ug/g

0.22

429

3037

Dermatographic urticaria

139

734

1.94

11.77

1.3

1.4

331.90

298.61

ug/g

1.03

404

Procreative management

606

3679

1.37

11.70

1.5

1.4

273.23

282.34

ug/g

0.46

342

2090

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

307

2.51

11.69

1.7

1.5

256.48

286.05

ug/g

0.59

180

Rheumatoid arthritis, including avohilmo

761

5828

1.32

11.68

1.4

287.02

271.19

ug/g

1.33

433

3408

Panniculitis affecting regions of neck and back

331

2.43

11.65

1.5

1.4

223.44

280.49

ug/g

1.56

200

Inguinal hernia

1050

5525

1.27

11.60

1.5

1.4

264.04

263.73

ug/g

0.01

627

3258

Degeneration of the brain due to alcohol

226

2.78

11.59

1.7

1.5

264.12

256.61

ug/g

0.08

137

Ehlers-Danlos syndrome

105

3.78

11.59

1.7

1.4

296.12

316.58

ug/g

0.18

Malignant neoplasm of kidney, except renal pelvis

172

975

1.80

11.59

1.4

245.56

284.35

ug/g

1.73

105

597

Folate deficiency anaemia

110

3.71

11.57

1.4

1.5

217.77

281.19

ug/g

0.97

Keratitis

695

5262

1.33

11.57

1.5

1.4

279.11

274.85

ug/g

0.13

409

3020

Sequelae of injuries of lower limb

185

1073

1.76

11.51

1.6

1.4

237.21

287.72

ug/g

2.89

118

612

Hydronephrosis

221

1345

1.67

11.47

1.6

1.4

243.93

273.36

ug/g

1.17

140

791

Methotrexate

268

1709

1.59

11.47

1.4

290.75

275.92

ug/g

0.54

148

994

Disorders of plasma-protein metabolism, not elsewhere classified

4.95

11.45

1.2

1.4

314.77

294.25

ug/g

0.13

Effects of foreign body entering through natural orifice

449

3180

1.43

11.41

1.4

1.5

283.13

273.46

ug/g

0.41

258

1822

Other and unspecified aplastic anaemias

106

3.72

11.41

1.4

1.3

254.89

329.64

ug/g

1.16

Wide developmental disorders, excluding more controls

182

2.91

11.40

1.6

1.4

343.08

346.46

ug/g

0.03

Dysplasia of cervi uteri

367

1741

1.50

11.38

1.3

338.15

279.04

ug/g

5.32

201

928

Other abnormalities of plasma proteins

162

3.13

11.37

1.4

1.5

246.63

267.90

ug/g

0.24

Other specified/unspecified spondylopathies

222

2.76

11.37

1.5

1.4

232.41

293.26

ug/g

1.36

143

Complications following infusion, transfusion and therapeutic injection

141

3.29

11.36

1.5

1.3

237.23

307.35

ug/g

1.28

Reactive arthropathies

160

893

1.82

11.34

1.4

251.12

254.94

ug/g

0.07

539

Disorders of psychological development

189

1021

1.74

11.34

1.4

325.20

314.88

ug/g

0.27

101

516

Open wound of wrist and hand

823

6169

1.30

11.33

1.4

265.85

273.96

ug/g

0.51

465

3558

Lung diseases due to external agents

262

1667

1.59

11.32

1.5

226.82

268.24

ug/g

2.97

164

1015

Degeneration of nervous system due to alcohol

229

2.75

11.31

1.7

1.5

264.12

258.43

ug/g

0.06

137

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

136

723

1.92

11.29

1.5

1.4

333.26

296.50

ug/g

0.35

385

Degenerative macular diseases

247

1553

1.62

11.28

1.4

263.47

269.04

ug/g

0.16

148

951

Other viral hepatitis

122

626

1.99

11.26

1.4

251.94

302.69

ug/g

1.96

345

Dislocation, sprain and strain of joints and ligaments of knee

1142

8325

1.25

11.24

1.4

279.22

281.26

ug/g

0.11

655

4681

Maltreatment syndromes

100

478

2.14

11.19

1.6

1.4

269.24

306.46

ug/g

0.72

253

Medial epicondylitis

356

2.34

11.19

1.3

1.4

293.15

287.94

ug/g

0.06

216

Hepatomegaly and splenomegaly, not elsewhere classified

4.61

11.17

1.4

1.3

307.05

262.27

ug/g

0.40

Malignant neoplasm of urinary organs

183

1068

1.74

11.14

1.4

238.93

282.40

ug/g

2.23

114

659

Ischaemic Stroke, excluding all haemorrhages

1121

6636

1.25

11.06

1.4

253.90

263.23

ug/g

0.80

677

3958

Other maltreatment syndromes

278

2.53

11.05

1.4

286.54

307.75

ug/g

0.25

156

Car occupant injured in other and unspecified transport accidents

339

2294

1.50

11.00

1.5

1.4

293.33

281.54

ug/g

0.43

180

1280

Other viral hepatitis, including avohilmo

127

666

1.95

11.00

1.4

249.04

297.04

ug/g

1.85

365

Other respiratory disorders and diseases

387

2689

1.46

10.97

1.5

1.4

263.68

264.96

ug/g

0.04

242

1641

Other diseases of the respiratory system

387

2689

1.46

10.97

1.5

1.4

263.68

264.96

ug/g

0.04

242

1641

Other benign neoplasms of skin

742

5714

1.31

10.97

1.5

1.4

264.76

271.94

ug/g

0.43

421

3365

Injuries to unspecified part of trunk, limb or body region

207

1255

1.68

10.95

1.5

1.4

262.33

284.15

ug/g

0.72

127

725

Congenital malformations of the urinary system, including avohilmo

129

682

1.94

10.94

1.4

299.68

299.72

ug/g

0.00

397

Other disorders of white blood cells

119

613

1.99

10.93

1.5

290.82

275.38

ug/g

0.31

370

AV-block

340

1960

1.50

10.92

1.5

1.4

241.34

260.05

ug/g

1.10

201

1197

Primary hyperparathyroidism

245

1552

1.61

10.91

1.4

258.36

271.73

ug/g

0.45

135

929

Sequelae of injuries of neck and trunk

311

2.43

10.89

1.6

1.4

257.07

286.19

ug/g

0.52

182

Corns and callosities

145

798

1.86

10.86

1.5

1.4

248.11

277.97

ug/g

1.13

473

Encephalopathy

105

3.68

10.86

1.5

1.4

298.81

282.01

ug/g

0.18

Systemic lupus erythematosus, unspecified

331

2.39

10.82

1.4

360.27

298.37

ug/g

1.84

193

Tonsillectomy and adenotomy

942

5172

1.27

10.82

1.4

322.19

291.00

ug/g

3.47

454

2870

Other noninflammatory disorders of vagina

150

834

1.83

10.80

1.4

1.3

317.46

273.99

ug/g

1.60

453

Sequelae of other external causes

123

644

1.96

10.75

1.4

274.80

285.71

ug/g

0.21

378

Achalasia of cardia

146

3.15

10.69

1.5

1.3

262.63

279.50

ug/g

0.18

Myocardial infarction, without ST-elevation

775

5424

1.30

10.68

1.5

1.4

256.60

257.92

ug/g

0.06

481

3318

Acne

162

918

1.78

10.66

1.4

1.3

269.47

318.76

ug/g

1.76

432

Vulvovaginal ulceration/inflammation in other diseases

129

687

1.91

10.66

1.5

1.3

332.97

306.52

ug/g

0.73

340

Disorders of refraction and accommodation

518

3786

1.38

10.66

1.5

1.4

287.00

282.30

ug/g

0.19

279

2110

Hypertrophic disorders of skin

116

597

1.99

10.64

1.5

1.4

286.69

300.64

ug/g

0.27

318

Ulcerative ileocolitis

390

2.24

10.63

1.5

1.4

286.74

298.88

ug/g

0.18

225

Allergic urticaria

162

927

1.78

10.61

1.3

1.4

312.87

291.76

ug/g

0.60

502

Congenital malformations of the urinary system

121

633

1.96

10.61

1.4

299.22

296.39

ug/g

0.05

367

Orchitis and epididymitis

158

897

1.79

10.59

1.5

246.38

253.34

ug/g

0.14

550

Presence of other devices

471

3353

1.40

10.58

1.6

1.4

267.65

265.00

ug/g

0.10

284

2029

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.87

10.54

1.6

1.4

304.94

307.67

ug/g

0.03

Benign neoplasm of mouth and pharynx

218

1354

1.64

10.52

1.5

1.4

299.56

277.30

ug/g

0.31

137

793

Chronic viral hepatitis

103

511

2.06

10.49

1.4

260.62

304.88

ug/g

1.34

275

Hypoparathyroidism

446

2.16

10.48

1.8

1.4

258.86

289.67

ug/g

0.89

260

Stroke, including SAH

1250

7340

1.23

10.47

1.4

256.79

263.84

ug/g

0.59

756

4356

Stroke, excluding SAH

1187

6974

1.24

10.47

1.4

254.29

263.82

ug/g

0.85

715

4155

Non-Hodgkin lymphoma, all, including Hilmo

243

1550

1.59

10.45

1.5

1.4

267.74

284.73

ug/g

0.65

147

944

Chondropathies

284

1876

1.53

10.42

1.4

321.95

278.92

ug/g

0.87

154

1046

Alcohol induced polyneuropathy

103

3.64

10.42

1.6

290.33

273.96

ug/g

0.17

Tumor necrosis factor alpha inhibitors

292

1940

1.52

10.41

1.4

296.17

286.45

ug/g

0.32

159

1080

Postprocedural disorders of nervous system

132

714

1.88

10.41

1.5

1.3

317.76

304.77

ug/g

0.27

358

Common variable immunodeficiency

4.60

10.40

1.4

1.2

399.45

336.28

ug/g

0.92

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

319

2095

1.50

10.39

1.5

1.4

294.84

286.02

ug/g

0.31

191

1180

Ulcerative enterocolitis

299

2.42

10.38

1.5

1.4

243.45

307.99

ug/g

1.84

176

Adalimumab

187

1120

1.70

10.38

1.5

1.4

305.51

294.28

ug/g

0.28

607

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

300

1943

1.52

10.38

1.4

288.57

286.73

ug/g

0.05

178

1094

Other congenital malformations of the digestive system, including avohilmo

112

571

2.00

10.36

1.7

1.4

274.35

309.37

ug/g

0.98

322

Morphin

176

2.88

10.31

1.3

1.4

240.45

285.39

ug/g

0.72

101

Lesion of lateral popliteal nerve

104

522

2.04

10.29

1.7

1.4

245.56

280.15

ug/g

0.82

301

Congenital malformations and deformations of the musculoskeletal system

161

922

1.77

10.29

1.5

1.4

310.48

309.68

ug/g

0.01

490

Acute and subacute iridocyclitis

356

2467

1.46

10.28

1.6

1.4

262.13

272.27

ug/g

0.39

222

1449

Ingrowing nail

115

598

1.97

10.28

1.6

1.4

252.17

287.72

ug/g

1.23

353

Glucosamine medication

951

6058

1.26

10.26

1.5

1.4

266.28

263.93

ug/g

0.14

592

3618

Congenital malformations of the musculoskeletal system, not elsewhere classified

150

3.09

10.26

1.7

1.4

308.70

315.90

ug/g

0.07

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

139

3.16

10.25

1.3

1.4

197.52

293.39

ug/g

2.63

Coxarthrosis, primary

1221

8313

1.23

10.25

1.4

271.32

264.38

ug/g

0.55

721

4966

Colorectal adenocarcinoma

366

2521

1.45

10.15

1.4

232.16

275.27

ug/g

3.46

223

1535

Periapical abscess

895

7126

1.27

10.14

1.5

1.4

268.32

273.97

ug/g

0.33

519

4129

Assault by unspecified means

178

2.86

10.13

1.4

1.5

271.53

286.34

ug/g

0.14

103

Atopic dermatitis, strict definition

493

3540

1.37

10.07

1.4

311.75

294.90

ug/g

0.94

264

1892

Campylobacter enteritis

285

2.44

10.07

1.4

1.5

269.95

278.37

ug/g

0.09

166

Multiple myeloma, including Hilmo

452

2.11

10.06

1.4

1.5

222.21

287.08

ug/g

2.46

281

Other/unspecified enthesopathies, not elsewhere classified

155

890

1.77

10.04

1.4

306.93

267.85

ug/g

1.41

544

Other and unspecified rosacea

189

1148

1.68

10.00

1.3

1.4

326.92

288.89

ug/g

1.28

101

654

Suppurative and necrotic conditions of lower respiratory tract

117

619

1.94

9.96

1.5

1.4

203.37

270.37

ug/g

3.34

388

Primary_lymphoid and hematopoietic malignant neoplasms

467

3415

1.38

9.93

1.5

1.4

266.89

266.45

ug/g

0.02

284

2082

Hemiplegia

105

537

2.00

9.86

1.5

1.4

277.25

282.81

ug/g

0.11

321

Implicit parasitic Sepsis, including avohilmo

4.66

9.84

1.9

1.3

287.37

318.63

ug/g

0.30

Other coagulation defects

149

852

1.78

9.84

1.5

1.4

295.76

290.26

ug/g

0.11

469

Cushing syndrome

117

3.36

9.84

1.5

1.4

213.09

312.10

ug/g

1.76

Other and unspecified abdominal hernia

443

2.11

9.83

1.6

1.4

275.13

268.45

ug/g

0.11

265

Postprocedural musculoskeletal disorders, not elsewhere classified

157

913

1.76

9.82

1.5

250.22

273.33

ug/g

0.77

102

538

Viral hepatitis, including avohilmo

143

808

1.80

9.82

1.5

1.4

249.41

292.26

ug/g

1.76

454

Spondylopathies (FG)

240

1549

1.57

9.81

1.5

1.4

266.42

269.25

ug/g

0.07

134

882

Excessive vomiting in pregnancy

145

823

1.79

9.79

1.3

1.4

329.53

309.44

ug/g

0.47

404

Cyst of kidney

154

892

1.77

9.77

1.4

244.79

270.77

ug/g

0.85

541

Speech disturbances, not elsewhere classified

181

1094

1.69

9.77

1.4

261.18

269.26

ug/g

0.20

108

653

Viral hepatitis

136

760

1.82

9.70

1.5

1.4

254.11

295.45

ug/g

1.62

430

Varicose veins of other sites

128

703

1.86

9.68

1.5

1.4

272.72

282.27

ug/g

0.18

422

COPD, hospital admissions 3, with asthma pneumonia sepsis

509

3234

1.36

9.67

1.4

268.37

256.71

ug/g

0.61

302

1999

conjunctival haemorrhage

160

939

1.74

9.67

1.6

1.4

256.32

275.47

ug/g

0.59

566

Short stature, not elsewhere classified

173

2.78

9.66

1.5

1.4

383.55

373.17

ug/g

0.13

Open wound of forearm

179

1081

1.68

9.66

1.5

1.4

258.79

276.69

ug/g

0.54

106

625

Endometriosis ASRM stages 1,2

318

2185

1.47

9.64

1.4

338.20

293.99

ug/g

2.97

154

1171

Toxic effects of substances chiefly nonmedicinal as to source

209

1313

1.62

9.63

1.5

1.4

258.84

285.70

ug/g

1.01

108

753

Psoriatic arthropathies

182

1105

1.67

9.62

1.5

1.4

273.23

259.23

ug/g

0.40

108

663

Benign neoplasm: Anus and anal canal

317

2.33

9.59

1.6

1.4

301.12

288.21

ug/g

0.21

197

Other congenital malformations of the digestive system

457

2.07

9.58

1.6

1.4

263.74

312.95

ug/g

1.50

268

Thyrotoxicosis

497

3691

1.36

9.58

1.4

281.78

277.68

ug/g

0.17

303

2106

Hypertensive Renal Disease

342

2.25

9.54

1.5

1.4

259.55

278.60

ug/g

0.41

210

Unstable angina pectoris

700

4266

1.30

9.53

1.5

1.4

252.43

258.93

ug/g

0.36

425

2554

Medical abortion

1183

5242

1.23

9.50

1.4

289.76

288.10

ug/g

0.09

654

2897

Unspecified acute lower respiratory infection

281

1891

1.50

9.47

1.4

279.41

269.35

ug/g

0.36

164

1088

Examination and encounter for administrative purposes

141

802

1.79

9.46

1.3

1.4

281.75

255.95

ug/g

0.64

483

Urethritis and urethral syndrome

232

2.55

9.46

1.4

1.5

359.96

280.66

ug/g

2.20

138

Bursitis of shoulder

244

2.50

9.44

1.3

1.5

256.87

286.04

ug/g

0.47

152

Other salmonella infections

357

2.22

9.44

1.5

1.4

398.31

283.10

ug/g

0.54

209

Female infertility

424

1819

1.41

9.41

1.4

1.3

305.48

278.32

ug/g

1.61

218

961

Lesion of radial nerve

391

2.16

9.37

1.7

1.4

264.44

281.47

ug/g

0.27

221

Mantle cell lymphoma, including Hilmo

100

3.45

9.32

1.3

240.17

305.98

ug/g

0.80

Ulcerative proctitis

112

598

1.91

9.26

1.5

1.4

289.03

296.88

ug/g

0.14

344

Isolated proteinuria

278

2.38

9.20

1.6

1.4

265.47

272.98

ug/g

0.10

164

Temporal arteritis

435

2.09

9.20

1.4

290.57

276.06

ug/g

0.24

265

Dependent personality disorder

206

2.63

9.16

1.4

428.17

297.30

ug/g

0.59

119

Anankastic personality disorder

381

2.15

9.16

1.4

301.96

302.81

ug/g

0.01

205

Ganglion

347

2447

1.43

9.13

1.4

297.70

274.89

ug/g

1.00

197

1410

Myocardial infarction, strict

866

4898

1.26

9.12

1.5

1.4

254.22

259.14

ug/g

0.29

558

2900

Viral warts

185

1145

1.64

9.10

1.5

1.4

278.52

290.19

ug/g

0.35

117

627

Other specified/unspecified inflammatory spondylopathies

415

2.09

9.08

1.5

1.4

278.38

292.06

ug/g

0.24

238

Sleep disorders, other/unspecified

343

2.21

9.07

1.4

312.48

292.17

ug/g

0.29

193

Lack of expected normal physiological development

100

3.23

9.06

1.4

1.3

342.26

409.45

ug/g

0.90

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

131

739

1.80

9.04

1.3

1.4

321.00

281.46

ug/g

1.39

424

Herpesviral [herpes simplex] infections

228

1485

1.56

9.03

1.5

1.4

271.23

283.28

ug/g

0.37

134

834

Clear cell adenocarcinoma of kidney

492

2.00

9.03

1.3

1.4

228.05

286.54

ug/g

2.10

307

Emphysema

140

808

1.77

8.98

1.6

1.4

223.93

264.78

ug/g

1.42

495

Respiratory insufficiency

143

827

1.75

8.98

1.4

267.52

272.81

ug/g

0.11

493

Scabies

493

1.99

8.96

1.5

1.4

274.11

284.99

ug/g

0.17

290

Giant cell arteritis with polymyalgia rheumatica

440

2.07

8.93

1.4

290.57

274.54

ug/g

0.27

268

Hypertrophy of breast

328

2303

1.44

8.92

1.4

299.53

291.77

ug/g

0.26

171

1227

Dissociative [conversion] disorders

326

2.23

8.90

1.3

353.61

297.17

ug/g

1.10

178

Mixed hyperlipidaemia

399

2.11

8.90

1.6

1.5

277.40

263.49

ug/g

0.24

241

Pediculosis, acariasis and other infestations

119

657

1.85

8.89

1.5

1.4

274.12

285.79

ug/g

0.21

383

Simple and mucopurulent chronic bronchitis

413

2.08

8.85

1.6

1.4

289.46

271.96

ug/g

0.32

242

L04AC Interleukin inhibitors

126

709

1.81

8.84

1.5

1.4

292.81

289.14

ug/g

0.07

391

Other and unspecified follicular disorders

448

2.04

8.82

1.8

1.5

286.39

285.45

ug/g

0.01

260

Other and unspecified papulosquamous disorders

4.35

8.74

1.4

303.33

297.64

ug/g

0.04

Iridocyclitis

420

3085

1.38

8.74

1.5

1.4

257.96

273.41

ug/g

0.81

264

1804

Osteonecrosis

136

787

1.77

8.72

1.7

1.4

258.72

272.42

ug/g

0.36

464

Nummular dermatitis

162

982

1.68

8.70

1.5

1.4

291.55

272.90

ug/g

0.55

582

Other strabismus

386

2787

1.39

8.70

1.5

1.4

283.72

283.05

ug/g

0.02

211

1561

Hydrocele

187

1173

1.61

8.69

1.7

1.5

223.70

246.86

ug/g

0.82

121

719

Parkinson's disease, strict definition, excluding more controls

206

1230

1.58

8.68

1.4

275.23

243.66

ug/g

1.49

140

753

Memory loss

182

1138

1.63

8.66

1.4

272.39

264.23

ug/g

0.20

101

694

Hepatocellular carcinoma

176

2.70

8.64

1.2

1.4

278.13

282.80

ug/g

0.05

111

Protozoal diseases, including avohilmo

338

2.20

8.63

1.6

1.4

247.13

284.48

ug/g

0.85

201

Heterophoria

149

885

1.71

8.63

1.4

297.95

295.13

ug/g

0.05

476

Organic, including symptomatic, mental disorders

1028

5925

1.23

8.62

1.4

259.44

258.86

ug/g

0.03

603

3616

All dysplastic lesions of the vulva

508

1.96

8.61

1.4

328.31

303.95

ug/g

0.45

287

Other diseases of blood and blood-forming organs

140

820

1.74

8.58

1.5

1.4

286.38

277.12

ug/g

0.19

493

Other peripheral vertigo

189

1196

1.61

8.56

1.5

1.4

284.31

272.82

ug/g

0.27

718

Other disorders of electrolyte and fluid balance, not elsewhere classified

3.58

8.55

1.5

1.4

231.67

280.03

ug/g

0.73

Benign neoplasm: Rectosigmoid junction

461

2.01

8.53

1.3

1.5

315.30

270.93

ug/g

1.14

288

Strabismus

473

3540

1.34

8.53

1.5

1.4

277.14

280.29

ug/g

0.12

270

2009

Other fall from one level to another

400

2926

1.38

8.51

1.5

1.4

272.95

278.71

ug/g

0.20

217

1675

Benign neoplasm: Liver/bile ducts

302

2.26

8.45

1.5

1.4

268.58

293.34

ug/g

0.37

172

Acute generalized exanthematous pustulosis

504

1.95

8.45

1.3

1.4

248.17

288.60

ug/g

1.01

290

Hidradenitis suppurativa

374

2.11

8.41

1.4

297.30

303.66

ug/g

0.09

207

Alzheimer disease, excluding more controls

301

1343

1.46

8.40

1.4

243.59

244.31

ug/g

0.02

171

833

Other superficial mycoses, including avohilmo

186

1176

1.60

8.40

1.3

1.4

319.94

290.40

ug/g

0.99

104

638

Benign neoplasm: Other and unspecified parts of small intestine

180

2.69

8.38

1.4

311.87

285.89

ug/g

0.36

111

Chronic nephritic syndrome

416

2.05

8.36

1.6

1.5

234.96

278.56

ug/g

1.23

253

Left ventricular outflow tract obstruction (LVOTO), broad definition

184

1165

1.60

8.30

1.4

264.17

271.58

ug/g

0.18

101

712

Somnolence, stupor and coma

444

2.01

8.30

1.5

1.4

222.84

277.72

ug/g

1.62

277

Corneal ulcer

334

2385

1.42

8.27

1.5

1.4

267.12

275.21

ug/g

0.29

191

1380

Recurrent dislocation and subluxation of joint

111

613

1.84

8.27

1.4

324.04

294.27

ug/g

0.73

351

Allergic contact dermatitis

243

1636

1.50

8.25

1.3

1.4

304.29

288.60

ug/g

0.52

130

920

Other salmonella infections, including avohilmo

438

2.01

8.25

1.5

1.4

397.52

282.80

ug/g

0.65

248

Acute posthaemorrhagic anaemia

357

2.13

8.25

1.4

1.5

221.00

277.45

ug/g

1.51

214

Congenital iodine-deficiency syndrome/hypothyroidism

292

2.26

8.24

1.4

252.78

301.32

ug/g

1.24

164

Endometriosis of rectovaginal septum and vagina

134

784

1.74

8.22

1.4

1.3

310.44

272.91

ug/g

1.13

430

Scar conditions and fibrosis of skin

446

2.00

8.21

1.4

307.34

298.04

ug/g

0.17

242

Drug-induced osteoporosis with pathological fracture

200

2.58

8.20

1.7

1.4

292.14

297.59

ug/g

0.09

120

Malignant neoplasm of rectum, including Hilmo

210

1373

1.55

8.20

1.4

249.90

280.42

ug/g

1.24

127

849

Parkinson's disease, excluding more controls

217

1310

1.54

8.19

1.4

275.43

245.82

ug/g

1.43

148

805

Dystonia

114

639

1.83

8.17

1.4

314.86

292.41

ug/g

0.56

361

Other disorders of Eustachian tube

339

2.16

8.17

1.5

287.14

280.54

ug/g

0.09

201

Anterior Iridocyclitis

368

2678

1.39

8.16

1.5

1.4

263.26

272.66

ug/g

0.37

233

1562

268

2.32

8.14

1.6

1.4

248.50

295.35

ug/g

0.88

153

Other infective otitis externa

121

691

1.79

8.13

1.5

1.4

281.85

284.16

ug/g

0.04

407

Other inflammation of vagina/vulva

359

2.11

8.12

1.5

1.3

293.33

312.33

ug/g

0.28

187

Pleural effusion

285

1987

1.45

8.11

1.4

1.5

237.23

263.67

ug/g

1.28

179

1233

Problems related to social environment

281

2.27

8.08

1.5

1.4

275.72

292.75

ug/g

0.25

154

Colitis, primary sclerosing, strict definition

3.50

8.08

1.4

1.3

253.20

302.44

ug/g

0.48

Aortic valve malfunction, age under 60 years

171

1072

1.62

8.06

1.4

264.84

266.93

ug/g

0.04

652

Necrobiosis lipoidica, not elsewhere classified

4.09

8.03

1.9

1.4

265.00

308.19

ug/g

0.46

Infective dermatitis

207

1357

1.55

8.01

1.4

270.97

274.15

ug/g

0.07

127

783

Other/unspecified soft tissue disorders related to use, overuse and pressure

276

2.27

7.99

1.5

1.4

308.84

295.39

ug/g

0.16

163

Unspecified renal colic

4.35

7.99

1.2

1.4

261.56

276.69

ug/g

—

Oral lichen planus

323

2.18

7.97

1.3

1.4

296.13

295.19

ug/g

0.01

197

Achilles tendinitis

178

1129

1.60

7.96

1.6

1.4

260.48

272.02

ug/g

0.33

103

676

Benign lipomatous neoplasm

555

4304

1.30

7.96

1.5

1.4

300.06

269.45

ug/g

2.76

325

2534

Reactive arthropathies, FINNGEN

129

755

1.74

7.93

1.4

258.35

276.35

ug/g

0.37

446

Alcohol abuse counselling and surveillance

167

2.69

7.93

1.7

1.4

231.95

278.24

ug/g

0.62

Toxic colitis

7.00

7.91

2.2

1.3

211.00

293.02

ug/g

0.90

Impacted cerumen

226

1515

1.51

7.90

1.5

1.4

253.17

269.81

ug/g

0.55

122

912

Spontaneous rupture of synovium and tendon

151

924

1.66

7.85

1.5

1.4

306.39

263.74

ug/g

1.53

576

Tobacco use

108

603

1.83

7.85

1.6

1.5

265.41

288.67

ug/g

0.47

354

Hypertrophic scar

100

545

1.87

7.84

1.5

1.4

300.50

302.01

ug/g

0.02

291

Chronic tubulo-interstitial nephritis

419

2.01

7.84

1.5

1.4

279.55

292.64

ug/g

0.23

247

Other specified disorders of muscle

285

2.24

7.84

1.5

1.4

278.28

283.52

ug/g

0.06

167

Dermatitis due to substances taken internally

105

582

1.84

7.80

1.4

271.21

284.88

ug/g

0.25

324

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

214

1405

1.53

7.80

1.5

1.4

251.94

271.64

ug/g

0.80

132

876

Pediculosis, acariasis and other infestations, including avohilmo

289

2034

1.43

7.78

1.4

267.54

287.22

ug/g

0.71

149

1095

Other aneurysm

106

590

1.83

7.78

1.6

1.5

250.56

270.70

ug/g

0.50

374

Tubulo-interstitial nephritis, not specified as acute or chronic

127

745

1.73

7.76

1.4

261.15

279.47

ug/g

0.39

431

Granulomatous disorders of skin and subcutaneous tissue

274

2.26

7.73

1.4

293.74

295.28

ug/g

0.02

150

Superficial injuries involving multiple body regions

274

2.26

7.73

1.4

321.69

291.94

ug/g

0.49

166

Other erythematous conditions

401

2.03

7.72

1.4

294.92

284.92

ug/g

0.14

239

Event of undetermined intent

117

672

1.77

7.71

1.4

281.70

294.97

ug/g

0.28

375

Carcinoma in situ of skin of other and unspecified parts of face

172

1093

1.60

7.71

1.4

1.5

290.01

262.85

ug/g

0.89

101

684

Progressive vascular leukoencephalopathy

464

1.95

7.70

1.4

1.5

259.84

266.86

ug/g

0.12

292

Exposure to other and unspecified inanimate mechanical forces

140

845

1.68

7.69

1.5

1.4

278.60

286.21

ug/g

0.17

486

Acne vulgaris

120

692

1.75

7.68

1.5

1.3

264.20

316.56

ug/g

1.39

317

Pyogenic arthritis

118

680

1.76

7.67

1.6

1.4

285.81

251.84

ug/g

0.85

421

Biomechanical lesions, not elsewhere classified

105

586

1.83

7.67

1.5

1.4

247.35

274.85

ug/g

0.79

348

Abnormal findings on examination of urine, without diagnosis

486

1.92

7.65

1.6

1.4

267.66

284.60

ug/g

0.32

293

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

141

2.80

7.64

1.4

1.5

221.71

312.65

ug/g

1.73

Autoimmune thyroiditis

164

2.65

7.64

1.5

310.14

318.45

ug/g

0.09

Protozoal diseases

322

2.15

7.62

1.6

1.4

235.22

284.17

ug/g

1.21

192

Pericarditis

348

2.09

7.61

1.4

234.19

272.28

ug/g

0.76

213

Anorexia

159

2.69

7.61

1.4

271.66

316.08

ug/g

0.84

Rare circulating lymphoid malignancy, including Hilmo

250

2.30

7.59

1.3

1.4

287.86

297.85

ug/g

0.14

152

Follicular cysts of skin and subcutaneous tissue

333

2415

1.39

7.58

1.5

1.4

283.63

273.83

ug/g

0.36

199

1413

Kyphosis

125

2.93

7.58

1.6

1.3

296.60

291.13

ug/g

0.04

Seropositive rheumatoid arthritis

452

3414

1.33

7.57

1.4

281.35

263.24

ug/g

1.13

256

1963

Acute laryngitis and tracheitis

174

1092

1.58

7.57

1.4

298.20

294.35

ug/g

0.08

588

Primary coxarthrosis, bilateral

563

4406

1.29

7.56

1.4

270.92

261.30

ug/g

0.51

338

2706

Other papulosquamous disorders

109

3.08

7.55

1.4

1.3

273.28

316.47

ug/g

0.49

Left hemicolectomy

239

2.34

7.53

1.6

1.4

216.21

270.19

ug/g

1.21

143

Olecranon bursitis

110

625

1.79

7.53

1.5

307.80

251.81

ug/g

1.65

394

Other symptoms and signs involving general sensations and perceptions

439

1.96

7.53

1.3

1.4

281.94

284.83

ug/g

0.04

260

Ulcerative rectosigmoiditis

137

827

1.68

7.52

1.6

1.4

293.61

291.16

ug/g

0.05

475

Contusion of other and unspecified parts of foot

538

1.86

7.52

1.3

1.4

312.23

305.96

ug/g

0.09

294

Other noninfective disorders of lymphatic vessels and lymph nodes

405

2.00

7.51

1.7

1.4

309.12

308.49

ug/g

0.01

245

Complications of other internal prosthetic devices, implants and grafts

475

1.92

7.50

1.4

212.76

286.05

ug/g

2.56

282

Tic and related disorders

3.63

7.47

1.6

1.3

242.91

360.86

ug/g

1.60

Sequelae of injuries of upper limb

180

1164

1.57

7.46

1.7

1.4

241.07

284.68

ug/g

1.84

671

Acute bronchiolitis

432

1.91

7.46

1.6

1.4

341.33

328.06

ug/g

0.25

206

Attention to artificial openings

385

2.02

7.44

1.3

1.5

248.95

272.70

ug/g

0.39

242

Haemangioma and lymphangioma, any site

175

1126

1.58

7.43

1.5

1.4

292.65

285.17

ug/g

0.20

108

643

Arterial embolism and thrombosis

108

613

1.79

7.42

1.5

232.76

266.59

ug/g

0.99

385

Fracture of neck

118

688

1.75

7.42

1.3

1.4

238.37

265.34

ug/g

0.72

420

Ankylosing spondylitis

137

830

1.67

7.41

1.4

267.68

273.34

ug/g

0.11

494

Sacroiliitis, not elsewhere classified

399

1.99

7.40

1.6

1.3

270.32

303.08

ug/g

0.64

217

Colitis due to radiation

3.38

7.39

1.6

1.4

297.15

290.80

ug/g

0.06

Pneumonia due to Streptococcus pneumoniae

428

1.96

7.38

1.5

311.54

276.96

ug/g

0.66

254

Cardiac murmurs and other cardiac sounds

149

912

1.63

7.36

1.5

1.4

277.58

278.02

ug/g

0.01

509

Eosinophilia

162

2.64

7.33

1.7

1.4

300.52

296.54

ug/g

0.03

Other and unspecified glaucoma

143

881

1.65

7.31

1.4

1.5

264.37

270.68

ug/g

0.12

533

Foreign body entering into or through eye or natural orifice

142

873

1.65

7.29

1.4

1.5

302.64

281.76

ug/g

0.50

522

Microscopic polyangiitis

4.05

7.27

1.5

1.4

291.73

271.91

ug/g

0.12

Benign neoplasm: Liver

269

2.23

7.24

1.5

1.4

271.21

296.28

ug/g

0.35

157

Other immunodeficiencies

112

3.01

7.22

1.6

1.4

318.24

314.23

ug/g

0.03

Idiopathic thrombocytopenic purpura

322

2.11

7.22

1.7

1.5

272.71

286.99

ug/g

0.27

201

Testicular hypofunction

342

2.07

7.20

1.4

1.5

306.37

261.41

ug/g

0.90

202

Polymyalgia rheumatica

258

1809

1.45

7.20

1.4

268.06

263.64

ug/g

0.14

156

1106

Asthma and opportunity respiratory infection

102

577

1.81

7.18

1.3

1.4

288.42

279.31

ug/g

0.17

330

Ulcer of vagina/vulva

296

2.16

7.17

1.4

299.86

304.08

ug/g

0.05

162

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

323

2353

1.39

7.17

1.4

263.28

274.27

ug/g

0.41

193

1378

Moderate visual impairment, binocular

316

2.11

7.16

1.4

292.45

278.46

ug/g

0.17

181

Fracture of forearm

1068

8061

1.20

7.16

1.4

263.47

279.62

ug/g

1.68

590

4653

Leiomyoma of uterus

1187

5615

1.19

7.16

1.4

292.84

284.89

ug/g

0.61

656

3178

Injury of intra-abdominal organs

238

2.29

7.13

1.3

1.5

305.44

290.66

ug/g

0.18

141

Arthropathy in Crohn disease

102

3.10

7.13

1.6

1.3

310.00

309.11

ug/g

0.01

Radial styloid tenosynovitis [de Quervain]

100

563

1.81

7.08

1.3

1.4

400.07

299.33

ug/g

0.76

324

D07AA Corticosteroids, weak (group I)

256

1794

1.44

7.06

1.5

1.4

286.70

295.85

ug/g

0.26

152

978

Right bundle-branch block

400

1.97

7.05

1.5

1.4

250.79

276.01

ug/g

0.52

239

Labour and delivery complicated by fetal stress [distress]

174

1723

0.65

7.05

1.3

350.02

320.05

ug/g

0.84

858

Adenocarcinoma and papilloma adenocarcinoma of rectum

166

1068

1.58

7.05

1.3

1.4

247.28

283.98

ug/g

1.31

100

663

Speech and linguistic disorders

139

820

1.64

7.03

1.4

317.30

307.69

ug/g

0.20

425

Injury of other and unspecified intrathoracic organs

117

691

1.72

7.03

1.6

1.4

227.93

272.23

ug/g

1.42

431

Gonarthrosis, primary, with knee surgery

1135

7466

1.19

7.03

1.5

1.4

273.73

262.69

ug/g

0.72

700

4467

Other and unspecified injuries of lower leg

140

866

1.64

7.02

1.5

1.4

283.01

294.18

ug/g

0.26

480

Unspecified severe protein-energy malnutrition

9.33

7.00

1.4

1.3

291.20

216.58

ug/g

—

Autoimmune hyperthyroidism

112

654

1.74

7.00

1.4

278.96

301.46

ug/g

0.58

361

254

2.24

6.95

1.5

294.50

260.54

ug/g

0.59

156

Other and unspecified erythematous conditions

361

2.02

6.95

1.4

291.33

287.98

ug/g

0.04

214

UC patients in KELA-register (code 208), prior to 1994

481

1.88

6.93

1.7

1.4

266.39

282.27

ug/g

0.35

289

Malignant neoplasm, without specification of site, including Hilmo

444

1.90

6.92

1.3

1.5

216.82

292.60

ug/g

2.55

282

Injury of unspecified body region

147

925

1.62

6.90

1.5

1.4

256.32

282.26

ug/g

0.67

537

Congenital lactase deficiency

8.86

6.89

1.7

1.4

388.25

445.14

ug/g

—

Other specified/unspecified disorders of bone/cartilage

308

2.11

6.88

1.5

266.13

269.23

ug/g

0.04

187

Residual foreign body in soft tissue

489

1.85

6.85

1.6

1.4

271.38

273.28

ug/g

0.03

294

Gout due to impairment of renal function

3.08

6.84

1.8

1.5

272.00

283.14

ug/g

0.12

Spirochaetal infections, other/unspecified

173

1133

1.55

6.84

1.4

295.60

277.81

ug/g

0.59

679

COPD, hospital admissions 1, only main diagnosis

621

4268

1.26

6.84

1.5

1.4

269.16

257.80

ug/g

0.70

378

2634

Squamous cell neoplasms and carcinomas of the skin

167

1083

1.56

6.83

1.5

1.4

262.68

276.08

ug/g

0.39

103

682

Rosacea

240

1678

1.45

6.82

1.3

1.4

328.88

282.82

ug/g

2.30

127

945

Injuries involving multiple body regions

405

1.95

6.82

1.5

288.72

283.34

ug/g

0.07

240

Carbimazole or st.post thyroidectomy, condition for graves disease

386

2915

1.34

6.82

1.4

286.26

279.41

ug/g

0.26

224

1645

Post-traumatic wound infection, not elsewhere classified

289

2.14

6.81

1.4

1.5

286.06

279.77

ug/g

0.09

175

Other and unspecified disorders of white blood cells

434

1.91

6.79

1.4

1.5

286.38

268.99

ug/g

0.30

262

Carcinoma in situ of other and unspecified digestive organs

521

1.83

6.78

1.4

1.5

219.61

266.66

ug/g

1.50

330

Personal history of certain other diseases

156

2.57

6.77

1.5

1.4

315.19

314.30

ug/g

0.01

Scabies, including avohilmo

239

1670

1.45

6.77

1.4

267.79

294.65

ug/g

0.96

120

898

Inflammatory diseases of the central nervous system

151

961

1.60

6.76

1.6

1.4

256.28

286.40

ug/g

0.93

565

Other epidermal thickening

514

1.83

6.75

1.4

1.5

232.45

278.24

ug/g

1.34

304

Nontoxic goitre/thyroid nodule

568

4517

1.27

6.75

1.4

301.33

273.22

ug/g

2.82

338

2642

Haemangioma, any site

161

1041

1.57

6.74

1.5

1.4

293.74

286.98

ug/g

0.17

102

598

Allergic colitis

150

2.59

6.74

1.3

364.69

353.79

ug/g

0.11

Other or unspecified common variable immunodeficiency

6.90

6.73

1.6

1.3

362.00

311.88

ug/g

0.35

Synovial cyst of popliteal space [Baker]

130

799

1.65

6.72

1.4

283.52

269.63

ug/g

0.34

497

Other specified/unspecified deforming dorsopathies

157

2.57

6.71

1.3

249.21

293.28

ug/g

0.73

Social disorders starting during childhood or adolecense, excluding more controls

6.13

6.70

1.2

349.33

334.09

ug/g

—

Retinal haemorrhage

271

2.17

6.70

1.5

289.92

276.16

ug/g

0.21

161

Meralgia paraesthetica

352

2.01

6.69

1.5

1.4

312.34

283.65

ug/g

0.59

200

169

2.49

6.68

1.7

1.3

272.12

308.75

ug/g

0.55

Mixed connective tissue disease

195

2.40

6.64

1.5

1.4

308.49

292.97

ug/g

0.18

113

Foreign body in alimentary tract

105

613

1.75

6.62

1.5

1.4

275.76

277.68

ug/g

0.03

367

Implicit parasitic Sepsis

4.22

6.61

2.0

1.3

272.23

309.64

ug/g

0.31

Cardiomyopathy

292

2123

1.39

6.58

1.4

281.02

262.15

ug/g

0.37

193

1296

Other specified/unspecified dorsopathies

313

2.06

6.56

1.5

1.4

285.25

281.68

ug/g

0.05

180

Viral infections of the central nervous system, including avohilmo

139

875

1.61

6.54

1.4

285.88

290.93

ug/g

0.11

491

Perineal laceration during delivery

114

1505

0.61

6.53

1.2

1.3

325.35

317.24

ug/g

0.12

733

Pustulosis palmaris et plantaris

476

1.85

6.53

1.6

1.4

259.67

296.33

ug/g

0.76

273

Other and unspecified mononeuropathies, also in other diseases

308

2.07

6.50

1.4

1.5

272.54

274.58

ug/g

0.02

178

Viral pneumonia (unknown virus, not influenza)

122

745

1.66

6.49

1.5

1.4

264.97

280.24

ug/g

0.35

430

Viral infections of the central nervous system

130

807

1.64

6.48

1.4

281.78

292.59

ug/g

0.24

449

Generalized skin eruption due to drugs and medicaments

434

1.89

6.48

1.3

1.4

262.00

286.50

ug/g

0.44

250

Female infertility, cervical, vaginal, other or unspecified origin

374

1793

1.34

6.47

1.4

1.3

309.80

278.54

ug/g

1.89

198

950

Unspecified chronic bronchitis

342

2.00

6.47

1.6

1.4

292.22

278.53

ug/g

0.15

206

Benign neoplasm: Skin of eyelid, including canthus

295

2159

1.38

6.46

1.5

1.4

249.05

271.40

ug/g

1.16

176

1293

Congenital malformations of gallbladder, bile ducts and liver

114

2.88

6.46

1.5

1.3

234.65

309.42

ug/g

1.13

Other nutritional anaemias

3.16

6.45

1.4

224.28

286.12

ug/g

0.75

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

255

2.17

6.45

1.5

1.4

246.31

299.43

ug/g

1.33

155

Multiple myeloma

255

2.17

6.45

1.5

1.4

246.31

299.43

ug/g

1.33

155

Malignant neoplasm of oesophagus, including Hilmo

336

2.01

6.44

1.5

259.35

280.42

ug/g

0.40

215

Female infertility, tubal origin

434

1.87

6.43

1.4

1.3

318.03

289.92

ug/g

0.37

228

Traumatic subarachnoid haemorrhage

329

2.02

6.43

1.4

227.13

248.72

ug/g

0.32

200

Symptoms and signs involving emotional state

309

2.06

6.43

1.6

1.4

278.65

291.04

ug/g

0.17

180

Malignant neoplasm of floor of mouth, including Hilmo

3.75

6.42

1.8

1.2

264.80

329.24

ug/g

0.67

Chronic myeloid leukaemia, including Hilmo

3.32

6.42

1.7

1.3

225.50

324.07

ug/g

1.39

Presbycusis

251

1766

1.42

6.41

1.5

1.4

269.78

257.34

ug/g

0.39

148

1104

Benign neoplasm: Other and unspecified parts of mouth

372

1.96

6.41

1.6

1.5

269.52

274.98

ug/g

0.08

235

Autism spe, excluding more controls

130

2.66

6.40

1.9

1.4

315.80

354.74

ug/g

0.37

Multiple myeloma and malignant plasma cell neoplasms

538

1.79

6.39

1.4

1.5

227.23

268.16

ug/g

1.24

331

Hordeolum and other deep inflammation of eyelid

113

680

1.69

6.38

1.6

1.4

256.57

288.53

ug/g

0.90

387

Lichen sclerosus et atrophicus

230

1618

1.44

6.38

1.4

288.17

283.59

ug/g

0.12

130

932

Nontoxic multinodular goitre

364

2756

1.33

6.36

1.5

1.4

295.59

273.46

ug/g

1.29

223

1631

Acquired absence of limb

3.13

6.35

1.3

1.5

305.43

280.07

ug/g

0.25

Nasal polyp

324

2412

1.36

6.33

1.4

1.5

277.49

261.49

ug/g

0.70

177

1418

Vasomotor rhinitis (mode)

139

883

1.60

6.33

1.7

1.4

302.41

283.20

ug/g

0.48

505

Other prurigo

104

2.91

6.28

1.4

1.3

264.35

325.38

ug/g

0.81

Pregnancy with abortive outcome

1191

5292

1.18

6.26

1.4

289.82

288.03

ug/g

0.10

660

2915

Lichen simplex chronicus

361

1.96

6.25

1.6

1.4

314.38

276.35

ug/g

0.70

208

Testicular dysfunction

396

1.91

6.24

1.4

1.5

308.77

258.37

ug/g

1.13

240

IBD (strict) with PSC

3.10

6.24

1.5

1.3

231.45

309.21

ug/g

0.89

Spondylopathies in diseases classified elsewhere

110

2.84

6.24

1.7

1.4

226.22

276.09

ug/g

0.59

Other disorders of amino-acid metabolism

4.41

6.23

1.4

1.3

227.00

282.42

ug/g

—

Other juvenile arthritis

312

2.02

6.23

1.4

1.3

290.45

307.82

ug/g

0.22

163

Other/unspecified rheumatoid arthritis

232

1642

1.43

6.22

1.5

1.4

284.35

274.28

ug/g

0.33

137

999

Open wound of abdomen, lower back and pelvis

313

2.03

6.21

1.6

1.5

271.23

285.31

ug/g

0.21

178

Recurrent dislocation of patella

410

1.88

6.21

1.3

315.94

302.69

ug/g

0.16

208

Additional codes for the location of defect, injury or illness

112

678

1.68

6.21

1.4

308.69

278.41

ug/g

0.74

392

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

383

1.92

6.21

1.4

1.5

303.33

297.75

ug/g

0.08

224

Superficial injury of forearm

171

1141

1.52

6.20

1.4

285.07

291.40

ug/g

0.13

634

Malignant neoplasm of rectum

165

1093

1.53

6.19

1.3

1.4

247.69

284.15

ug/g

1.26

675

Haemorrhage in early pregnancy

459

3490

1.29

6.19

1.3

1.4

294.41

300.83

ug/g

0.27

245

1827

Amoebiasis, including avohilmo

3.24

6.18

1.7

1.3

271.69

346.01

ug/g

1.12

Congenital malformation of biliary tract

6.14

6.16

1.4

1.5

270.09

317.46

ug/g

0.35

Arthropathic psoriasis

200

1380

1.47

6.15

1.5

1.4

278.24

285.99

ug/g

0.21

119

793

Fall involving bed

392

1.91

6.14

1.5

1.4

235.65

276.97

ug/g

1.03

229

Oral lichen planus, including avohilmo , including avohilmo

146

946

1.57

6.13

1.3

1.4

305.24

286.23

ug/g

0.45

550

Single delivery by forceps and vacuum extractor

107

1047

0.60

6.11

1.2

1.4

363.76

308.59

ug/g

1.38

524

Neuroendocrine tumor and carcinoma of stomach

3.96

6.09

1.3

1.2

281.56

307.90

ug/g

—

LSIL lesion of the vulva

330

2.00

6.09

1.4

304.59

305.72

ug/g

0.01

189

Other and unspecified psoriasis

126

790

1.62

6.07

1.4

271.75

279.16

ug/g

0.16

472

Other and unspecified intracranial injuries

302

2.04

6.07

1.3

1.5

265.27

282.41

ug/g

0.28

185

Premenstrual syndrome

100

2.88

6.07

1.2

1.3

347.07

337.83

ug/g

0.07

Stenosis and insufficiency of lacrimal passages

173

1165

1.51

6.04

1.5

1.4

288.92

277.50

ug/g

0.34

702

Other and unspecified injuries of ankle and foot

451

1.83

6.04

1.3

1.4

309.26

300.02

ug/g

0.14

255

Open wound of shoulder and upper arm

184

2.35

6.04

1.5

1.4

334.24

293.87

ug/g

0.50

100

Other congenital malformations, including avohilmo

211

1475

1.45

6.02

1.5

1.4

308.61

300.97

ug/g

0.20

121

798

Other mental disorders due to brain damage and dysfunction and to physical disease

220

1552

1.44

6.02

1.5

1.4

250.94

264.09

ug/g

0.42

129

969

Cardiomyopathy, other and unspecified

138

886

1.58

6.01

1.3

1.4

319.76

264.95

ug/g

0.60

515

Ectopic pregnancy

294

2176

1.36

6.01

1.4

274.00

296.72

ug/g

0.92

148

1152

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

168

1125

1.51

6.00

1.3

1.4

249.21

283.44

ug/g

1.19

101

704

Pyothorax

467

1.82

6.00

1.4

1.5

217.38

267.37

ug/g

1.56

287

Eustachian salpingitis and obstruction

130

823

1.60

5.99

1.4

310.99

295.61

ug/g

0.28

420

Gastrointestinal stromal tumor and sarcoma

107

2.83

5.98

1.6

1.3

225.18

285.10

ug/g

0.80

Other lack of coordination

192

2.33

5.96

1.7

1.4

273.57

297.24

ug/g

0.31

113

Burns and corrosions

230

1637

1.42

5.96

1.5

1.4

275.66

281.65

ug/g

0.15

136

931

Pneumonia derived septicemia

360

1.93

5.96

1.5

1.4

264.07

276.03

ug/g

0.15

216

Alzheimer’s disease (Late onset), excluding more controls

243

1121

1.42

5.96

1.3

1.4

269.34

244.78

ug/g

1.05

140

687

Malignant neoplasm of bladder, including Hilmo

177

1184

1.49

5.94

1.5

1.4

226.89

269.17

ug/g

1.77

732

Diabetes mellitus in pregnancy

449

2222

1.29

5.93

1.4

1.3

292.88

323.06

ug/g

2.03

249

1101

Endocarditis

382

1.90

5.93

1.4

265.79

274.18

ug/g

0.12

232

Benign neoplasm: Skin of trunk

469

1.81

5.92

1.3

1.4

309.79

283.33

ug/g

0.56

274

Benign neoplasm of urinary organs

543

1.75

5.92

1.5

1.4

248.73

279.14

ug/g

0.63

332

Molar incisor enamel hypoplasia, with caries

3.32

5.90

1.5

1.4

342.92

369.49

ug/g

0.21

Scleritis and episcleritis

113

695

1.65

5.90

1.5

1.4

282.03

296.15

ug/g

0.30

385

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

417

2027

1.30

5.89

1.3

339.58

329.74

ug/g

0.34

190

963

Isolated proteinuria with specified morphological lesion

114

2.75

5.87

1.7

1.4

223.22

298.39

ug/g

1.20

Explicit fungal Sepsis

3.42

5.86

1.5

1.4

153.71

308.65

ug/g

3.32

Other congenital malformations

141

914

1.56

5.86

1.5

1.4

300.17

310.73

ug/g

0.24

493

Anomalies of dental arch relationship, including avohilmo

324

2205

1.34

5.83

1.4

323.31

295.85

ug/g

1.49

170

1185

Acute nasopharyngitis (common cold)

189

1293

1.46

5.82

1.5

1.4

277.10

271.96

ug/g

0.13

109

777

Mixed disorders of conduct and emotions, excluding more controls

2.90

5.81

1.2

1.3

265.63

369.62

ug/g

—

Maternal care for other conditions predominantly related to pregnancy

302

2197

1.35

5.80

1.3

1.4

316.29

317.45

ug/g

0.03

154

1106

Mental disorders, not otherwise specified

129

822

1.59

5.79

1.4

269.50

295.60

ug/g

0.76

429

Calcific tendinitis of shoulder

591

1.70

5.79

1.5

1.4

275.47

280.06

ug/g

0.07

362

Emotional disorders starting during childhood or adolescence

366

1.89

5.78

1.4

288.62

358.14

ug/g

1.40

173

Use of antiglaucoma preparations and miotics

146

959

1.55

5.76

1.3

1.5

258.20

273.24

ug/g

0.42

577

Muscle strain

315

1.98

5.75

1.3

1.4

272.71

282.93

ug/g

0.13

188

Behavioural disorders, excluding more controls

120

2.63

5.73

1.5

300.88

326.94

ug/g

0.25

Explicit fungal Sepsis, including avohilmo

3.37

5.73

1.5

1.4

153.71

308.65

ug/g

3.32

Contraceptive management

686

3943

1.22

5.72

1.4

307.79

282.50

ug/g

1.11

355

2231

Diffuse brain injury

288

2.01

5.70

1.5

1.4

283.42

270.26

ug/g

0.16

175

Other acquired deformities of musculoskeletal system and connective tissue

512

1.75

5.69

1.4

295.35

280.29

ug/g

0.35

301

Infective bursitis

255

2.09

5.67

1.3

1.5

257.51

259.75

ug/g

0.02

159

Other diseases of pericardium

490

1.77

5.67

1.4

259.38

277.14

ug/g

0.33

292

Pneumocystosis, including avohilmo

210

2.22

5.63

1.3

1.4

242.11

276.56

ug/g

0.54

127

Pneumocystosis

210

2.22

5.63

1.3

1.4

242.11

276.56

ug/g

0.54

127

Prurigo nodularis

270

2.06

5.63

1.5

1.4

212.20

296.55

ug/g

2.98

155

Torticollis

140

2.50

5.62

1.6

1.3

360.26

288.15

ug/g

1.00

Need for immunization against other single viral diseases

197

2.26

5.62

1.5

230.13

293.76

ug/g

1.30

117

Other and unspecified medical devices associated with adverse incidents

3.59

5.61

1.4

1.5

311.92

284.92

ug/g

0.19

Otitis media, unspecified

167

1041

1.49

5.60

1.5

1.4

294.68

303.55

ug/g

0.19

534

Macular pucker

300

2255

1.35

5.60

1.5

1.4

268.91

266.17

ug/g

0.09

187

1395

Juvenile arthritis (FINNGEN)

389

1.85

5.58

1.4

292.17

309.80

ug/g

0.26

209

Peptic ulcer

3.18

5.58

1.4

1.3

259.60

266.85

ug/g

0.05

Sudden idiopathic hearing loss

181

1251

1.47

5.57

1.5

1.4

266.05

268.17

ug/g

0.05

104

764

IgA nephropathy (IgA glomerulonephritis)

244

2.11

5.56

1.6

1.5

278.94

281.42

ug/g

0.03

144

Other disorders starting during childhood or adolescence

421

1.81

5.55

1.2

1.4

354.84

343.18

ug/g

0.15

197

Assault by blunt object

123

2.60

5.54

1.4

1.5

311.53

278.94

ug/g

0.29

Mantle cell lymphoma

3.36

5.54

1.2

1.3

260.67

308.42

ug/g

—

Polyarthritis, unspecified

348

1.91

5.52

1.4

1.5

306.32

260.88

ug/g

1.16

208

Carcinoma in situ of colon

328

1.94

5.51

1.3

1.4

206.22

268.37

ug/g

1.69

205

Rheumatic fever with heart involvement

3.99

5.50

1.6

1.3

322.77

308.09

ug/g

—

Background retinopathy and retinal vascular changes

212

2.19

5.48

1.7

1.4

283.33

288.24

ug/g

0.06

126

Other and unspecified mononeuropathies of upper limb

307

1.97

5.48

1.5

283.26

270.23

ug/g

0.15

174

Abnormality of white blood cells, not elsewhere classified

3.00

5.47

1.3

1.5

193.08

290.30

ug/g

1.66

Haemorrhagic disorder due to circulating anticoagulants

124

2.59

5.47

1.5

299.56

267.27

ug/g

0.37

Shock, not elsewhere classified

3.13

5.46

1.7

1.3

236.56

275.18

ug/g

0.39

ILD-related respiratory insufficiency

372

1.87

5.44

1.5

245.67

270.16

ug/g

0.41

236

Colon adenocarcinoma

202

1431

1.43

5.43

1.4

222.15

278.54

ug/g

3.51

125

876

Other disorders of the genitourinary system

248

1821

1.38

5.42

1.4

287.95

276.37

ug/g

0.41

135

1086

Other and unspecified paralytic syndromes

143

2.47

5.41

1.4

251.05

303.63

ug/g

0.70

Secondary thrombocytopenia

131

2.55

5.41

1.4

280.24

279.82

ug/g

0.00

Disorders of porphyrin and bilirubin metabolism

2.88

5.39

1.6

1.5

285.80

251.26

ug/g

—

Erythema intertrigo

268

2.03

5.36

1.4

240.34

289.36

ug/g

1.07

164

Other specified disorders of kidney and ureter

367

1.87

5.35

1.7

1.5

238.33

275.74

ug/g

0.85

225

Secondary and unspecified malignant neoplasm of lymph nodes

138

911

1.53

5.34

1.5

1.4

275.74

290.30

ug/g

0.37

557

Other obstetric conditions, not elsewhere classified

426

2109

1.28

5.34

1.3

341.99

326.33

ug/g

0.62

195

1013

Bullous disorders

108

675

1.63

5.34

1.5

1.4

240.33

278.39

ug/g

0.96

405

Acute lymphadenitis

605

1.66

5.33

1.4

299.16

298.67

ug/g

0.01

325

Carrier of infectious disease

255

2.05

5.32

1.6

1.5

223.19

289.78

ug/g

1.42

139

Other and unspecified trigeminal disorders

163

2.35

5.32

1.4

268.71

297.56

ug/g

0.30

Carcinoma in situ of skin of upper limb, including shoulder

297

1.98

5.32

1.6

1.5

276.71

263.58

ug/g

0.22

183

Habit and impulse disorders

144

2.43

5.31

1.6

1.5

269.29

288.25

ug/g

0.17

Somnolence

120

2.59

5.31

1.5

1.4

243.32

302.34

ug/g

0.80

Other keratitis

189

1329

1.44

5.31

1.5

1.4

284.48

288.20

ug/g

0.04

113

752

Abnormal findings in nipple discharge synovial fluid wound secretions

157

2.38

5.30

1.6

1.3

259.65

287.85

ug/g

0.33

Injury of nerves at wrist and hand level

382

1.84

5.30

1.5

292.89

274.61

ug/g

0.26

228

Deep bite

184

1127

1.45

5.29

1.3

1.4

319.52

304.56

ug/g

0.46

102

616

Sequelae of injuries of head

569

1.68

5.27

1.6

1.4

233.85

276.17

ug/g

1.22

339

Overexertion and strenuous or repetitive movements

168

1158

1.47

5.27

1.3

1.4

272.51

287.09

ug/g

0.46

106

666

Combined immunodeficiencies

109

2.69

5.25

1.8

1.3

294.00

305.12

ug/g

0.11

Peritonsillar abscess

310

2361

1.32

5.25

1.4

283.01

272.86

ug/g

0.32

164

1321

Carcinoma in situ of skin

162

1111

1.48

5.24

1.3

1.5

309.56

265.10

ug/g

1.81

682

Seminoma of testis, including Hilmo

3.34

5.24

1.7

1.4

285.67

307.25

ug/g

—

Anxious personality disorder

170

2.30

5.24

1.6

1.4

484.35

305.58

ug/g

0.39

Bacterial, viral and other infectious agents, including avohilmo

156

1061

1.49

5.24

1.4

284.37

279.47

ug/g

0.10

610

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

121

2.57

5.22

1.6

1.3

275.61

304.84

ug/g

0.31

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

275

2062

1.35

5.21

1.5

1.4

261.00

277.98

ug/g

0.66

165

1197

Hyphaema and other vascular disorders of iris and ciliary body

210

2.16

5.20

1.7

1.5

210.64

285.41

ug/g

1.88

130

Inflammatory disease of cervix uteri

120

775

1.58

5.18

1.3

1.4

279.54

290.97

ug/g

0.25

428

Other neurotic disorders

519

1.71

5.17

1.5

1.4

261.02

273.34

ug/g

0.21

308

ILD medications: nintedanib

3.79

5.16

1.4

218.80

280.21

ug/g

—

Amoebiasis

3.61

5.14

1.9

1.3

245.60

364.51

ug/g

—

Disorders of optic nerve and visual pathways

159

1090

1.48

5.14

1.4

290.16

290.70

ug/g

0.01

605

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

471

1.73

5.13

1.2

1.4

331.31

334.15

ug/g

0.03

234

Manic episode

265

2.00

5.13

1.4

1.5

334.09

279.17

ug/g

1.04

154

Certain conditions originating in the perinatal period

114

643

1.59

5.12

1.5

1.3

298.22

335.06

ug/g

0.89

322

Sequelae of intentional self-harm, assault and events of undetermined intent

3.56

5.12

1.3

1.4

389.50

321.82

ug/g

—

Bronchitis, not specified as acute or chronic

144

969

1.50

5.10

1.5

1.4

232.76

278.49

ug/g

2.16

552

Malignant neoplasm of testis, including Hilmo

110

2.61

5.10

1.7

1.4

270.71

289.76

ug/g

0.15

Pustular psoriasis

537

1.69

5.08

1.6

1.4

263.90

292.34

ug/g

0.58

313

severe traumatic brain injury, does not include concussion

379

2979

1.28

5.07

1.4

261.33

260.40

ug/g

0.03

220

1812

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

129

2.50

5.07

1.4

228.72

284.53

ug/g

0.62

Other and unspecified nail disorders

267

2.00

5.07

1.6

1.4

248.27

291.11

ug/g

0.73

156

Glaucoma suspect

687

5750

1.20

5.06

1.5

1.4

265.40

267.83

ug/g

0.11

416

3410

Amyloidosis

219

2.11

5.06

1.4

1.5

403.14

275.08

ug/g

0.42

134

Dermatitis due to ingested food

267

1.97

5.06

1.4

1.3

374.39

345.56

ug/g

0.47

127

Fall on and from ladder

131

867

1.53

5.05

1.5

1.4

264.52

261.39

ug/g

0.06

549

Abnormal findings on diagnostic imaging of central nervous system

576

1.66

5.05

1.5

1.4

302.50

289.58

ug/g

0.22

321

Procedures for purposes other than remedying health state

240

2.05

5.02

1.4

364.21

303.94

ug/g

0.93

134

Malignant neoplasm of oesophagus

233

2.06

5.02

1.3

1.5

284.29

278.75

ug/g

0.08

147

Pneumonia due to other infectious organisms, not elsewhere classified

360

1.85

5.02

1.4

1.5

260.44

278.42

ug/g

0.27

218

Other and unspecified coagulation defects

554

1.67

5.02

1.5

1.4

276.55

296.69

ug/g

0.39

313

Chronic hepatitis NAS

130

2.48

5.00

1.3

1.4

242.73

314.58

ug/g

0.96

Other/unspecified reactive arthropathies

115

743

1.57

4.96

1.4

271.96

283.88

ug/g

0.20

425

Dislocation, sprain and strain of joints and ligaments of head

405

1.78

4.95

1.3

1.5

310.97

298.80

ug/g

0.15

233

Benign neoplasm: Kidney

406

1.79

4.94

1.5

1.4

255.71

285.49

ug/g

0.47

249

Hypersomnia

137

2.42

4.92

1.5

1.4

268.04

310.13

ug/g

0.40

Bell's palsy

195

1399

1.41

4.92

1.4

296.11

278.44

ug/g

0.64

104

805

Infection due to other mycobacteria

156

2.32

4.91

1.4

1.3

256.71

308.85

ug/g

0.63

Abnormal findings in peritoneal fluid saliva

3.87

4.91

1.6

1.3

337.75

292.17

ug/g

—

Status epilepticus

348

1.84

4.90

1.3

1.4

249.29

274.85

ug/g

0.46

214

Other specified and unspecified disorders of eye and adnexa

437

1.75

4.89

1.5

260.47

283.70

ug/g

0.49

258

Ovarian dysfunction

110

705

1.58

4.88

1.5

1.3

316.28

320.75

ug/g

0.06

321

Other and unspecified injuries of shoulder and upper arm

327

1.87

4.88

1.5

1.4

282.69

279.16

ug/g

0.04

183

Malignant neoplasm, without specification of site

277

1.95

4.87

1.4

223.94

289.68

ug/g

1.28

179

Hyperosmolality and hypernatraemia

113

2.56

4.87

1.5

1.4

216.75

286.52

ug/g

1.12

Hyperfunction of pituitary gland

505

1.69

4.86

1.5

1.4

241.73

297.64

ug/g

1.72

273

Laparoscopic right hemicolectomy

113

732

1.57

4.86

1.4

1.5

237.14

267.89

ug/g

0.76

444

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.78

4.85

1.4

1.3

298.83

304.66

ug/g

0.05

Neovascular glaucoma

438

1.74

4.84

1.5

251.56

285.19

ug/g

0.69

264

Early lumbar disc prolapse operation

162

1128

1.45

4.83

1.4

289.67

296.02

ug/g

0.13

586

Toxic liver disease

164

2.27

4.82

1.7

1.5

327.63

311.51

ug/g

0.17

101

Other and unspecified epidermal thickening

265

1.97

4.80

1.5

230.05

275.09

ug/g

0.84

156

Ménière disease

171

1206

1.44

4.80

1.4

292.30

272.63

ug/g

0.51

101

714

Astigmatism

110

708

1.57

4.80

1.4

293.76

293.85

ug/g

0.00

398

Wet age-related macular degeneration

310

2307

1.31

4.80

1.5

1.4

254.37

262.36

ug/g

0.29

179

1417

Toxic effect of other and unspecified substances

108

2.58

4.79

1.4

279.60

280.70

ug/g

0.01

Congenital malformations of the circulatory system

232

1670

1.36

4.77

1.5

1.4

290.76

290.04

ug/g

0.02

139

944

Prolonged pregnancy

107

1401

0.65

4.77

1.2

1.3

352.51

319.88

ug/g

0.79

689

Familial hypercholesterolemia, with ischemic heart disease

164

1149

1.45

4.77

1.4

1.5

259.12

255.22

ug/g

0.09

717

Blood alcohol or alcohol intoxication level

231

2.04

4.77

1.5

243.65

288.09

ug/g

0.67

132

Other disorders of bone density and structure

273

1.95

4.76

1.5

1.4

261.81

293.38

ug/g

0.47

166

Causalgia

152

2.31

4.74

1.6

1.4

254.47

303.84

ug/g

0.64

Pneumococcal septicemia

345

1.84

4.74

1.5

278.82

278.18

ug/g

0.01

209

Specific development disorders of scholastic skills

351

1.81

4.73

1.4

373.61

339.47

ug/g

0.46

172

Palindromic rheumatism

103

2.63

4.73

1.4

347.43

281.28

ug/g

0.68

Panniculitis, unspecified

2.68

4.73

1.6

1.4

268.63

299.56

ug/g

0.32

Primary adrenocortical insufficiency

109

2.58

4.73

1.6

1.3

272.59

312.71

ug/g

0.47

Other congenital malformations of intestine, including avohilmo

109

2.58

4.73

1.7

1.4

344.31

296.76

ug/g

0.49

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

426

1.74

4.71

1.3

1.4

284.11

282.81

ug/g

0.02

252

Early complications of trauma

510

1.68

4.71

1.3

1.5

292.59

277.92

ug/g

0.27

302

!Aliquae complicationes praecoces traumatis

510

1.68

4.71

1.3

1.5

292.59

277.92

ug/g

0.27

302

Wide developmental disorders

279

1.92

4.71

1.6

1.4

343.08

347.93

ug/g

0.05

144

Persons encountering health services in circumstances related to reproduction

988

5722

1.16

4.71

1.4

284.52

281.47

ug/g

0.11

546

3291

Intentional self-harm by unspecified means

115

2.51

4.71

1.8

1.4

312.75

299.10

ug/g

0.12

Pilonidal cyst

125

832

1.52

4.69

1.5

1.4

286.71

293.70

ug/g

0.13

464

Disorders of male genital organs in diseases classified elsewhere

3.49

4.69

1.8

1.5

240.63

249.86

ug/g

—

Nontoxic single thyroid nodule

128

858

1.51

4.68

1.3

1.4

323.29

285.23

ug/g

1.36

492

Malignant neoplasm of oropharynx, including Hilmo

179

2.18

4.67

1.7

1.4

215.64

297.46

ug/g

1.47

110

Thyrotoxicosis with diffuse goitre

236

1762

1.35

4.67

1.5

1.4

284.52

282.63

ug/g

0.05

150

971

Burns and corrosions of external body surface, specified by site

176

1254

1.42

4.65

1.5

1.4

275.12

284.97

ug/g

0.22

106

713

Abnormal blood-pressure reading, without diagnosis

481

1.69

4.65

1.3

1.4

314.46

278.04

ug/g

0.81

284

Myocarditis

420

1.74

4.64

1.6

1.4

230.10

289.97

ug/g

1.35

244

Benign neoplasm: Oesophagus

135

2.39

4.64

1.6

1.4

329.45

288.26

ug/g

0.59

Motor disorders, excluding more controls

2.76

4.63

1.3

1.5

317.12

375.90

ug/g

0.76

Acquired absence of organs, not elsewhere classified

110

2.54

4.63

1.6

1.4

233.13

292.34

ug/g

0.82

Episcleritis

582

1.62

4.62

1.5

1.4

290.95

296.49

ug/g

0.09

328

Amyloidosis, other/unspecified

180

2.17

4.62

1.4

424.00

269.87

ug/g

0.48

112

Malignant neoplasm of testis

2.61

4.60

1.6

1.4

243.57

304.49

ug/g

0.54

Congenital malformations of the respiratory system, including avohilmo

221

2.05

4.60

1.5

1.4

300.81

306.56

ug/g

0.07

129

Other abnormal findings of blood chemistry

537

1.65

4.58

1.4

1.5

286.03

275.47

ug/g

0.15

324

Spinal enthesopathy

186

2.12

4.58

1.6

1.4

230.53

254.30

ug/g

0.31

111

Meningitis

537

1.65

4.58

1.4

1.5

270.15

282.76

ug/g

0.22

306

Erythema multiforme

228

2.02

4.58

1.2

1.4

352.35

302.23

ug/g

0.86

135

Assault by sharp object

161

2.24

4.57

1.4

198.74

285.95

ug/g

1.34

Malignant neoplasm of gallbladder, including Hilmo

3.29

4.57

1.6

1.3

206.39

296.55

ug/g

0.91

Colorectal neuroendocrine tumor and carcinoma

142

2.33

4.57

1.5

1.4

208.75

319.05

ug/g

2.02

Contact with and exposure to communicable diseases

440

3547

1.24

4.56

1.4

323.99

296.02

ug/g

1.78

248

1858

Other obstructive and reflux uropathy

423

1.73

4.56

1.3

1.4

245.05

290.19

ug/g

1.06

242

Suggestive for eosinophilic asthma

156

1093

1.44

4.55

1.4

271.98

272.40

ug/g

0.01

636

Thoracic aortic aneurysm

246

1857

1.34

4.54

1.4

1.5

259.70

264.57

ug/g

0.13

151

1143

Pleural plaque with presence of asbestos

113

743

1.54

4.54

1.5

254.86

245.73

ug/g

0.21

491

Poisoning by medicine, drug-induced

130

2.39

4.52

1.6

1.5

237.96

306.82

ug/g

0.79

Abscess of lung

149

2.28

4.52

1.7

1.4

169.70

284.88

ug/g

2.37

Malignant neoplasm of head and neck, including Hilmo

149

1036

1.45

4.51

1.5

1.4

268.61

283.69

ug/g

0.45

635

Benign neoplasm: Tongue

315

1.86

4.49

1.5

274.43

283.30

ug/g

0.11

190

Assault by other specified means

2.71

4.47

1.4

227.88

260.89

ug/g

—

Orthopaedic devices associated with adverse incidents

224

2.03

4.46

1.4

1.5

273.30

273.26

ug/g

0.00

141

Tetraplegia

2.87

4.46

1.3

287.62

309.25

ug/g

0.15

Other surgical follow-up care

315

1.84

4.46

1.7

1.5

241.36

294.38

ug/g

1.41

178

Malignant neoplasm of tonsil, including Hilmo

137

2.33

4.45

1.6

1.4

241.40

309.95

ug/g

0.95

Perforation of tympanic membrane

167

1190

1.42

4.44

1.4

247.55

279.82

ug/g

1.20

678

Lung transplant status

2.79

4.44

1.2

1.4

276.46

297.56

ug/g

0.17

Other disorders of optic [2nd] nerve and visual pathways

110

723

1.54

4.44

1.5

1.4

272.37

287.73

ug/g

0.29

424

Selective deficiency of immunoglobulin A [IgA]y

4.53

4.44

1.4

349.56

353.07

ug/g

—

Progressive systemic sclerosis

3.18

4.44

1.3

1.5

267.10

282.12

ug/g

—

Nontoxic diffuse goitre

338

1.81

4.43

1.5

1.4

268.52

302.71

ug/g

0.69

191

Unspecified nephritic syndrome

231

2.00

4.43

1.3

1.5

243.83

272.14

ug/g

0.46

138

Social disorders starting during childhood or adolescence

3.21

4.43

1.2

1.4

349.33

354.15

ug/g

—

Other noninflammatory disorders of cervix uteri

527

1.64

4.41

1.4

285.90

275.70

ug/g

0.19

298

Vitiligo

119

2.44

4.41

1.6

1.4

223.89

313.42

ug/g

1.35

Crystalline deposits in vitreous body

2.64

4.40

1.6

1.4

254.04

275.81

ug/g

0.24

Infection of intervertebral disc (pyogenic)

113

2.46

4.38

1.6

1.4

220.43

255.28

ug/g

0.23

Inguinal or femoral hernia, bilateral

171

1227

1.41

4.37

1.4

1.5

281.36

251.06

ug/g

0.32

100

783

Malignant neoplasm of larynx, including Hilmo

138

2.30

4.36

1.6

1.4

277.92

282.01

ug/g

0.04

Endometriosis ASRM stages 3,4

387

3112

1.25

4.35

1.4

302.34

288.62

ug/g

0.58

199

1736

Psoriasis (vulgaris), strict definition

362

1.77

4.35

1.4

255.28

278.19

ug/g

0.45

212

Xerosis cutis

178

2.14

4.35

1.3

1.4

232.63

281.92

ug/g

0.69

113

Injury of muscle and tendon at wrist and hand level

222

1662

1.35

4.35

1.4

297.13

267.84

ug/g

1.18

124

982

Other specific arthropathies, wide

212

2.03

4.33

1.3

1.5

344.48

278.22

ug/g

1.00

127

Cardiac arrest

539

1.58

4.33

1.6

1.4

236.96

276.25

ug/g

1.12

318

Atypical mycobacterium lung infection

133

2.35

4.32

1.4

277.13

296.95

ug/g

0.16

Bicipital tendinitis

468

1.67

4.32

1.5

1.4

266.67

273.72

ug/g

0.10

289

Foreign body on external eye

229

1724

1.34

4.32

1.5

272.16

266.67

ug/g

0.13

133

1026

Vascular dementia (other)

2.97

4.31

1.6

1.3

246.89

295.41

ug/g

—

Nonspecific lymphadenitis

624

1.58

4.31

1.8

1.4

268.02

293.93

ug/g

0.57

361

Psoriatic arthropathies, ICD10

178

1291

1.39

4.29

1.6

1.4

272.63

282.66

ug/g

0.27

107

752

Sarcoidosis

229

1727

1.34

4.29

1.4

288.05

274.13

ug/g

0.44

133

1019

L01XE Protein kinase inhibitors

634

1.57

4.29

1.4

1.5

234.92

275.73

ug/g

1.13

390

Other and/or unspecified nontoxic goitre

150

1057

1.44

4.28

1.4

324.49

281.64

ug/g

1.90

615

Myeloid leukaemia

284

1.87

4.26

1.5

235.07

271.93

ug/g

0.64

171

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

200

2.06

4.26

1.7

1.4

304.52

282.88

ug/g

0.25

124

Lung transplantation

2.72

4.25

1.2

1.4

276.46

297.56

ug/g

0.17

Malignant neoplasm of tonsil

121

2.38

4.24

1.6

1.4

214.67

315.89

ug/g

1.58

Pyoderma gangrenosum

2.71

4.24

1.2

1.4

247.22

318.04

ug/g

—

Other contact dermatitis

130

893

1.47

4.23

1.4

294.65

294.33

ug/g

0.01

493

Myelodysplastic syndrome, including Hilmo

270

1.89

4.23

1.4

248.96

297.64

ug/g

0.74

165

Gingival hyperplasia

403

1.72

4.23

1.4

1.5

284.90

275.41

ug/g

0.10

240

Malignant neoplasm of oropharynx

134

2.30

4.22

1.6

1.4

210.83

305.98

ug/g

1.59

Inguinal hernia, bilateral

167

1202

1.40

4.21

1.4

1.5

281.36

250.56

ug/g

0.32

100

767

Evidence of alcohol involvement determined by level of intoxication

2.56

4.21

1.3

1.5

261.56

272.55

ug/g

—

Bacterial, viral and other infectious agents

140

977

1.45

4.21

1.5

1.4

275.86

278.48

ug/g

0.05

566

Entropion and trichiasis of eyelid

143

1002

1.44

4.20

1.4

292.60

262.70

ug/g

1.13

633

Other condition

239

1819

1.33

4.19

1.6

1.4

262.36

284.57

ug/g

0.90

132

1042

Infection due to other mycobacteria, including avohilmo

174

2.13

4.19

1.4

1.3

264.77

310.54

ug/g

0.55

100

Focal brain injury

604

1.57

4.19

1.5

1.3

300.05

255.26

ug/g

1.07

356

Other orthopaedic follow-up care

589

1.58

4.19

1.5

1.4

278.31

288.08

ug/g

0.16

336

Chronic conjunctivitis

315

1.82

4.18

1.4

304.32

293.72

ug/g

0.12

189

Aspergillosis

2.81

4.17

1.3

1.6

287.29

280.11

ug/g

0.05

Other specified/unspecified hearing loss

155

1104

1.42

4.17

1.4

253.16

268.95

ug/g

0.39

667

Other and unspecified diseases of blood and blood-forming organs

301

1.84

4.16

1.4

1.5

275.03

280.95

ug/g

0.06

178

Juvenile rheumatoid arthirtis

174

2.11

4.16

1.3

1.4

313.90

303.55

ug/g

0.10

100

Acquired haemolytic anaemia

265

1.90

4.16

1.4

267.04

280.46

ug/g

0.21

162

Hypertension, portal

4.57

4.16

1.5

1.3

252.13

309.63

ug/g

—

Other forms of systemic lupus erythematosus

2.67

4.15

1.5

1.4

392.23

324.27

ug/g

1.12

Intermittent heterotropia

621

1.56

4.14

1.5

1.4

302.90

313.89

ug/g

0.20

336

Seminoma of testis

3.19

4.14

1.6

1.3

261.86

294.21

ug/g

—

Disorders of purine and pyrimidine metabolism

3.35

4.14

1.6

1.4

310.00

251.12

ug/g

—

Disturbances of smell and taste

482

1.65

4.14

1.6

1.4

299.83

290.45

ug/g

0.15

292

Benign lipomatous neoplasm of other sites/unspecified

150

1064

1.43

4.14

1.4

259.20

272.20

ug/g

0.33

621

Other disorders of iris and ciliary body

287

1.85

4.13

1.7

1.4

236.24

277.30

ug/g

0.68

177

Personal history of risk-factors, not elsewhere classified

110

2.43

4.13

1.5

1.4

285.76

296.32

ug/g

0.07

Dependence on enabling machines and devices, not elsewhere classified

110

2.44

4.11

1.5

1.4

343.21

315.06

ug/g

0.25

Complications of cardiac and vascular prosthetic devices, implants and grafts

182

2.08

4.10

1.6

1.4

248.22

287.99

ug/g

0.65

120

Glaucoma secondary to other eye disorders

460

1.66

4.10

1.5

251.56

278.66

ug/g

0.52

276

Tic disorders

2.57

4.10

1.5

1.4

226.40

311.77

ug/g

—

Aortic aneurysm

368

2905

1.25

4.09

1.4

259.03

259.34

ug/g

0.01

222

1773

Drug-induced neutropenia

130

901

1.46

4.09

1.4

253.00

275.66

ug/g

0.63

521

Dyshidrosis [pompholyx]

149

2.21

4.09

1.6

1.3

199.50

322.99

ug/g

2.32

Otorrhagia

3.06

4.08

1.5

333.80

300.01

ug/g

—

Drug-induced osteoporosis

163

2.17

4.08

1.6

1.4

225.71

288.50

ug/g

1.02

101

LSIL lesion of the cervix uteri, vagina or vulva

222

1680

1.33

4.06

1.3

1.4

322.76

305.46

ug/g

0.62

133

868

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1019

6943

1.14

4.06

1.4

308.77

282.08

ug/g

3.41

577

3894

Contact with heat and hot substances

571

1.58

4.03

1.4

256.87

288.26

ug/g

0.65

322

Myasthenia gravis

191

2.05

4.01

1.4

300.24

283.18

ug/g

0.20

117

Disorders of iron metabolism

157

2.16

4.01

1.3

1.4

318.21

270.64

ug/g

0.56

Haemolytic anaemias

372

1.73

3.99

1.5

266.80

285.50

ug/g

0.38

221

Disorders of puberty, all

118

2.34

3.99

1.4

1.3

289.03

352.81

ug/g

0.79

Other nonscarring hair loss

125

2.32

3.99

1.7

1.4

274.59

319.84

ug/g

0.73

All dysplastic lesions of the cervix uteri, vagina or vulva

445

3575

1.22

3.98

1.3

1.4

328.11

303.22

ug/g

1.55

253

1847

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

230

1756

1.32

3.98

1.4

299.93

279.96

ug/g

0.72

130

1029

Other specified and unspecified strabismus

125

2.32

3.98

1.7

1.4

289.22

303.79

ug/g

0.11

Aspergillosis, including avohilmo

2.73

3.97

1.3

1.6

287.29

280.11

ug/g

0.05

Calcaneal spur

125

2.31

3.97

1.4

1.5

241.41

290.46

ug/g

0.73

Other arterial embolism and thrombosis

269

1.86

3.96

1.5

249.76

278.79

ug/g

0.47

174

Malignant neoplasm of head and neck

121

831

1.47

3.96

1.5

258.48

284.51

ug/g

0.82

507

Oral lichen planus and hypothyroidism or thyroxine medication

227

1.95

3.96

1.3

1.4

274.08

299.75

ug/g

0.31

129

Other psoriatic arthropathies

172

1259

1.38

3.95

1.6

1.4

275.33

283.21

ug/g

0.20

104

731

Abscess of Bartholin gland

262

1.87

3.95

1.3

307.50

317.06

ug/g

0.09

147

Factitial dermatitis

3.14

3.95

1.9

1.3

276.21

322.88

ug/g

0.30

138

973

1.43

3.95

1.4

1.5

256.18

254.99

ug/g

0.02

619

Contracture of joint

119

2.34

3.94

1.9

1.4

238.32

284.15

ug/g

0.42

Dislocation, sprain and strain of joint and ligaments of hip

427

1.67

3.93

1.5

252.56

278.54

ug/g

0.58

263

Crushed, pushed or stepped on by crowd or human stampede

111

751

1.49

3.93

1.4

305.73

304.21

ug/g

0.02

392

Hypermetropia

123

849

1.46

3.93

1.3

1.4

301.47

298.21

ug/g

0.05

486

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

241

1.90

3.92

1.5

1.3

325.92

297.84

ug/g

0.37

120

Bitten or struck by other mammals

182

1346

1.36

3.91

1.4

292.75

298.69

ug/g

0.15

116

714

Benign neoplasm of bone and articular cartilage

137

967

1.43

3.90

1.5

1.4

252.38

288.11

ug/g

1.14

549

Drug-induced polyneuropathy

2.53

3.90

1.4

281.98

280.99

ug/g

0.01

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

3.90

3.89

1.6

1.4

310.00

259.07

ug/g

—

Malignant melanoma, including Hilmo

277

2174

1.28

3.88

1.4

282.42

283.98

ug/g

0.05

180

1305

Retinal detachments and breaks

632

5391

1.18

3.88

1.4

258.13

266.12

ug/g

0.46

380

3234

Non-follicular lymphoma

164

1196

1.39

3.87

1.5

256.21

267.80

ug/g

0.29

102

742

Autonomic disorders

257

1.87

3.87

1.4

343.38

304.03

ug/g

0.54

155

120

827

1.46

3.86

1.4

1.3

316.44

334.32

ug/g

0.40

377

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

133

2.24

3.86

1.6

1.5

233.06

298.65

ug/g

0.89

Peroneal tendinitis

146

2.17

3.86

1.3

251.00

281.95

ug/g

0.33

Exposure to other and unspecified animate mechanical forces

338

1.75

3.86

1.2

1.5

335.97

298.04

ug/g

0.93

197

Other maternal disorders predominantly related to pregnancy

941

5148

1.15

3.85

1.3

1.4

291.96

296.23

ug/g

0.24

523

2762

Hypoplasia of dental enamel

2.56

3.84

1.4

1.5

363.79

365.36

ug/g

0.01

Thrombotic microangiopathy

3.05

3.82

1.5

1.4

320.00

293.17

ug/g

—

Dissocial personality disorder

134

2.22

3.79

1.3

1.5

288.89

269.69

ug/g

0.18

Other abnormal immunological findings in serum

209

1.96

3.79

1.4

334.80

302.58

ug/g

0.39

119

Osteonecrosis due to drugs

168

2.09

3.78

2.1

1.4

210.96

278.01

ug/g

1.26

106

Calculus of lower urinary tract

525

1.58

3.78

1.4

1.5

251.51

255.28

ug/g

0.05

346

Secondary polycythaemia

252

1.87

3.78

1.7

1.4

286.33

274.97

ug/g

0.12

160

Visual field defects

140

999

1.42

3.77

1.3

1.4

283.43

276.06

ug/g

0.16

594

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

168

2.08

3.77

1.5

1.3

211.35

312.11

ug/g

2.02

Poisoning by narcotics and psychodysleptics [hallucinogens]

141

2.18

3.76

1.3

1.4

284.83

288.85

ug/g

0.04

Malignant neoplasm of tonsil and base of tongue

175

2.05

3.74

1.5

1.4

251.20

299.67

ug/g

0.62

107

Defects in the complement system

2.73

3.73

1.8

1.4

364.11

305.69

ug/g

—

Malignant neoplasm of endocrine gland, including Hilmo

133

943

1.43

3.72

1.4

320.41

303.65

ug/g

0.41

538

Dementia in other diseases classified elsewhere

504

1.59

3.71

1.4

295.74

262.32

ug/g

0.69

309

Open wound of thorax

142

2.17

3.71

1.4

285.12

282.34

ug/g

0.02

Malignant melanoma

245

1906

1.30

3.70

1.4

279.44

284.40

ug/g

0.16

158

1160

Acute epiglottitis

149

2.14

3.69

1.6

1.4

245.28

269.02

ug/g

0.29

Retinal detachment with retinal break

213

1628

1.32

3.69

1.4

260.74

270.76

ug/g

0.30

134

990

Phakomatoses, not elsewhere classified

110

2.35

3.69

1.8

1.4

219.06

313.30

ug/g

1.45

Benign intracranial hypertension

2.61

3.68

1.7

1.4

273.27

342.03

ug/g

0.60

Myositis

233

1.88

3.65

1.4

1.5

299.73

281.48

ug/g

0.21

136

conjunctival degenerations and deposits

234

1.88

3.63

1.7

1.5

238.77

283.94

ug/g

0.87

147

Carcinoma in situ of skin of scalp and neck

300

1.77

3.62

1.5

1.4

278.65

266.75

ug/g

0.15

193

3.22

3.61

1.6

1.4

308.13

237.88

ug/g

—

Other vitreous opacities

492

1.59

3.61

1.5

1.4

289.82

275.74

ug/g

0.23

298

Diastasis of muscle

2.65

3.61

1.8

1.4

271.77

297.61

ug/g

0.26

Idiopathic pulmonary fibrosis

125

882

1.43

3.61

1.3

1.5

254.74

268.93

ug/g

0.33

549

Impaction of intestines

3.15

3.58

1.4

1.2

215.33

292.77

ug/g

—

538

1.55

3.57

1.5

1.4

253.33

265.88

ug/g

0.20

325

Habitual aborter

124

2.21

3.57

1.4

1.3

252.67

330.32

ug/g

0.75

Viral meningitis, including avohilmo

392

1.66

3.56

1.5

1.4

262.91

301.51

ug/g

0.75

231

Benign neoplasm of other and unspecified sites

362

1.69

3.55

1.5

233.91

277.58

ug/g

1.02

224

Lesion of sciatic nerve

431

1.63

3.55

1.5

1.4

249.17

273.28

ug/g

0.44

255

Sequelae of cerebrovascular disease

639

4689

1.17

3.54

1.5

1.4

248.83

263.11

ug/g

1.04

405

2855

HSIL lesion of the vulva

222

1.90

3.54

1.2

1.4

363.83

302.15

ug/g

0.83

128

Benign neoplasm: Skin of other and unspecified parts of face

177

1327

1.35

3.53

1.6

1.4

246.65

274.86

ug/g

1.09

102

787

Acute alcohol intoxication ICD-9

332

1.72

3.53

1.6

1.5

269.86

266.27

ug/g

0.04

210

Liposarcoma, including Hilmo

2.55

3.52

1.4

1.2

228.08

320.33

ug/g

0.93

Presbyopia

134

963

1.41

3.50

1.5

1.4

289.99

289.54

ug/g

0.01

559

Chloasma

2.81

3.49

1.3

280.90

313.29

ug/g

—

Pervasive developmental disorders excl. Autism + Asperger

111

2.28

3.49

1.8

1.3

337.64

374.65

ug/g

0.31

2.86

3.48

1.6

1.4

241.73

352.01

ug/g

1.31

Disorders of puberty

100

2.35

3.47

1.4

1.3

296.74

345.92

ug/g

—

Dislocation, sprain and strain of joints and ligaments of elbow

103

707

1.47

3.45

1.3

1.4

307.39

295.98

ug/g

0.20

389

Personal history of allergy to drugs, medicaments and biological substances

120

2.23

3.45

1.4

1.3

323.74

306.08

ug/g

0.15

107

2.31

3.44

1.4

248.67

299.34

ug/g

0.51

Polycystic ovarian syndrome

489

1.57

3.44

1.5

1.3

349.26

329.82

ug/g

0.23

217

Foreign body in respiratory tract

562

1.53

3.43

1.4

303.69

287.94

ug/g

0.26

329

Drug-induced headache, not elsewhere classified

2.97

3.43

1.5

1.2

288.40

323.05

ug/g

—

Any dementia, excluding more controls

618

3638

1.17

3.42

1.4

266.63

250.10

ug/g

1.20

352

2255

Mental retardation, excluding more controls

308

1.71

3.41

1.4

1.5

308.37

303.89

ug/g

0.05

193

Other disorders of pigmentation

531

1.55

3.41

1.6

1.4

275.30

279.79

ug/g

0.07

312

Arthropod-borne viral fevers and viral haemorrhagic fevers

150

1103

1.37

3.41

1.4

286.82

276.14

ug/g

0.23

662

Congenital malformations of the respiratory system

196

1.94

3.40

1.5

1.4

297.18

309.42

ug/g

0.15

114

Arthropathy in ulcerative colitis

134

2.15

3.40

1.6

1.4

253.43

305.92

ug/g

0.68

Left bundle-branch block

124

884

1.42

3.40

1.7

1.4

237.51

270.76

ug/g

1.14

522

Other bacterial agents as the cause of diseases classified to other chapters

108

2.30

3.39

1.4

216.15

287.04

ug/g

0.86

Other disorders of male genital organs

328

1.70

3.39

1.5

267.32

254.55

ug/g

0.17

207

2.51

3.38

1.7

1.3

353.33

335.47

ug/g

0.15

Cardiomyopathies, Primary/intrinsic

189

1440

1.32

3.38

1.5

1.4

256.44

260.04

ug/g

0.09

124

860

Lesion of plantar nerve

106

736

1.46

3.37

1.5

1.4

280.92

282.99

ug/g

0.03

413

Effects of other external causes

269

1.78

3.36

1.4

311.33

290.10

ug/g

0.26

146

Helminthiases

169

2.00

3.34

1.5

1.4

279.91

298.45

ug/g

0.22

Pedestrian injured in transport accident

116

820

1.43

3.34

1.4

280.33

287.84

ug/g

0.15

478

Pleural plaque

145

1065

1.38

3.33

1.4

1.5

265.40

252.58

ug/g

0.34

684

Cutaneous lupus erythematosus

263

1.79

3.33

1.3

1.5

294.20

291.58

ug/g

0.02

154

Deep endometriosis

157

1168

1.36

3.33

1.4

334.15

288.95

ug/g

1.54

615

Open wound of hip and thigh

323

1.70

3.31

1.5

1.4

284.74

299.01

ug/g

0.19

181

Congenital malformations of heart and great arteries

193

1435

1.31

3.30

1.5

1.4

281.51

296.61

ug/g

0.45

113

817

Congenital malformations of genital organs

133

959

1.39

3.28

1.5

1.4

319.45

318.04

ug/g

0.03

484

Autoimmune hepatitis

2.52

3.27

1.6

1.4

287.48

297.43

ug/g

0.10

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

3.00

3.26

1.6

1.5

136.22

265.21

ug/g

—

Melanocytic naevi of trunk

194

1492

1.31

3.26

1.4

295.07

281.71

ug/g

0.36

118

855

Enteritis due to Yersinia enterocolitica

2.99

3.26

1.8

1.4

167.50

306.27

ug/g

—

Coxarthrosis, primary, with hip surgery

862

7064

1.14

3.26

1.4

271.51

262.17

ug/g

0.66

523

4280

Malignant neoplasm of larynx

103

2.28

3.26

1.7

1.4

233.53

283.59

ug/g

0.52

Benign neoplasm: Other/unspecified site

171

1.98

3.26

1.5

1.4

255.54

297.39

ug/g

0.63

102

Preterm labour and delivery

410

3427

1.20

3.25

1.3

1.4

307.09

293.51

ug/g

0.67

222

1883

Unspecified lump in breast

278

2236

1.25

3.25

1.5

1.4

262.63

283.68

ug/g

1.03

179

1244

Acute otitis externa, noninfective

178

1.96

3.25

1.5

240.00

280.86

ug/g

0.46

111

Patellar tendinitis

123

2.15

3.23

1.7

1.3

284.71

275.65

ug/g

0.07

Femoral hernia

466

1.57

3.23

1.7

1.4

264.77

274.84

ug/g

0.18

277

Myopia

189

1450

1.31

3.23

1.5

1.4

265.33

300.76

ug/g

1.29

770

Hypotension due to drugs

137

2.10

3.22

1.6

1.4

292.86

275.78

ug/g

0.15

Separation of retinal layers (serosa)

459

1.57

3.20

1.5

260.56

280.05

ug/g

0.36

267

Varicella [chickenpox]

475

1.56

3.19

1.4

264.56

275.63

ug/g

0.17

279

Idiopathic urticaria

215

1.85

3.18

1.7

1.4

319.05

302.78

ug/g

0.16

123

Disorders of orbit

484

1.55

3.17

1.4

266.42

292.81

ug/g

0.52

275

Unspecified event, undetermined intent

252

1.78

3.17

1.5

246.50

300.80

ug/g

0.97

149

Tic and related disorders

111

2.21

3.17

1.6

1.4

242.91

337.33

ug/g

1.23

Arterial embolism and thrombosis of lower extremity artery

366

1.64

3.16

1.5

223.97

272.61

ug/g

1.00

232

Marginal zone B-cell lymphoma, including Hilmo

145

2.05

3.15

1.5

1.4

297.68

300.64

ug/g

0.02

Valvular operations

218

1710

1.28

3.15

1.4

275.59

259.49

ug/g

0.58

146

1046

Unspecified visual impairment (binocular)

159

2.00

3.15

1.4

266.70

297.09

ug/g

0.33

Impetigo

469

1.55

3.14

1.6

1.4

279.38

304.40

ug/g

0.42

260

Other localized connective tissue disorders

224

1.83

3.13

1.5

1.4

242.95

297.76

ug/g

1.00

127

Disorders of optic nerve, not elsewhere classified

224

1.83

3.12

1.5

234.84

278.70

ug/g

0.64

133

Family history of other specific disorders

132

2.10

3.12

1.6

1.4

260.54

296.88

ug/g

0.34

Secondary parkinsonism, excluding more controls

209

1.85

3.12

1.3

235.95

257.16

ug/g

0.26

125

Mixed specific developmental disorders

166

1.93

3.11

1.1

1.4

383.14

372.95

ug/g

0.11

Gangrene, not elsewhere classified

2.77

3.10

2.1

1.4

70.93

270.21

ug/g

—

Viral meningitis

376

1.62

3.10

1.5

1.4

257.18

295.87

ug/g

0.75

223

Hypogonadotropic hypogonadism

284

1.72

3.09

1.5

286.44

262.18

ug/g

0.32

167

Primary open-angle glaucoma

565

4688

1.16

3.09

1.5

1.4

252.35

264.17

ug/g

0.70

347

2840

Inflammatory disorders of male genital organs, not elsewhere classified

106

2.22

3.07

1.7

1.6

287.00

241.85

ug/g

0.59

Injury of muscle and tendon at lower leg level

240

1912

1.26

3.07

1.5

1.4

292.86

270.04

ug/g

0.95

157

1109

Dislocation, sprain and strain of joints and ligaments of thorax

377

1.62

3.07

1.5

1.4

253.98

277.09

ug/g

0.41

219

Dronedarone medication

331

1.66

3.07

1.7

1.4

250.54

268.68

ug/g

0.38

189

Dermatopolymyositis (FG)

147

2.03

3.06

1.3

1.5

289.60

281.85

ug/g

0.06

Other nonthrombocytopenic purpura

2.31

3.02

1.6

1.4

269.77

304.39

ug/g

0.34

Other and unspecified hypertrophic disorders of skin

2.56

3.02

1.6

1.3

215.56

303.74

ug/g

—

Other deformities of toe(s)

363

1.62

3.02

1.5

1.4

303.97

264.95

ug/g

0.67

209

Chorioretinal inflammation

294

1.70

3.01

1.6

1.4

258.46

301.08

ug/g

0.93

172

Carcinoma in situ of skin of lower limb, including hip

272

1.73

3.01

1.2

1.4

296.51

268.05

ug/g

0.39

163

Cardiomyopathy (excluding other)

196

1528

1.29

3.00

1.5

253.27

262.33

ug/g

0.25

129

901

Vascular dementia

144

1036

1.35

3.00

1.5

257.95

256.40

ug/g

0.03

662

Long labour

235

2489

0.80

2.99

1.3

1.4

358.51

304.43

ug/g

2.99

116

1321

Personality and behavioural disorders due to brain disease, damage and dysfunction

148

2.01

2.99

2.2

1.5

243.40

289.07

ug/g

0.48

Other secondary coxarthrosis

388

1.60

2.98

1.6

1.5

267.63

282.52

ug/g

0.22

235

Congenital malformations of trachea and bronchus

108

2.21

2.97

1.7

1.4

319.20

286.01

ug/g

0.47

Other bullous disorders

303

1.68

2.97

1.5

1.4

233.64

292.43

ug/g

0.95

188

Malignant neoplasm of hypopharynx, including Hilmo

2.92

2.96

1.4

333.71

272.70

ug/g

—

Malignant neoplasm of bone and articular cartilage

2.39

2.96

1.5

1.3

246.56

321.60

ug/g

—

Female infertility, associated with anovulation

572

1.48

2.96

1.3

334.64

312.33

ug/g

0.45

260

Epileptic seizures related to alcohol

2.81

2.95

1.5

1.6

138.67

288.62

ug/g

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

626

0.57

2.94

1.4

1.5

279.59

290.53

ug/g

0.11

369

Hyperprolactinaemia

350

1.62

2.94

1.4

236.74

303.25

ug/g

1.61

186

Pedestrian injured in collision with pedal cycle

335

1.64

2.93

1.5

1.4

299.27

283.77

ug/g

0.25

209

Other pulmonary heart/vessel disease

518

1.51

2.93

1.6

1.4

260.89

279.16

ug/g

0.38

322

Severe visual impairment, monocular

102

2.22

2.92

1.5

1.3

328.41

317.90

ug/g

—

Leiomyosarcoma

2.68

2.92

1.5

1.3

245.40

318.62

ug/g

—

Burns and corrosions of multiple body regions

2.50

2.92

1.5

180.51

277.10

ug/g

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

2.67

2.92

1.1

1.3

333.60

325.96

ug/g

—

Diffuse large B-cell lymphoma, helper endpoint

502

1.51

2.92

1.7

1.4

225.97

293.45

ug/g

2.18

305

Diffuse large B-cell lymphoma, including Hilmo

502

1.51

2.92

1.7

1.4

225.97

293.45

ug/g

2.18

305

Diffuse large B-cell lymphoma

502

1.51

2.92

1.7

1.4

225.97

293.45

ug/g

2.18

305

Nonischemic cardiomyopathy

162

1236

1.32

2.92

1.5

1.4

278.06

265.42

ug/g

0.32

103

742

Mental and behavioural disorders due to use of other stimulants, including caffeine

251

1.74

2.91

1.4

254.75

308.29

ug/g

0.76

133

Polymyositis

2.37

2.90

1.3

1.4

269.77

265.78

ug/g

0.03

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

375

1.60

2.90

1.5

260.09

285.69

ug/g

0.54

222

Contusion of toe(s) without damage to nail

267

1.71

2.89

1.3

1.4

295.00

315.22

ug/g

0.19

153

Malignant neoplasm of bone and articular cartilage, including Hilmo

157

1.95

2.89

1.5

1.4

263.25

314.69

ug/g

0.70

Fasciculation

116

2.13

2.88

1.6

1.4

321.29

303.61

ug/g

0.16

Adult respiratory distress syndrome

116

2.12

2.87

1.7

1.5

238.06

293.08

ug/g

0.53

Single delivery by caesarean section

174

1285

0.77

2.87

1.3

1.4

307.20

299.42

ug/g

0.17

648

Nonalcoholic steatohepatitis

103

2.21

2.87

1.2

1.3

344.56

310.70

ug/g

—

ILD and respiratory illness in diseases classified elsewhere

2.77

2.86

1.6

1.4

308.13

258.75

ug/g

—

Other factor of the environment

130

2.06

2.86

1.4

349.67

305.16

ug/g

—

Malignant melanoma of skin, including Hilmo

220

1752

1.26

2.85

1.4

283.53

284.64

ug/g

0.03

148

1067

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

216

1.80

2.85

1.2

1.4

313.63

294.93

ug/g

0.20

131

Other primary thrombocytopenia

3.25

2.84

1.1

1.3

360.40

351.96

ug/g

—

Malignant neoplasm of tonsil and base of tongue, including Hilmo

216

1.79

2.84

1.5

1.4

269.86

305.73

ug/g

0.45

137

Retinal vascular occlusion

191

1497

1.29

2.84

1.4

245.97

268.17

ug/g

0.80

115

921

Other complications of labour and delivery, not elsewhere classified

1046

0.69

2.83

1.2

1.3

379.29

325.35

ug/g

1.06

493

Other appendicitis

134

1001

1.35

2.82

1.3

1.4

264.32

286.90

ug/g

0.67

583

Other injuries of spine and trunk, level unspecified

2.33

2.82

1.4

1.5

275.45

280.81

ug/g

0.04

Dermatopolymyositis

159

1.94

2.81

1.3

1.4

294.29

287.94

ug/g

0.05

Other hyperalimentation

3.45

2.81

1.4

179.67

311.12

ug/g

—

Atopic conjunctivitis

474

1.52

2.80

1.5

1.4

284.85

303.59

ug/g

0.33

273

Benign leiomyoma with endometriosis

274

2242

1.23

2.80

1.5

1.4

288.86

277.52

ug/g

0.45

157

1308

Endometriosis of intestine

117

2.09

2.80

1.3

1.2

485.30

339.17

ug/g

—

Contact with other sharp object(s)

705

1.42

2.79

1.3

1.4

294.70

300.99

ug/g

0.10

391

Viral encephalitis, not elsewhere classified/unspecified

210

1.80

2.79

1.2

1.4

304.39

295.17

ug/g

0.09

129

Cardiodefibrillation

604

5266

1.15

2.79

1.5

1.4

262.51

259.58

ug/g

0.13

377

3237

Specific development disorders of speech and language

551

1.47

2.78

1.4

291.53

307.28

ug/g

0.30

289

Intracranial and intraspinal abscess and granuloma

111

2.13

2.78

1.7

1.4

200.43

282.30

ug/g

1.32

Retinal vascular disorders

194

1528

1.28

2.77

1.4

244.10

267.34

ug/g

0.85

116

937

Bacterial meningitis

372

1.58

2.76

1.4

268.48

277.99

ug/g

0.13

219

Renal cell carcinoma of kidney

286

1.67

2.76

1.5

1.4

246.87

299.01

ug/g

0.91

176

Helminthiases, including avohilmo

436

1.53

2.75

1.6

1.4

258.86

316.81

ug/g

1.41

233

Vascular dementia (undefined)

400

1.55

2.73

1.6

1.4

275.24

249.09

ug/g

0.53

249

Other specified and unspecified retinal disorders

397

1.56

2.73

1.4

1.5

230.78

277.26

ug/g

1.11

234

Other congenital malformations of intestine

2.35

2.73

1.4

1.3

333.08

301.58

ug/g

0.24

Other and unspecified bullous disorders

112

2.12

2.73

1.5

1.3

176.36

316.30

ug/g

2.31

Synovial hypertrophy, not elsewhere classified

2.34

2.72

1.5

1.4

391.50

329.14

ug/g

0.62

Malignant melanoma of skin

179

1400

1.29

2.71

1.4

282.98

285.23

ug/g

0.06

119

856

Other and unspecified nonorganic psychotic disorders

276

2266

1.22

2.71

1.4

298.14

280.79

ug/g

0.63

159

1243

Open bite

510

1.49

2.71

1.4

299.78

323.63

ug/g

0.43

271

Multifocal fibrosclerosis

2.49

2.70

1.8

1.4

238.32

294.39

ug/g

—

Symptoms and signs involving appearance and behaviour

2.40

2.70

1.6

1.5

408.43

277.03

ug/g

—

Allergic contact dermatitis due to drugs in contact with skin

235

1.74

2.69

1.3

1.4

273.50

295.73

ug/g

0.27

145

Malignant immunoproliferative diseases

106

2.14

2.69

1.4

265.19

283.51

ug/g

0.15

Aphakia

140

1.97

2.68

1.7

1.4

201.41

262.88

ug/g

0.84

Benign neoplasm: Skin of ear and external auricular canal

423

1.53

2.67

1.5

254.35

276.69

ug/g

0.35

264

Benign neoplasm of other and unspecified intrathoracic organs

113

2.10

2.67

1.5

1.4

232.94

300.32

ug/g

0.71

Exposure to other and unspecified forces of nature

2.64

2.66

1.6

1.3

219.29

323.67

ug/g

—

Cauda equina syndrome

148

1.94

2.66

1.5

1.4

242.14

288.20

ug/g

0.58

Alzheimer’s disease (Atypical or mixed), excluding more controls

124

686

1.36

2.66

1.4

234.90

250.15

ug/g

0.39

417

Hereditary motor and sensory neuropathy

2.32

2.66

1.3

277.65

304.01

ug/g

0.20

Autism

198

1.79

2.65

1.8

1.5

315.80

340.29

ug/g

0.21

103

Carcinoma in situ of other and unspecified sites

424

1.53

2.65

1.4

1.5

240.17

252.96

ug/g

0.16

277

Malignant neoplasm of cervix uteri, including Hilmo

259

1.69

2.65

1.6

1.4

300.88

319.70

ug/g

0.24

147

Schizophrenia, schizotypal and delusional disorders

486

4202

1.16

2.64

1.4

288.22

276.52

ug/g

0.58

277

2379

Obstructed labour due to malposition and malpresentation of fetus

213

2450

0.80

2.64

1.3

1.4

321.24

306.59

ug/g

0.41

113

1292

Paranoid personality disorder

177

1.84

2.64

1.4

291.44

310.57

ug/g

0.20

101

Hypoplasia of dental enamel, prenatal

3.34

2.63

1.4

1.3

352.33

368.82

ug/g

—

Other and unspecified degenerative diseases of nervous system

298

1.64

2.63

1.7

1.5

239.69

271.74

ug/g

0.46

186

Malignant neoplasm of endocrine gland

112

824

1.37

2.63

1.4

319.67

306.18

ug/g

0.28

465

Spasmodic torticollis

377

1.56

2.63

1.3

1.4

295.62

290.17

ug/g

0.07

216

Tibial collateral bursitis [Pellegrini-Stieda]

100

2.15

2.63

1.3

1.4

265.33

272.80

ug/g

—

Pyoderma

192

1.81

2.62

1.4

218.96

298.16

ug/g

0.96

117

Malignant neoplasm of oropharynx, including Hilmo

3.19

2.61

2.0

1.3

173.57

268.54

ug/g

—

Disorders of parathyroid gland, other and/or unspecified

2.31

2.60

1.6

1.3

195.36

275.72

ug/g

—

Artificial joint re-operation

123

921

1.35

2.60

1.4

1.5

324.45

266.36

ug/g

2.45

545

Myeloproliferative diseases

136

1033

1.33

2.60

1.5

1.4

270.45

272.53

ug/g

0.04

619

Status post-ami

414

2679

1.18

2.59

1.5

1.4

251.87

255.89

ug/g

0.16

249

1629

Juvenile Open Angle Glaucoma

2.83

2.59

1.5

209.86

268.51

ug/g

—

Psoas tendinitis

2.83

2.59

1.0

1.3

326.16

295.37

ug/g

—

Brain meningioma, including Hilmo

574

1.45

2.59

1.4

298.66

303.56

ug/g

0.07

333

Pathological resorption of teeth

419

1.53

2.57

1.5

1.4

256.15

287.69

ug/g

0.51

243

Injury of nerves at shoulder and upper arm level

101

2.13

2.57

1.7

1.3

202.09

296.93

ug/g

1.04

Major anomalies of jaw size

269

1.66

2.57

1.4

1.5

290.18

298.84

ug/g

0.11

156

Melanocytic naevi

507

4409

1.15

2.57

1.4

299.81

279.76

ug/g

1.35

303

2512

Fistulae involving female genital tract

157

1.89

2.56

1.6

1.4

280.98

288.29

ug/g

0.06

Benign neoplasm: Skin, unspecified

452

1.50

2.56

1.4

1.5

360.22

285.62

ug/g

2.04

274

Benign neoplasm of eye and adnexa

175

1378

1.28

2.55

1.4

282.63

275.82

ug/g

0.19

109

817

Viral haemorrhagic fevers, not elsewhere classified/unspecified

119

889

1.35

2.55

1.4

286.70

280.65

ug/g

0.10

534

Ankylosing hyperostosis [Forestier]

122

2.01

2.54

1.5

1.4

283.44

264.07

ug/g

0.21

Spontaneous abortion

734

4366

1.13

2.54

1.4

304.69

293.94

ug/g

0.62

400

2381

Torsion of ovary, ovarian pedicle and fallopian tube

179

1.81

2.54

1.5

1.3

368.64

314.26

ug/g

0.64

Haemophilus septicemia

4.70

2.54

1.7

1.3

201.43

334.47

ug/g

—

Chronic iridocyclitis

535

1.46

2.53

1.4

256.11

286.29

ug/g

0.69

315

Malignant neoplasm of thyroid gland, including Hilmo

114

847

1.36

2.53

1.4

319.44

308.63

ug/g

0.23

479

Burn and corrosion confined to eye and adnexa

232

1.71

2.52

1.6

1.4

295.41

283.42

ug/g

0.14

142

Other other unspecified disorders of the circulatory system

405

1.53

2.52

1.7

1.4

237.47

273.94

ug/g

0.78

240

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

443

3822

1.17

2.52

1.4

280.95

269.26

ug/g

0.61

253

2262

Other and unspecified mononeuropathies of lower limb

294

1.63

2.51

1.4

1.5

247.99

290.41

ug/g

0.59

169

Epiphora

271

1.66

2.51

1.6

1.4

243.80

291.13

ug/g

0.82

164

2.80

2.51

1.2

1.4

365.00

302.73

ug/g

—

Non-Hodgkin lymphoma, all

405

1.52

2.51

1.3

1.4

251.82

291.68

ug/g

0.84

254

Discitis, unspecified

151

1.89

2.51

1.5

1.4

233.53

264.93

ug/g

0.36

Herpesviral keratitis and keratoconjunctivitis

487

1.48

2.50

1.7

1.5

213.21

281.59

ug/g

2.22

292

Respiratory conditions due to other external agents

233

1.71

2.50

1.3

1.5

262.12

283.94

ug/g

0.26

144

Progressive supranuclear ophthalmoplegia (Steele-Richardson-Olszewski)

2.55

2.50

1.5

206.71

273.92

ug/g

—

Delayed milestone in childhood

161

1.82

2.50

1.4

330.40

389.66

ug/g

0.84

Other or ill-defined heart diseases

561

1.44

2.49

1.5

1.4

246.75

276.45

ug/g

0.74

330

Pneumothorax

103

755

1.38

2.49

1.4

274.69

268.10

ug/g

0.11

460

Disorder of external ear, unspecified

382

1.54

2.49

1.6

1.5

252.89

272.20

ug/g

0.27

224

Primary open-angle glaucoma, strict

457

3945

1.16

2.49

1.5

1.4

255.04

262.49

ug/g

0.34

278

2409

Shigellosis, including avohilmo

2.53

2.49

1.2

1.5

293.43

305.45

ug/g

—

Toxic effect of ethanol

398

1.53

2.48

1.5

1.4

226.60

297.68

ug/g

1.56

230

Macular hole

100

731

1.38

2.48

1.5

1.4

269.75

274.12

ug/g

0.08

432

Glaucoma, exfoliation

175

1383

1.27

2.48

1.5

1.4

240.79

269.74

ug/g

1.26

119

847

Other and unspecified disease of Bartholin gland

319

1.60

2.48

1.3

1.4

308.69

302.03

ug/g

0.06

184

Carcinoma in situ of skin of trunk

375

1.54

2.47

1.2

1.5

251.73

260.73

ug/g

0.12

242

Ectropion of eyelid

415

1.51

2.46

1.5

279.50

258.45

ug/g

0.38

267

Galactorrhea

103

2.10

2.46

1.3

315.27

320.11

ug/g

0.04

Non-allergic asthma

130

989

1.32

2.45

1.4

287.29

279.70

ug/g

0.16

578

Hereditary deficiency of other clotting factors

2.23

2.45

1.8

1.4

339.90

332.44

ug/g

0.04

Dislocation of lens

145

1.90

2.45

1.3

1.5

243.31

273.89

ug/g

0.34

Disorders of speech understanding and production

439

1.49

2.45

1.5

1.4

292.90

318.10

ug/g

0.45

239

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

698

1.39

2.45

1.4

241.39

286.98

ug/g

1.72

428

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

131

1.96

2.45

1.3

1.4

339.62

270.68

ug/g

1.53

Blindness, monocular

2.23

2.45

1.6

1.4

211.46

309.43

ug/g

—

Hyperaldosteronism

328

1.58

2.45

1.5

291.40

275.94

ug/g

0.19

201

Exfoliative dermatitis

2.22

2.44

1.8

1.3

252.85

326.89

ug/g

1.10

Intentional self-harm by sharp object

219

1.71

2.44

1.3

1.4

280.84

299.93

ug/g

0.20

112

Varicella [chickenpox], including avohilmo

564

1.43

2.43

1.4

274.07

288.80

ug/g

0.24

329

Benign neoplasm: Pituitary gland, craniopharyngeal duct

590

1.42

2.43

1.4

1.5

264.97

281.79

ug/g

0.39

339

Collapsed vertebra, not elsewhere classified

2.41

2.43

1.5

1.3

246.22

289.94

ug/g

—

Vertigo of central origin

175

1.81

2.42

1.6

1.4

251.98

287.37

ug/g

0.46

102

Benign neoplasm of middle ear and respiratory system

121

914

1.34

2.42

1.5

1.4

267.29

272.24

ug/g

0.10

556

Asthma mixed form (mode), excluding more controls

465

1.47

2.42

1.5

1.4

292.84

284.46

ug/g

0.12

252

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

102

737

1.37

2.42

1.4

338.69

321.12

ug/g

0.36

382

Convergent concomitant strabismus

590

1.42

2.42

1.6

1.4

275.53

307.11

ug/g

0.58

316

Nosocomial condition (hospital)

2.51

2.42

2.0

1.3

181.46

307.58

ug/g

—

Conductive hearing loss, unspecified

128

975

1.32

2.42

1.5

1.4

284.60

275.76

ug/g

0.16

576

Contact with other hot fluids

313

1.59

2.41

1.3

1.4

280.34

295.12

ug/g

0.15

183

Burn and corrosion of hip and lower limb, except ankle and foot

220

1.71

2.41

1.5

1.4

307.54

289.62

ug/g

0.19

129

Schizophrenia or delusion

479

4171

1.15

2.40

1.4

287.90

275.67

ug/g

0.61

274

2358

Burns and corrosions confined to eye and internal organs

282

1.62

2.40

1.6

1.4

297.17

283.61

ug/g

0.17

167

Hyperkinetic disorders (excl. ADHD)

158

1.84

2.40

1.2

1.5

343.25

342.43

ug/g

0.01

Contact with machinery

161

1266

1.28

2.39

1.5

275.65

258.67

ug/g

0.54

107

783

Ankylosing spondylitis, ICD10

130

994

1.32

2.39

1.4

265.98

283.42

ug/g

0.40

579

Disorders in reading

118

1.98

2.38

1.1

1.4

402.13

336.21

ug/g

—

Crossbite

100

676

1.37

2.38

1.4

315.89

318.84

ug/g

0.05

354

Spermatocele

100

736

1.37

2.37

1.6

1.5

205.80

239.21

ug/g

1.14

458

Anomalies of pupillary function

206

1.73

2.37

1.4

288.94

308.84

ug/g

0.19

116

Drug-induced systemic lupus erythematosus

2.27

2.37

1.2

1.4

352.60

316.90

ug/g

—

Narcolepsy and cataplexy

2.90

2.37

1.3

1.4

342.00

341.57

ug/g

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

411

1.50

2.36

1.4

1.5

233.14

290.84

ug/g

1.56

243

Other and unspecified primary disorders of muscles

2.26

2.36

1.5

1.4

273.83

314.36

ug/g

0.33

Injury of muscle and tendon at hip and thigh level

161

1269

1.28

2.35

1.3

1.4

299.06

279.68

ug/g

0.56

742

Thiamine deficiency

2.47

2.34

1.6

1.5

231.40

254.20

ug/g

—

Amiodarone users

156

1226

1.28

2.34

1.5

251.60

261.82

ug/g

0.28

103

755

Other misadventures during surgical and medical care

253

1.65

2.34

1.5

1.4

257.60

283.74

ug/g

0.31

154

Childhood allergy (age < 16)

148

948

1.29

2.34

1.4

1.3

345.25

334.66

ug/g

0.20

402

Corneal scars and opacities

300

1.59

2.34

1.5

236.54

278.23

ug/g

0.61

189

Seropositive rheumatoid arthritis, wide

452

3931

1.16

2.33

1.4

281.35

268.83

ug/g

0.67

256

2326

False labour

400

2127

1.17

2.33

1.3

1.4

335.27

308.28

ug/g

1.40

175

1091

Conduct disorder

177

1.78

2.32

1.5

1.4

310.60

318.60

ug/g

0.07

Malignant neoplasm of other endocrine glands and related structures, including Hilmo

2.86

2.32

1.3

387.60

287.65

ug/g

—

Pseudomembranous colitis

2.29

2.31

1.4

1.3

287.22

309.12

ug/g

—

Cardiomyopathy in other diseases

2.64

2.31

1.1

1.4

847.43

273.32

ug/g

—

Viral pneumonia (known virus, not influenza)

317

1.57

2.31

1.3

1.4

244.91

275.36

ug/g

0.45

192

Benign neoplasm: Long bones of lower limb

349

1.54

2.30

1.5

251.95

287.21

ug/g

0.68

206

Lifestyle-related condition

120

1.97

2.30

1.4

1.3

341.75

311.83

ug/g

—

Scleritis

127

1.93

2.30

1.6

1.4

251.42

300.52

ug/g

0.44

Previous suicide attempt

2.07

2.30

1.6

1.5

265.34

312.31

ug/g

0.35

Thyrotropin deficiency

113

2.00

2.30

1.5

1.4

358.09

318.29

ug/g

0.36

Malignant neoplasm of other and ill-defined sites, including Hilmo

134

1.90

2.29

1.4

148.47

312.62

ug/g

5.92

Other disorders of peripheral nervous system

2.36

2.29

1.7

1.4

281.50

314.55

ug/g

—

Asthma mixed form (mode)

471

1.46

2.29

1.5

1.3

292.84

289.20

ug/g

0.05

256

Graves disease, strict definition

157

1239

1.28

2.28

1.5

1.4

292.51

298.35

ug/g

0.13

100

662

Endometriosis of fallopian tube

2.34

2.28

1.2

1.3

305.86

314.86

ug/g

—

Haemorrhagic and haematological disorders of fetus and newborn

149

1.83

2.27

2.0

1.4

315.59

375.56

ug/g

0.78

Benign neoplasm: Cerebral meninges

161

1277

1.27

2.26

1.4

300.65

282.58

ug/g

0.49

756

Other and unspecified vaccines and biological substances

2.41

2.26

1.2

1.3

350.43

331.22

ug/g

—

Cervical polyps

137

1064

1.30

2.26

1.4

279.84

274.79

ug/g

0.11

588

Benign neoplasm of meninges

177

1420

1.26

2.25

1.4

295.24

278.88

ug/g

0.46

100

834

Benign neoplasm of soft tissue of retroperitoneum and peritoneum

2.51

2.25

1.9

1.3

205.13

291.75

ug/g

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

100

2.05

2.24

1.5

1.4

321.75

295.72

ug/g

0.24

Tooth eruption problems

173

1335

1.26

2.24

1.3

293.44

322.27

ug/g

0.92

643

Precocious central puberty

2.94

2.23

1.4

1.3

248.20

315.77

ug/g

—

Thyroiditis

113

857

1.33

2.23

1.4

307.56

293.12

ug/g

0.29

474

Complications of genitourinary prosthetic devices, implants and grafts

272

1.61

2.23

1.4

243.60

301.76

ug/g

1.10

164

Thyrotoxicosis with toxic multinodular goitre

105

789

1.35

2.22

1.3

1.5

275.09

280.54

ug/g

0.09

450

Secondary right heart disease

475

1.45

2.22

1.5

1.4

262.12

279.61

ug/g

0.32

295

Injury of nerves at forearm level

136

1.88

2.22

1.4

1.5

218.57

286.87

ug/g

—

Patent foramen ovale

226

1.67

2.21

1.6

1.4

307.92

314.18

ug/g

0.07

133

Delayed puberty

2.56

2.21

1.5

1.3

265.40

372.79

ug/g

—

Periodontal disease, other/unspecified

297

1.57

2.19

1.2

1.4

344.68

300.56

ug/g

0.66

172

Carcinoma in situ of rectum

144

1.85

2.19

1.4

1.5

261.39

264.64

ug/g

0.03

Malignant neoplasm of bladder

618

1.38

2.19

1.5

225.96

274.09

ug/g

1.38

391

Puerperal sepsis

211

1732

1.23

2.18

1.4

303.66

289.68

ug/g

0.46

116

974

Osteopathy in diseases classified elsewhere

2.17

1.6

1.3

133.60

308.65

ug/g

3.04

Postpartum haemorrhage

254

2503

0.83

2.17

1.3

1.4

329.09

306.96

ug/g

0.87

121

1314

Systemic sclerosis,strict definition

116

1.96

2.16

1.8

1.4

262.05

311.46

ug/g

0.40

Mental and behavioural disorders due to cannabinoids

227

1.65

2.16

1.4

1.5

299.95

294.95

ug/g

0.04

114

Malignant neoplasm of bronchus and lung

191

1958

0.81

2.15

1.3

1.4

268.86

275.52

ug/g

0.17

121

1195

Osteomalacia

2.06

2.15

1.5

1.4

290.82

290.61

ug/g

0.00

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

123

1.91

2.15

1.2

1.4

417.86

317.59

ug/g

0.91

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

371

1.50

2.15

1.5

1.4

310.26

343.71

ug/g

0.53

195

Diabetes insipidus

2.06

2.15

1.6

1.3

275.69

295.71

ug/g

0.18

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

140

1100

1.28

2.14

1.2

1.4

320.57

286.69

ug/g

1.21

595

Non-small cell lung cancer, squamous, helper endpoint

486

0.59

2.14

1.1

1.5

227.22

250.33

ug/g

0.33

316

Urethral stricture

571

1.40

2.13

1.4

1.5

267.56

257.38

ug/g

0.15

365

Brain meningioma

555

1.40

2.12

1.5

1.4

298.22

301.98

ug/g

0.05

320

Burns and corrosions of multiple and unspecified body regions

221

1.65

2.12

1.4

218.91

287.20

ug/g

1.02

134

Vasculitis limited to skin, not elsewhere classified

292

1.57

2.12

1.5

277.48

287.78

ug/g

0.13

178

Use of rotigotine

124

1.91

2.11

1.6

1.4

254.44

285.55

ug/g

0.31

Spinal osteochondrosis

2.18

2.11

1.6

1.3

303.33

283.80

ug/g

—

Other/unspecified seropositive rheumatoid arthritis

444

3890

1.15

2.10

1.4

280.95

269.21

ug/g

0.61

253

2305

Amputation of thigh

284

1.57

2.10

1.6

1.4

215.36

261.46

ug/g

0.74

170

Behavioural disorders

183

1.72

2.10

1.5

1.4

300.88

324.09

ug/g

0.23

102

Gonococcal infection

357

1.50

2.10

1.5

1.4

246.30

293.91

ug/g

0.82

204

Vascular dementia (mixed)

191

1.70

2.09

1.3

1.4

286.78

258.71

ug/g

0.48

117

Infliximab

191

1.70

2.09

1.3

1.4

313.39

302.66

ug/g

0.13

102

Oral leukoplakia, including avohilmo

293

1.56

2.09

1.4

204.29

278.14

ug/g

1.60

173

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

440

1.45

2.08

1.5

261.51

277.90

ug/g

0.26

261

Motorcycle rider injured in noncollision transport accidents

285

1.56

2.08

1.5

232.78

280.46

ug/g

0.73

164

Infectious mononucleosis

101

762

1.33

2.08

1.4

311.16

303.18

ug/g

0.14

378

Infectious mononucleosis, including avohilmo

101

762

1.33

2.08

1.4

311.16

303.18

ug/g

0.14

378

Transient global amnesia

157

1258

1.26

2.06

1.6

1.4

288.62

265.58

ug/g

0.85

104

778

Hypothyroidism, autoimmune, DX-based

2.61

2.06

1.2

306.20

306.13

ug/g

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

2.61

2.06

1.5

1.4

296.80

328.39

ug/g

—

Lesion of femoral nerve

2.11

2.05

1.7

1.3

289.45

273.32

ug/g

0.12

Antenatal screening

209

1420

0.82

2.05

1.3

1.4

353.23

304.90

ug/g

1.93

105

732

Injury of cranial nerves

2.30

2.05

1.3

1.4

305.73

309.82

ug/g

—

Injury of blood vessels at neck level

2.74

2.04

1.6

1.4

229.00

268.54

ug/g

—

Calcific tendinitis

2.01

2.04

1.3

1.5

369.08

300.58

ug/g

0.62

Other and unspecified vasculitis limited to skin

255

1.59

2.04

1.5

269.17

291.52

ug/g

0.29

160

Disorders of lacrimal system and orbit in diseases classified elsewhere

271

1.57

2.03

1.3

1.4

275.41

299.76

ug/g

0.33

157

Prolapse and hernia of ovary and fallopian tube

372

1.48

2.03

1.3

1.4

276.57

264.23

ug/g

0.19

215

Necrotizing fasciitis

2.71

2.03

1.1

1.3

289.00

328.37

ug/g

—

Calcific aortic valvular stenosis, operated

485

4122

1.14

2.03

1.4

245.47

257.88

ug/g

0.69

314

2552

Calcific aortic valvular stenosis

485

4122

1.14

2.03

1.4

245.47

257.88

ug/g

0.69

314

2552

Autism spe

208

1.65

2.03

1.9

1.4

315.80

344.09

ug/g

0.26

110

Burn and corrosion of ankle and foot

133

1.84

2.02

1.2

1.4

277.15

295.97

ug/g

0.12

Specific developmental disorder of motor function

129

1.84

2.02

1.3

1.4

317.12

375.87

ug/g

0.82

Other degenerative diseases of the basal ganglia

209

1.66

2.02

1.6

1.5

194.32

263.97

ug/g

1.27

131

Malignant neoplasm of thyroid gland

100

758

1.33

2.02

1.4

320.94

312.65

ug/g

0.16

427

Complications associated with artificial fertilization

1.98

2.01

1.4

1.2

389.89

353.45

ug/g

—

Use of donepezil

245

2773

0.84

2.01

1.3

1.4

279.51

257.51

ug/g

1.00

131

1730

Other congenital malformations of skin, including avohilmo

116

898

1.30

2.01

1.4

314.04

296.23

ug/g

0.33

491

Operations 2 for CAVS

484

4117

1.14

2.00

1.4

245.64

257.74

ug/g

0.67

313

2549

Calcific aortic valvular stenosis, diagnosis (helper)

484

4117

1.14

2.00

1.4

245.64

257.74

ug/g

0.67

313

2549

Polycystic ovarian syndrome, broad definition

129

1012

1.28

2.00

1.3

349.30

329.21

ug/g

0.41

471

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

386

1.47

1.99

1.4

282.55

295.49

ug/g

0.20

229

Pedal cyclist injured in other and unspecified transport accidents

167

1352

1.24

1.99

1.4

249.71

285.41

ug/g

1.54

773

Calcific aortic valvular stenosis, including rheumatic fever

485

4124

1.13

1.99

1.4

245.61

257.75

ug/g

0.67

314

2552

Follicular lymphoma, hilmo

495

1.41

1.99

1.4

1.5

290.67

274.89

ug/g

0.30

301

Other disorders of cornea

155

1246

1.25

1.98

1.5

1.4

281.55

280.35

ug/g

0.02

730

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

142

1.80

1.96

1.6

1.4

243.54

294.83

ug/g

0.51

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

129

1017

1.28

1.95

1.5

1.4

335.19

281.75

ug/g

2.16

585

Dilated cardiomyopathy

173

1410

1.24

1.95

1.5

258.72

261.19

ug/g

0.05

113

873

Congenital malformations of ovaries, fallopian tubes and broad ligaments

564

1.38

1.95

1.4

1.3

330.01

318.79

ug/g

0.18

277

Malignant neoplasm of cervix uteri

180

1.70

1.95

1.6

1.4

282.76

323.96

ug/g

0.51

100

Other and unspecified pemphigoid

2.01

1.94

1.8

1.4

279.64

289.56

ug/g

0.06

Malignant neoplasm of oral cavity, including Hilmo

438

1.43

1.94

1.5

1.4

271.72

288.15

ug/g

0.30

270

2.09

1.93

1.3

1.4

194.50

324.22

ug/g

—

Abscess of external ear

128

1.83

1.92

1.2

1.5

355.50

296.31

ug/g

0.78

Gonococcal infection, including avohilmo

381

1.46

1.92

1.6

1.4

246.90

292.55

ug/g

0.81

217

Panhypopituitarism

181

1.69

1.91

1.3

1.4

290.19

286.00

ug/g

0.03

110

Retained placenta and membranes, without haemorrhage

191

1577

1.22

1.91

1.3

1.4

290.98

289.44

ug/g

0.03

865

Hypertrophy of tongue papillae

151

1.76

1.90

2.0

1.4

342.71

304.71

ug/g

0.32

Cicatricial alopecia [scarring hair loss]

100

1.96

1.90

1.1

1.3

384.55

314.50

ug/g

0.66

Chronic Coagulation defects

244

1.58

1.90

1.7

1.4

321.23

310.15

ug/g

0.11

135

Congenital malformations of cardiac septa

725

1.32

1.88

1.6

1.4

282.74

307.23

ug/g

0.54

402

Other specified/unspecified necrotizing vasculopathies

144

1.77

1.88

1.8

1.4

313.44

275.24

ug/g

0.65

Leiomyosarcoma, including Hilmo

2.07

1.88

1.4

1.3

245.40

333.58

ug/g

—

Hypertrophy of (infrapatellar) fat pad

1.98

1.88

1.3

1.4

209.59

308.80

ug/g

—

Struck by thrown, projected or falling objec

568

1.37

1.88

1.3

1.4

292.20

288.45

ug/g

0.05

336

Abnormal findings in secretions and smears from cervix uteri vagina vulva

787

5270

1.10

1.87

1.4

312.10

294.43

ug/g

1.49

439

2839

Other/unspecified disorders of vestibular function

484

1.40

1.87

1.7

1.4

267.69

278.13

ug/g

0.15

287

HSIL lesion of the cervix uteri, vagina or vulva

275

2350

1.18

1.86

1.3

1.4

335.02

309.19

ug/g

1.03

151

1211

Disorders of synovium and tendon in diseases classified elsewhere

190

1.65

1.86

1.3

1.5

286.38

277.15

ug/g

0.10

112

Contusion of ankle

417

1.43

1.85

1.8

1.5

254.96

298.74

ug/g

0.91

236

Other sexually transmitted chlamydial diseases

535

1.37

1.85

1.5

1.4

243.43

320.08

ug/g

1.73

246

Chronic myeloproliferative disease

145

1.76

1.85

1.4

1.6

289.12

276.55

ug/g

0.13

Contact with lifting and transmission devices, not elsewhere classified

183

1.67

1.85

1.7

1.5

196.56

277.69

ug/g

1.28

103

Benign neoplasm of major salivary glands

148

1195

1.25

1.84

1.5

1.4

269.63

268.47

ug/g

0.02

714

Single spontaneous delivery

576

3393

0.89

1.84

1.3

1.4

295.24

278.71

ug/g

1.02

319

1879

Other acute skin changes due to ultraviolet radiation

368

1.46

1.84

1.5

287.61

278.96

ug/g

0.10

222

Other specified congenital malformation syndromes affecting multiple systems

160

1.72

1.84

1.4

354.58

305.30

ug/g

0.78

Other ill-defined and unspecified causes of mortality

136

1088

1.26

1.84

1.5

1.4

219.99

265.85

ug/g

1.71

672

Undescended testis, unilateral

2.11

1.83

1.3

1.5

360.00

311.54

ug/g

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

101

1.92

1.83

1.4

1.3

322.00

332.25

ug/g

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

469

1.40

1.83

1.4

1.5

260.72

274.77

ug/g

0.20

294

Burns classified according to extent of body surface involved

2.00

1.83

1.4

1.5

214.00

320.43

ug/g

—

Graves ophthalmopathy, strict

247

1.56

1.82

1.3

1.4

255.87

301.03

ug/g

0.74

146

Inflammation of lacrimal passages (acute and unspecified)

184

1.66

1.81

1.7

1.3

316.20

305.79

ug/g

0.11

107

Carcinoma in situ, bladder

386

1.44

1.81

1.4

1.5

256.47

249.43

ug/g

0.07

249

Lower leg

2.23

1.81

1.4

184.33

322.40

ug/g

—

Medicines for HER+ breast cancer

540

5600

0.89

1.80

1.4

277.12

281.36

ug/g

0.19

318

3211

Malignant neoplasm of anus and anal canal, including Hilmo

109

1.87

1.80

1.4

214.99

303.50

ug/g

1.24

Benign mammary dysplasia

239

2028

1.19

1.80

1.5

1.4

288.80

281.51

ug/g

0.25

148

1153

Benign neoplasm: Pharynx, unspecified

2.14

1.79

1.8

1.3

129.25

297.60

ug/g

—

Other disorders of binocular movement

224

1.58

1.78

1.5

1.3

236.14

324.27

ug/g

2.42

128

Lymphangioma, anys site

2.08

1.78

1.3

1.4

274.17

294.53

ug/g

—

Pterygium

305

1.49

1.77

1.4

1.5

332.70

269.43

ug/g

0.98

191

Occupant of streetcar injured in transport accident

4.24

1.77

2.0

1.6

171.80

214.88

ug/g

—

Blepharospasm

110

1.87

1.77

1.5

1.4

215.30

290.93

ug/g

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

102

791

1.30

1.76

1.5

1.4

251.00

272.49

ug/g

0.53

482

Congenital malformations of the nervous system

217

1.59

1.76

1.3

1.4

308.55

341.41

ug/g

0.39

120

Failure in dosage during surgical and medical care

4.14

1.76

1.2

1.8

348.60

303.19

ug/g

—

Other and unspecified mental retardation

184

1.65

1.76

1.2

1.4

337.73

338.24

ug/g

0.00

106

Traumatic amputation of lower leg

4.03

1.74

1.4

1.8

294.00

216.38

ug/g

—

Use of rivastigmine

251

2138

1.18

1.74

1.4

258.38

260.62

ug/g

0.06

142

1345

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

2.36

1.73

1.3

334.60

301.82

ug/g

—

Endometriosis diagnosis and infertility diagnosis occurring together

145

1177

1.24

1.73

1.4

329.69

311.22

ug/g

0.43

596

Sexual dysfunction

163

1.68

1.73

1.8

1.6

346.26

267.55

ug/g

0.80

Cerebral aneurysm, nonruptured

141

1143

1.24

1.72

1.5

1.4

282.82

279.29

ug/g

0.07

677

Multiple delivery

1073

0.76

1.71

1.3

1.4

389.49

285.85

ug/g

3.29

569

Viral agents as the cause of diseases classified to other chapters, including avohilmo

275

1.51

1.71

1.5

1.4

302.26

292.93

ug/g

0.11

153

Acute nephritic syndrome

211

1.59

1.70

1.4

1.5

268.61

280.27

ug/g

0.11

134

Hypothermia

172

1.65

1.69

1.5

202.91

272.35

ug/g

0.95

Cutis laxa senilis

1.95

1.69

1.4

1.3

247.20

293.29

ug/g

—

Graves ophthalmopathy

276

1.51

1.69

1.3

1.4

281.88

297.35

ug/g

0.19

160

Colon adenocarcinoma, helper endpoint

202

1700

1.20

1.69

1.4

1.5

222.15

260.65

ug/g

1.91

125

1051

Granuloma annulare

157

1.69

1.68

1.1

1.4

315.14

306.51

ug/g

0.10

Optic atrophy, wide definition

196

1.61

1.68

1.4

316.79

291.70

ug/g

0.22

120

Injury of nerves at ankle and foot level

2.03

1.67

1.8

1.4

229.78

293.66

ug/g

—

Valgus deformity, not elsewhere classified

2.02

1.67

1.1

1.4

285.77

287.62

ug/g

—

Hypoplasia of dental enamel, prenatal , including avohilmo

2.33

1.67

1.4

1.3

352.33

354.97

ug/g

—

Papilloedema, unspecified

228

1.56

1.67

1.6

1.4

268.58

305.77

ug/g

0.43

132

Generalized epilepsy, strict definition

220

1.57

1.67

1.3

1.4

301.72

309.48

ug/g

0.07

125

Recurrent and persistent haematuria

2.07

1.67

1.6

1.4

208.00

291.47

ug/g

—

Other acute viral hepatitis

127

1.77

1.67

1.4

1.3

227.06

305.22

ug/g

1.28

Malignant neoplasm of other and ill-defined digestive organs

2.07

1.67

1.2

141.00

330.87

ug/g

—

Toxic effect of contact with venomous animals

478

1.37

1.66

1.4

1.5

255.80

283.52

ug/g

0.46

283

Corneal degeneration

181

1.63

1.66

1.2

1.4

317.95

292.31

ug/g

0.23

108

Other lesions of median nerve

302

1.48

1.65

1.5

1.4

271.95

275.27

ug/g

0.03

166

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

419

1.40

1.65

1.6

1.5

252.53

279.56

ug/g

0.46

250

Left ventricular outflow tract obstruction, narrow definition

530

1.35

1.65

1.3

1.5

269.24

286.87

ug/g

0.24

328

Disorders of adrenal gland, other and/or unspecified

2.22

1.64

2.1

1.4

283.14

297.04

ug/g

—

Other secondary gonarthrosis

652

1.32

1.64

1.5

288.19

269.63

ug/g

0.33

397

Carcinoma in situ of skin, other sites/unspecified

166

1.66

1.64

1.3

263.86

264.68

ug/g

0.01

Other specified and unspecified disorders of conjunctiva

1.88

1.64

1.2

1.4

267.00

315.94

ug/g

0.43

Relapsing fevers

3.74

1.64

1.4

—

270.66

ug/g

—

Evidence of alcohol involvement determined by blood alcohol level

143

1.71

1.63

1.8

1.4

232.91

292.03

ug/g

0.73

Anisometropia and aniseikonia

361

1.43

1.63

1.4

281.34

292.61

ug/g

0.17

218

Benign neoplasm: Tonsil

128

1.75

1.63

1.4

302.07

310.98

ug/g

0.08

Other injuries of upper limb, level unspecified

128

1.75

1.63

1.5

1.4

238.54

288.36

ug/g

0.47

Convergence insufficiency and excess

128

1.75

1.62

1.5

1.4

221.07

339.10

ug/g

3.25

Carcinoma in situ of vulva

106

1.84

1.62

1.2

1.3

346.80

308.76

ug/g

—

Supervision of normal pregnancy

203

1373

0.84

1.62

1.3

1.4

323.93

304.54

ug/g

0.52

104

704

Caught, crushed, jammed or pinched in or between objects

575

1.33

1.62

1.3

1.4

279.06

287.65

ug/g

0.14

335

Melanocytic naevi, other sites/unspecified

122

981

1.25

1.62

1.4

300.64

286.20

ug/g

0.35

549

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

1.99

1.61

1.7

1.2

205.70

330.32

ug/g

—

malignant neoplasm of male genital organs, including Hilmo

376

1989

1.14

1.61

1.4

1.5

273.58

267.06

ug/g

0.22

226

1228

Allergic purpura

312

1.46

1.61

1.4

313.32

302.59

ug/g

0.12

181

Monoplegia

167

1.65

1.61

1.2

1.4

340.77

290.33

ug/g

0.81

Exclusion endpoint for clefts

190

1.60

1.61

1.4

363.32

311.39

ug/g

0.95

101

Congenital deformities of hip, including avohilmo

190

1.60

1.61

1.2

1.3

313.70

331.68

ug/g

0.18

100

Use of anticholinesterases

497

4259

0.90

1.61

1.4

268.65

257.08

ug/g

0.65

287

2643

N06DA Anticholinesterases

497

4259

0.90

1.61

1.4

268.65

257.08

ug/g

0.65

287

2643

Other and unspecified vascular occlusions

141

1153

1.23

1.60

1.5

1.4

251.19

268.70

ug/g

0.46

697

Postzoster neuralgia

175

1.63

1.60

1.3

1.4

290.23

265.82

ug/g

0.28

Acute and transient psychotic disorders

166

1380

1.21

1.60

1.4

267.49

288.15

ug/g

0.62

788

Primary angle-closure glaucoma

525

1.35

1.59

1.5

1.4

256.32

278.37

ug/g

0.42

306

Myelodysplastic syndrome

1.85

1.59

1.2

1.3

235.64

300.25

ug/g

0.70

Other and unspecified injuries of wrist and hand

422

1.39

1.59

1.5

1.4

305.72

300.44

ug/g

0.06

236

Striae atrophicae

114

1.79

1.59

1.4

296.69

322.93

ug/g

0.15

Other intracranial haemorrhages

338

1.44

1.59

1.7

1.5

253.24

271.79

ug/g

0.26

215

Other disorders of binocular vision

114

1.78

1.58

1.5

1.4

264.73

325.38

ug/g

0.71

Shoulder region

160

1.65

1.58

1.3

1.5

280.60

277.77

ug/g

0.02

Other disorders of breast and lactation associated with childbirth

152

1.67

1.58

1.4

1.3

313.80

337.90

ug/g

—

Other abnormal findings in urine

168

1.63

1.57

1.9

1.4

272.22

297.36

ug/g

0.22

Congenital malformations of pulmonary and tricuspid valves

2.08

1.56

1.5

1.4

213.88

309.76

ug/g

—

Toxic effect of carbon monoxide

192

1.59

1.56

1.6

1.5

222.67

282.69

ug/g

0.93

115

L02BG Aromatase inhibitors

445

4897

0.89

1.56

1.4

274.24

278.40

ug/g

0.16

262

2839

Other articular cartilage disorders

224

1.54

1.56

1.6

1.4

161.59

267.22

ug/g

1.78

140

Atrial septal defect

421

1.38

1.56

1.5

1.4

282.79

309.40

ug/g

0.40

251

malignant neoplasm of male genital organs

368

1955

1.14

1.55

1.4

1.5

271.34

267.85

ug/g

0.11

221

1205

Benign neoplasm: Parotid gland

118

951

1.25

1.55

1.4

269.12

273.34

ug/g

0.07

566

L02BA Anti-estrogens

208

2436

0.85

1.55

1.4

277.43

284.76

ug/g

0.20

127

1380

Occupational exposure to risk-factors

357

1.42

1.54

1.4

1.5

298.77

272.87

ug/g

0.40

216

Unspecified threat to breathing

1.87

1.54

1.2

1.4

367.82

312.85

ug/g

0.71

Use of riluzole

0.00

1.54

0.0

1.4

—

300.49

—

Alzheimer’s disease (Early onset), excluding more controls

312

1.43

1.53

1.2

1.4

264.68

251.84

ug/g

0.18

188

Mixed disorders of conduct and emotions

161

1.63

1.53

1.2

1.3

265.63

364.41

ug/g

—

Cyst of Bartholin Gland

391

1.39

1.53

1.5

1.3

292.46

314.37

ug/g

0.27

216

Arteriovenous malformation of peripheral vessels

2.22

1.53

1.8

1.3

362.40

324.42

ug/g

—

Varus deformity, not elsewhere classified

108

1.79

1.53

1.5

1.3

349.86

279.98

ug/g

0.87

Motor disorders

145

1.67

1.52

1.3

1.4

317.12

379.93

ug/g

0.94

Melanocytic naevi of scalp and neck

258

1.49

1.52

1.3

1.4

330.53

302.78

ug/g

0.28

154

Chronic suppurative otitis media

730

1.28

1.52

1.4

286.10

284.99

ug/g

0.02

410

Viral agents as the cause of diseases classified to other chapters

234

1.52

1.51

1.5

1.4

285.92

295.89

ug/g

0.10

131

Complications predominantly related to the puerperium

368

3268

1.13

1.51

1.4

303.42

299.04

ug/g

0.15

188

1706

Right ventricular outflow tract obstruction

1.99

1.51

1.5

1.4

232.67

325.23

ug/g

—

Femoral hernia, unilateral

300

1.45

1.51

1.8

1.4

260.10

280.75

ug/g

0.31

180

Inguinal hernia, unilateral

300

1.45

1.51

1.8

1.4

260.10

280.75

ug/g

0.31

180

Inguinal of femoral hernia, unilateral

300

1.45

1.51

1.8

1.4

260.10

280.75

ug/g

0.31

180

Injury of muscle and tendon at forearm level

178

1.60

1.50

1.3

1.5

248.26

287.33

ug/g

0.43

107

Other superficial mycoses

218

1.53

1.50

1.5

288.02

286.22

ug/g

0.02

128

Persistent delusional disorders

112

901

1.25

1.50

1.4

290.85

283.32

ug/g

0.12

514

Benign neoplasm: Parathyroid gland

124

1.73

1.50

1.4

258.89

297.76

ug/g

0.36

Congenital deformities of hip

170

1.61

1.50

1.2

1.3

319.70

341.40

ug/g

—

All dysplastic lesions of the vagina

309

1.44

1.49

1.6

1.4

295.07

304.52

ug/g

0.10

172

Malignant neoplasm of respiratory system and intrathoracic organs

229

2204

0.86

1.49

1.4

264.35

274.74

ug/g

0.32

144

1350

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

574

1.32

1.49

1.6

1.4

306.91

290.60

ug/g

0.27

329

Other and unspecified haemorrhagic conditions

155

1.64

1.49

1.9

1.4

294.89

289.27

ug/g

—

Disorders of brain, other and unspecified

1.88

1.48

1.4

1.3

296.27

330.11

ug/g

0.41

Malignant neoplasm of other connective and soft tissue

227

1.52

1.48

1.4

261.35

311.61

ug/g

0.83

131

Contact with sharp object, undetermined intent

227

1.52

1.48

1.4

1.5

322.89

278.03

ug/g

0.51

133

Undescended testicle

1.84

1.48

1.3

1.4

386.55

347.15

ug/g

0.36

Benign neoplasm: salivary glands, exclude unknown (D119)

132

1084

1.23

1.47

1.5

1.4

275.60

271.64

ug/g

0.07

645

Delivery

587

3398

0.91

1.47

1.4

297.41

278.71

ug/g

1.24

322

1879

Maternal care for known or suspected disproportion

427

0.65

1.47

1.3

345.77

317.28

ug/g

0.23

212

Septal defects

702

1.28

1.46

1.5

1.4

302.16

310.33

ug/g

0.14

392

Benign neoplasm of breast

192

1634

1.18

1.46

1.5

1.4

264.89

288.41

ug/g

0.92

932

Other sexually transmitted chlamydial diseases, including avohilmo

106

850

1.25

1.46

1.4

1.3

259.10

328.46

ug/g

2.18

377

Car occupant injured in noncollision transport accident

361

1.40

1.46

1.3

1.4

253.52

291.28

ug/g

0.64

203

Other encephalitis

294

1.45

1.46

1.8

1.4

277.67

291.22

ug/g

0.12

174

Melanoma in situ of trunk

164

1.61

1.46

1.5

294.65

280.04

ug/g

0.12

106

Pulmonary eosinophilia, not elsewhere classified

133

1.69

1.45

1.5

1.4

243.40

294.90

ug/g

—

Optic atrophy

188

1.57

1.45

1.4

312.56

294.08

ug/g

0.14

114

Encephalitis

311

1.43

1.45

1.8

1.5

274.50

289.58

ug/g

0.14

185

Contusion of toe(s) with damage to nail

110

1.76

1.45

2.2

1.3

290.72

298.77

ug/g

0.06

Other disorders of central nervous system

110

1.76

1.45

1.4

281.55

317.58

ug/g

0.43

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

763

1.27

1.44

1.4

1.5

312.64

270.59

ug/g

0.87

469

Normotensive glaucoma

140

1160

1.22

1.44

1.4

1.5

267.82

269.25

ug/g

0.03

711

Sequelae of other and unspecified infectious and parasitic diseases

569

1.31

1.44

1.6

1.4

304.59

288.65

ug/g

0.25

325

Drug-induced obesity

1.86

1.44

1.1

1.4

247.75

333.43

ug/g

—

Benign neoplasm: Connective and other soft tissue, unspecified

118

1.73

1.43

1.4

1.3

313.08

306.79

ug/g

0.04

Cystic disease of liver

1.91

1.43

1.5

1.3

191.33

309.54

ug/g

—

Benign neoplasm: Choroid

104

836

1.25

1.43

1.4

282.90

276.70

ug/g

0.12

505

Prophylactic surgery

1.93

1.41

1.1

1.4

247.00

319.54

ug/g

—

Hypoplasia of dental enamel , including avohilmo

308

1.42

1.41

1.3

1.4

349.28

343.48

ug/g

0.06

165

Maternal care for cervical incompetence

458

1.35

1.41

1.4

259.84

306.42

ug/g

0.97

257

Other/unspecified crystal arthropathies

1.99

1.41

1.5

267.67

272.32

ug/g

—

Dementia in Alzheimer disease

210

2039

0.86

1.40

1.3

1.4

242.40

254.91

ug/g

0.45

115

1291

Nystagmus and other irregular eye movements

150

1.63

1.40

1.3

292.82

317.16

ug/g

0.18

Macular cyst

373

1.38

1.40

1.5

249.23

275.52

ug/g

0.47

227

Burn and corrosion of trunk

305

1.42

1.40

1.4

1.5

273.60

284.82

ug/g

0.12

178

Erythema nodosum

322

1.41

1.40

1.4

260.60

283.92

ug/g

0.33

193

Respiratory and cardiovascular disorders specific to the perinatal period

176

1.54

1.40

1.3

393.53

366.28

ug/g

0.35

Other congenital malformations of circulatory system

297

1.43

1.39

1.6

1.5

325.80

288.37

ug/g

0.70

181

Other abnormal auditory perceptions

127

1.68

1.39

1.6

1.3

293.69

307.55

ug/g

0.13

Malignant neoplasm of ureter

2.70

1.38

1.7

1.3

127.65

286.10

ug/g

—

Benign neoplasm: Conjunctiva

365

1.38

1.6

1.5

277.33

278.40

ug/g

0.01

217

Donors of organs and tissues

127

1.68

1.38

1.4

1.3

352.44

322.04

ug/g

—

Biological medicines for asthma

240

1.48

1.36

1.5

330.50

290.92

ug/g

0.47

146

Adhesive middle ear disease

151

1.61

1.36

1.4

316.25

297.97

ug/g

0.15

Tetralogy of Fallot, a congenital heart defect.

0.00

1.36

0.0

1.3

—

332.97

—

Acute myeloid leukaemia and myelodysplastic syndromes

199

1.52

1.36

1.3

1.4

254.44

306.54

ug/g

0.70

122

Idiopathic hypercalciuria

2.02

1.35

1.5

266.46

287.51

ug/g

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

1.82

1.35

1.6

1.5

291.33

292.12

ug/g

—

Central retinal artery occlusion

224

1.49

1.35

1.4

1.5

240.35

270.59

ug/g

0.43

142

Acute appendicitis, with complications

291

2570

1.14

1.35

1.5

1.4

296.80

272.94

ug/g

0.95

162

1526

Malignant neoplasm of adrenal gland, including Hilmo

2.01

1.35

1.3

238.83

315.26

ug/g

—

Congenital malformations of aortic and mitral valves

453

1.34

1.35

1.4

1.5

262.00

290.55

ug/g

0.39

280

Rheumatic fever incl heart disease

299

1.42

1.34

1.5

1.4

282.60

274.54

ug/g

0.10

178

Iliotibial band syndrome

1.81

1.34

1.4

1.3

299.00

320.33

ug/g

—

Neonatal jaundice from other and unspecified causes

124

1.66

1.34

2.3

1.3

342.36

377.59

ug/g

0.34

Focal epilepsy, strict definition

295

2609

1.13

1.33

1.4

264.14

274.58

ug/g

0.38

176

1540

Abdominal aortic aneurysm (AAA)

122

997

1.22

1.33

1.5

252.03

249.52

ug/g

0.05

639

Alzheimer disease, including avohilmo

541

4098

0.91

1.33

1.3

1.4

267.04

255.66

ug/g

0.66

306

2563

Toxic effect of alcohol

225

1.49

1.33

1.6

1.4

209.81

283.27

ug/g

1.03

134

Chondromalacia

317

1.40

1.33

1.4

1.5

308.08

299.55

ug/g

0.11

187

Other facial nerve disorders

292

1.42

1.32

1.5

1.4

273.90

292.78

ug/g

0.25

166

Universal erythroderma, KELA reimbursement

129

1.65

1.32

1.4

1.5

257.67

279.43

ug/g

0.18

Abnormal spermatozoa

175

1494

1.18

1.31

1.4

1.5

319.28

244.43

ug/g

3.69

103

955

All dysplastic lesions of the cervix uteri

346

3045

1.12

1.31

1.3

1.4

332.58

307.11

ug/g

1.38

194

1560

Placenta praevia

450

0.68

1.30

1.5

1.3

289.91

317.17

ug/g

0.20

227

Amblyopia ex anopsia

421

1.34

1.30

1.6

1.4

294.23

295.69

ug/g

0.02

234

Unspecified contracted kidney

2.05

1.29

1.5

1.4

338.33

306.92

ug/g

—

Malignant neoplasm of prostate, including Hilmo

361

1903

1.12

1.29

1.4

1.5

273.54

267.01

ug/g

0.22

217

1178

Erectile dysfunction

105

856

1.23

1.29

1.4

1.5

298.31

243.69

ug/g

1.78

562

Other osteochondropathies

757

1.25

1.29

1.4

381.39

284.54

ug/g

0.56

429

Other congenital malformations of nervous system

1.75

1.29

1.4

303.20

319.19

ug/g

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

659

1.27

1.28

1.4

1.3

320.27

325.75

ug/g

0.09

316

Unspecific neurodegenerative disorder

631

4687

0.92

1.28

1.4

266.47

255.28

ug/g

0.72

360

2901

Malignant neoplasm of rectosigmoid junction, including Hilmo

260

1.44

1.28

1.4

214.45

301.29

ug/g

2.00

161

Hirsutism in women

194

1.51

1.28

1.5

1.4

291.17

338.56

ug/g

0.54

104

Non-seminoma of testis, including Hilmo

2.33

1.28

1.6

1.3

298.25

299.06

ug/g

—

Perichondritis of external ear

178

1.54

1.28

1.3

1.4

310.59

286.16

ug/g

0.27

103

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

277

1.42

1.28

1.4

257.50

305.22

ug/g

0.70

172

Chronic lymphocytic leukaemia, helper endpoint

277

1.42

1.28

1.4

257.50

305.22

ug/g

0.70

172

Chronic lymphocytic leukaemia

277

1.42

1.28

1.4

257.50

305.22

ug/g

0.70

172

Superficial injury of neck

186

1.52

1.28

1.2

1.4

311.33

298.97

ug/g

0.12

Congenital deformities of feet

252

1.44

1.27

1.4

1.5

265.16

292.71

ug/g

0.34

153

Congenital malformations of anterior segment of eye

1.86

1.27

1.6

1.4

271.50

305.45

ug/g

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

121

1.66

1.27

1.2

1.3

448.00

374.85

ug/g

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.85

1.27

1.4

1.5

220.89

267.11

ug/g

—

Contact with venomous snakes and lizards

115

1.68

1.27

1.4

1.3

243.59

307.76

ug/g

0.56

Paralytic strabismus

101

822

1.24

1.27

1.5

1.4

260.10

274.70

ug/g

0.38

485

Focal epilepsy

315

2807

1.13

1.27

1.4

265.14

274.02

ug/g

0.33

190

1651

Ill-defined and unknown causes of mortality

143

1204

1.19

1.27

1.5

1.4

219.86

265.45

ug/g

1.79

737

Vestibular neuronitis

133

1113

1.20

1.26

1.4

287.97

275.31

ug/g

0.24

665

Glaucoma-related operations

724

1.25

1.26

1.5

238.52

271.69

ug/g

1.00

439

Transitory endocrine and metabolic disorders specific to fetus and newborn

128

1.63

1.25

1.8

1.4

341.09

371.08

ug/g

0.26

Malignant neoplasm of oral cavity

329

1.38

1.25

1.5

1.4

264.45

298.02

ug/g

0.58

200

Motorcycle rider injured in other and unspecified transport accidents

573

1.28

1.25

1.4

285.10

293.85

ug/g

0.11

331

Hypertrichosis

220

1.47

1.25

1.5

1.4

273.33

333.58

ug/g

0.85

115

Respiratory tuberculosis, confirmed, including avohilmo

163

1.55

1.24

1.6

1.4

331.39

287.18

ug/g

0.40

LSIL lesion of the cervix uteri

151

1280

1.18

1.24

1.2

1.4

332.16

310.47

ug/g

0.68

649

Embedded teeth, including avohilmo

104

851

1.23

1.24

1.3

1.4

276.96

311.90

ug/g

0.89

421

Congenital deformities of feet, including avohilmo

399

1.34

1.23

1.3

1.5

283.37

297.30

ug/g

0.20

227

Vertical strabismus

382

1.35

1.23

1.6

1.4

260.67

285.15

ug/g

0.34

222

Monoarthritis, not elsewhere classified

399

1.34

1.23

1.5

1.4

245.92

269.51

ug/g

0.31

236

Use of other anti-dementia drugs

371

3308

0.90

1.22

1.3

1.4

267.54

255.54

ug/g

0.55

207

2051

Use of memantine

371

3308

0.90

1.22

1.3

1.4

267.54

255.54

ug/g

0.55

207

2051

Inflammation of lacrimal passages (chronic)

164

1.55

1.22

1.5

1.4

278.40

285.52

ug/g

0.06

Papillary adenocarcinoma of thyroid gland

558

1.28

1.21

1.3

1.4

335.73

313.08

ug/g

0.60

312

Foreign body in ear

205

1.48

1.21

1.1

1.5

342.08

302.31

ug/g

0.52

121

Androgenic alopecia

109

1.69

1.21

1.6

1.3

296.45

315.11

ug/g

0.14

Other drug-induced secondary parkinsonism

109

1.68

1.21

1.4

280.38

286.99

ug/g

—

Melanoma in situ

541

1.29

1.21

1.3

1.5

295.07

271.63

ug/g

0.40

328

Malignant neoplasm of ovary

592

0.74

1.21

1.3

1.4

254.43

299.22

ug/g

0.69

350

Parapsoriasis

189

1.50

1.20

1.3

1.4

237.69

294.01

ug/g

0.87

107

Benign neoplasm: Appendix

117

1.65

1.20

1.5

1.4

177.86

286.70

ug/g

—

Gestational diabetes (for exclusion)

463

2900

1.10

1.20

1.3

1.4

306.54

316.71

ug/g

0.41

237

1459

Migraine without aura, drug-induced

117

1.65

1.20

1.7

1.4

353.23

329.54

ug/g

0.18

Congenital ovarian cysts

436

1.32

1.19

1.4

1.3

335.72

324.65

ug/g

0.14

214

Respiratory disorders in diseases classified elsewhere

149

1.57

1.19

1.7

1.3

253.97

299.66

ug/g

0.52

Fibrosis of liver

1.81

1.19

1.6

1.4

264.13

281.30

ug/g

—

Disorder of thyroid, unspecified

133

1.60

1.19

1.6

1.4

258.31

312.97

ug/g

0.58

Other bursitis of knee

133

1.60

1.19

1.3

1.4

280.38

272.83

ug/g

—

Contact with other hot metals

149

1.56

1.19

1.6

1.5

226.90

298.40

ug/g

1.07

Molar incisor enamel hypoplasia

334

1.35

1.18

1.3

1.4

338.23

338.28

ug/g

0.00

173

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

758

1.23

1.17

1.2

1.3

278.94

313.38

ug/g

0.70

361

Other and unspecified iridocyclitis

535

1.28

1.16

1.4

253.90

283.50

ug/g

0.60

317

Use of levodopa decarboxylase inhibitor

211

1848

1.15

1.16

1.5

1.4

265.47

260.02

ug/g

0.15

147

1137

Respiratory tuberculosis, confirmed

158

1.54

1.16

1.7

1.4

315.48

291.32

ug/g

0.19

Postpartum hemorraghe, all women as controls

254

2791

0.89

1.15

1.3

329.09

314.58

ug/g

0.49

121

1420

Contact with other specified venomous animals

1.89

1.15

1.8

1.4

283.60

317.20

ug/g

—

Malignant neoplasm of ovary, including Hilmo

811

0.78

1.14

1.4

257.88

301.04

ug/g

1.04

471

Myeloproliferative diseases (CML excluded)

112

934

1.21

1.14

1.4

279.44

273.84

ug/g

0.11

559

Malignant neoplasm of prostate

352

1876

1.11

1.13

1.4

1.5

271.16

266.91

ug/g

0.13

211

1157

Subacute thyroiditis

379

1.33

1.13

1.5

1.4

322.19

303.77

ug/g

0.22

220

Retinoschisis and retinal cysts

259

1.41

1.13

1.3

1.5

235.75

275.78

ug/g

0.66

160

Exposure to unspecified smoke, fire and flames

1.73

1.13

1.1

1.4

246.44

295.95

ug/g

—

Other renal tubulo-interstitial diseases

259

1.40

1.13

1.5

1.4

269.89

299.38

ug/g

0.42

144

Later onset COPD

444

3259

1.10

1.11

1.4

1.5

259.84

253.23

ug/g

0.28

268

2038

Focal epilepsy, mode (most common among epilepsy diagnosis)

275

2456

1.12

1.11

1.4

261.76

273.22

ug/g

0.42

163

1445

Sequelae of infectious and parasitic diseases

100

827

1.22

1.11

1.7

1.4

278.36

286.96

ug/g

0.16

481

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

125

1.59

1.11

1.8

1.3

345.10

374.54

ug/g

—

Pemphigoid

320

1.36

1.11

1.5

1.4

268.52

271.52

ug/g

0.03

192

Hypothyroidism due to medicaments and other exogenous substances

104

1.66

1.11

1.1

1.5

322.10

308.97

ug/g

—

Other superficial injuries of ankle and foot

1.86

1.11

1.7

1.4

306.86

274.12

ug/g

—

Viral infections of central nervous system, not elsewhere classified/unspecified

112

1.63

1.10

1.2

1.4

350.51

307.76

ug/g

—

Cerebral palsy

152

1.53

1.10

1.7

1.4

280.53

341.10

ug/g

0.76

Postdysenteric arthropathy

1.71

1.09

1.5

1.4

209.22

298.69

ug/g

—

Prepatellar bursitis

434

1.30

1.09

1.4

254.83

259.92

ug/g

0.07

279

Mental retardation, wide definition

457

1.29

1.08

1.4

305.95

315.93

ug/g

0.14

274

Abnormalities of forces of labour

1168

0.83

1.08

1.3

1.4

305.65

299.95

ug/g

0.10

621

Male infertility

356

1.33

1.07

1.6

1.5

288.10

265.84

ug/g

0.26

201

Lagophthalmos

137

1.56

1.07

1.5

320.69

275.54

ug/g

0.45

Embolic stroke with flimmer

253

1.39

1.07

1.4

1.5

189.74

262.47

ug/g

1.12

151

Other assisted single delivery

179

0.55

1.06

1.3

1.4

352.80

306.84

ug/g

—

129

1.56

1.06

1.5

1.3

324.71

352.42

ug/g

—

Malignant neoplasm of base of tongue, including Hilmo

1.82

1.06

1.4

1.3

289.83

300.91

ug/g

—

Hodgkin lymphoma, hilmo

280

1.37

1.05

1.6

1.5

262.91

289.24

ug/g

0.35

160

Follicular adenocarcinoma of thyroid gland, including Hilmo

1.66

1.05

1.6

1.3

297.77

338.61

ug/g

—

Other bursal cyst

146

1.53

1.04

1.3

1.5

327.88

302.85

ug/g

—

Pemphigus

1.87

1.04

1.7

1.4

146.80

291.34

ug/g

—

Exophthalmic conditions

114

1.61

1.04

1.2

1.3

282.00

315.37

ug/g

—

Inflammatory disorders of breast

697

1.23

1.04

1.3

1.4

300.56

306.79

ug/g

0.10

365

Benign neoplasm of brain and other parts of central nervous system

761

1.22

1.04

1.4

277.31

282.78

ug/g

0.10

453

Use of cabergoline

130

1.56

1.04

1.6

1.4

254.27

286.72

ug/g

0.37

Dementia due to Parkinsons disease, excluding more controls

204

1.43

1.04

1.4

307.00

251.57

ug/g

0.56

130

Dermatitis herpetiformis

196

1.45

1.04

1.6

1.4

273.49

293.39

ug/g

0.15

123

HSIL lesion of the cervix uteri

230

2044

1.13

1.03

1.3

1.4

332.45

312.83

ug/g

0.62

123

1036

Routine general health check-up of defined subpopulation

138

1.53

1.03

1.3

333.90

308.53

ug/g

—

Polymorphous light eruption

1.72

1.03

1.4

399.40

326.98

ug/g

—

Aneurysms, operations, SAH

250

2234

1.12

1.03

1.5

1.4

292.75

270.22

ug/g

0.94

148

1346

Sequelae of infectious and parasitic diseases, including avohilmo

101

844

1.20

1.02

1.6

1.4

280.42

285.33

ug/g

0.08

490

Other and unspecified injuries of abdomen, lower back and pelvis

139

1.53

1.01

1.4

1.5

255.22

293.24

ug/g

—

Non-small cell lung cancer, squamous

403

0.72

1.00

1.1

1.4

227.22

288.39

ug/g

1.19

257

Golimumab

387

1.30

1.00

1.4

1.5

326.74

292.95

ug/g

0.65

224

Unspecified parasitic disease, including avohilmo

1.74

1.00

1.7

1.4

328.57

307.03

ug/g

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

695

5640

1.07

0.99

1.4

302.78

295.19

ug/g

0.41

407

3019

Other diseases of spinal cord

309

1.34

0.99

1.4

317.56

282.01

ug/g

0.44

184

Open wound of neck

1.70

0.99

1.6

1.3

233.95

280.38

ug/g

—

Unspecified abortion

566

1.25

0.99

1.4

314.55

312.49

ug/g

0.03

318

Viral conjunctivitis, including avohilmo

432

1.28

0.99

1.3

1.4

314.64

300.97

ug/g

0.21

249

Premature rupture of membranes

217

1738

0.89

0.99

1.3

349.00

311.30

ug/g

1.27

884

Schizoaffective disorder

811

1.20

0.99

1.4

327.26

295.40

ug/g

0.77

450

Syndrome of inappropriate secretion of antidiuretic hormone

1.90

0.98

1.9

1.4

171.60

274.22

ug/g

—

Tuberculosis, IBD comorbidity

748

1.21

0.98

1.5

1.4

261.96

266.90

ug/g

0.08

450

Sixth [abducent] nerve palsy

380

1.30

0.98

1.5

252.65

257.75

ug/g

0.08

229

Other meningitis

165

1.47

0.98

1.2

1.4

225.50

316.26

ug/g

1.45

Suppurative otitis media, unspecified

241

1.38

0.97

1.8

1.5

290.30

289.72

ug/g

0.00

134

Acute drug-induced interstitial lung disorder

1.72

0.97

1.1

1.4

261.20

293.06

ug/g

—

Other spirochaetal diseases, including avohilmo

565

5263

1.08

0.96

1.4

284.33

274.98

ug/g

0.51

306

3054

Intrahepatic Cholestasis of Pregnancy (ICP)

686

1.22

0.96

1.4

1.3

320.27

323.05

ug/g

0.04

332

Contact with sharp glass

399

1.29

0.95

1.4

274.35

296.70

ug/g

0.33

222

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

319

1.32

0.95

1.5

1.4

367.90

327.17

ug/g

0.67

174

Tarsal tunnel syndrome

109

1.59

0.95

2.0

1.4

232.64

300.03

ug/g

0.61

Postpartum hemorraghe, parous women as controls

254

2360

0.90

0.95

1.3

329.09

316.15

ug/g

0.42

121

1227

Mandibular retrognathia

658

1.22

0.94

1.5

1.4

293.06

303.77

ug/g

0.17

354

Bus occupant injured in other and unspecified transport accidents

1.75

0.94

1.8

1.4

173.83

310.29

ug/g

—

Parkinson's disease, including avohilmo

235

2107

1.12

0.94

1.4

1.5

275.59

259.81

ug/g

0.60

155

1311

Pedal cyclist injured in transport accident

327

2982

1.10

0.94

1.4

259.96

276.36

ug/g

0.71

192

1702

Tuberculosis, wide, including avohilmo

807

1.20

0.94

1.5

275.26

266.24

ug/g

0.16

484

Benign neoplasm: Lip

226

1.39

0.94

1.5

1.4

259.50

286.55

ug/g

0.33

136

Malignant neoplasm of tongue, including Hilmo

226

1.38

0.93

1.5

1.4

247.09

300.41

ug/g

0.82

138

Other osteochondrodysplasias

1.69

0.93

1.4

1.3

386.43

314.68

ug/g

—

Other congenital malformations of skin

428

1.27

0.92

1.5

1.4

287.16

305.95

ug/g

0.23

244

Localized skin eruption due to drugs and medicaments

118

1.55

0.92

1.3

1.4

324.75

307.99

ug/g

—

Dissection of aorta

322

1.31

0.92

1.5

1.4

208.87

278.61

ug/g

1.52

197

Lymphoid leukaemia

608

1.22

0.92

1.5

1.4

288.04

268.43

ug/g

0.38

379

Infections of genitourinary tract in pregnancy

125

1077

1.17

0.91

1.3

1.4

299.88

301.16

ug/g

0.02

571

Burn and corrosion of shoulder and upper limb, except wrist and hand

227

1.38

0.91

1.5

1.4

244.96

299.89

ug/g

0.57

138

Maternal care for known or suspected fetal abnormality and damage

147

1426

0.87

0.91

1.3

337.27

314.47

ug/g

0.60

718

Burn and corrosion of wrist and hand

384

1.28

0.91

1.5

1.4

283.17

286.89

ug/g

0.04

223

Respiratory tuberculosis, bacteriologically and histologically confirmed

168

1.44

0.90

1.7

1.4

315.48

287.91

ug/g

0.22

184

1.41

0.90

1.8

1.3

338.29

375.62

ug/g

0.45

Other and unspecified disorders of psychological development

1.58

0.90

1.1

1.3

389.29

367.24

ug/g

—

Hereditary corneal dystrophies

421

1.27

0.90

1.6

1.5

289.04

280.83

ug/g

0.10

259

Generalized epilepsy, mode (most common among epilepsy diagnosis)

315

1.31

0.89

1.2

1.4

325.25

297.45

ug/g

0.43

184

Other specified and unspecified disorders of lens

1.67

0.89

1.2

1.5

306.00

246.31

ug/g

—

Chronic suppurative otitis media, including avohilmo

106

905

1.18

0.88

1.4

295.31

286.95

ug/g

0.15

512

Etanercept

749

1.19

0.87

1.6

1.4

276.62

288.97

ug/g

0.23

427

Use of rasagiline

290

1.32

0.87

1.3

1.5

295.03

271.38

ug/g

0.35

178

Other and specified injuries of hip and thigh

255

1.35

0.87

1.4

255.76

284.84

ug/g

0.48

153

Essential (haemorrhagic) thrombocythaemia

378

1.28

0.87

1.5

1.4

260.96

301.38

ug/g

0.77

226

Embolic stroke

494

1.24

0.87

1.4

194.61

272.66

ug/g

2.23

312

Certolizumab pegol

178

1.42

0.87

1.6

1.3

331.63

326.98

ug/g

0.03

Other crystal arthropathies

178

1.42

0.87

1.6

1.5

244.30

259.09

ug/g

—

109

Other spirochaetal diseases

555

5192

1.07

0.87

1.4

283.71

275.14

ug/g

0.45

300

3021

Dementia, including avohilmo

807

5200

1.06

0.87

1.4

269.74

256.82

ug/g

1.03

462

3210

Crushing injury of wrist and hand

153

1.45

0.87

1.4

1.6

233.64

273.34

ug/g

0.39

Generalized epilepsy

432

1.26

0.86

1.3

1.4

291.25

302.22

ug/g

0.16

245

Mental retardation

437

1.26

0.86

1.4

304.21

322.74

ug/g

0.28

259

Other osteochondrodysplasias, including avohilmo

120

1.52

0.86

1.3

360.11

286.33

ug/g

—

Malignant neoplasm of bronchus and lung, including Hilmo

241

2224

0.90

0.86

1.4

258.84

275.86

ug/g

0.63

150

1356

Squamous cell neoplasms and carcinoma of cervix

1.70

0.86

1.1

1.2

296.40

341.80

ug/g

—

Accidental poisoning by and exposure to alcohol

153

1.45

0.86

1.3

1.4

267.29

309.71

ug/g

—

Myotonic disorders

1.65

0.86

1.2

1.3

284.59

306.07

ug/g

—

Other and unspecified acute skin changes due to ultraviolet radiation

256

1.34

0.86

1.4

1.5

286.50

272.65

ug/g

0.17

152

Other abortion

1.59

0.85

1.4

1.3

378.17

342.66

ug/g

—

Thyrotoxicosis with toxic single thyroid nodule

1.62

0.85

2.1

1.3

323.00

338.43

ug/g

—

Alopecia areata

291

1.32

0.85

1.4

307.81

297.06

ug/g

0.11

170

Secondary parkinsonism+Parkinsonism in other disease

309

1.31

0.85

1.3

1.4

247.67

274.93

ug/g

0.36

180

Chromosomal abnormalities, not elsewhere classified

230

1.36

0.85

1.3

1.4

334.61

323.68

ug/g

0.15

134

Chalazion

154

1357

1.14

0.84

1.4

268.88

277.87

ug/g

0.20

799

Bicuspidal aortic valve syndrome

398

1.27

0.84

1.3

1.5

265.08

281.22

ug/g

0.17

246

Localized scleroderma [morphea]

171

1.42

0.84

1.5

1.4

234.92

296.98

ug/g

0.80

100

Ankylosing spondylitis, strict definition

443

1.25

0.84

1.4

309.22

301.18

ug/g

0.08

244

Pyogenic granuloma

171

1.42

0.84

1.3

1.4

303.65

282.63

ug/g

0.31

100

Acute hepatitis A

1.78

0.84

1.9

1.4

263.75

278.85

ug/g

—

Other and unspecified acne

121

1.50

0.83

1.3

1.4

201.02

309.37

ug/g

—

Other melanin hyperpigmentation

258

1.33

0.82

1.5

258.32

274.41

ug/g

0.22

163

Benign neoplasm: Bronchus and lung

130

1.48

0.82

1.3

1.4

287.73

301.68

ug/g

0.12

Traumatic ischaemia of muscle

130

1.48

0.82

1.3

1.4

305.45

289.28

ug/g

0.10

Noise effects on inner ear

418

1.25

0.81

1.6

1.5

278.96

255.55

ug/g

0.36

263

Von Willebrand disease

122

1.49

0.81

1.5

1.3

297.60

322.96

ug/g

0.19

Antepartum haemorrhage, not elsewhere classified

101

867

1.17

0.80

1.3

320.02

313.35

ug/g

0.13

436

Guttate psoriasis

139

1.45

0.80

1.6

1.3

227.00

307.58

ug/g

1.01

Other disorders of amniotic fluid and membranes

163

1397

1.13

0.80

1.4

1.3

334.46

315.39

ug/g

0.41

694

Accessory breast

1.70

0.80

1.2

1.4

369.60

321.45

ug/g

—

Alzheimer disease

464

3555

0.93

0.80

1.3

1.4

255.90

256.82

ug/g

0.03

263

2226

Injury of muscle and tendon at ankle and foot level

277

1.31

0.80

1.5

296.29

288.44

ug/g

0.08

170

Schizotypal disorder

242

1.33

0.79

1.4

308.86

291.15

ug/g

0.13

128

Horner syndrome

131

1.47

0.79

1.1

1.4

445.13

273.70

ug/g

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.61

0.79

1.6

1.3

250.00

324.65

ug/g

—

Spirochaetal infections, other/unspecified, including avohilmo

553

5194

1.07

0.79

1.4

283.35

275.03

ug/g

0.44

304

3017

Unspecified parasitic disease

1.65

0.79

1.7

1.4

310.83

305.34

ug/g

—

Acute mastoiditis

1.58

0.79

1.2

1.4

274.72

283.19

ug/g

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

106

915

1.16

0.79

1.4

315.80

306.88

ug/g

0.17

471

Exposure to smoke, fire and flames

251

1.33

0.79

1.5

265.71

283.38

ug/g

0.17

148

Benign neoplasm: Rectum/anal canal icd-9

1.64

0.79

1.3

1.4

363.83

287.97

ug/g

—

Vascular dementia (sudden onset)

0.00

0.79

0.0

1.5

—

225.06

—

Guillain-Barre syndrome

165

1.41

0.79

1.7

1.4

254.93

293.92

ug/g

0.39

Eclampsia

0.00

0.78

0.0

1.1

—

432.18

—

Melanocytic naevi of lower limb, including hip

520

1.22

0.78

1.6

1.5

277.87

289.24

ug/g

0.17

309

168

1.40

0.78

1.8

1.3

344.38

377.94

ug/g

0.37

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

106

916

1.16

0.78

1.4

315.80

310.86

ug/g

0.09

471

Fourth [trochlear] nerve palsy

243

1.33

0.78

1.5

1.4

284.14

290.33

ug/g

0.07

149

Nutritional marasmus

2.26

0.78

1.8

1.3

436.60

312.08

ug/g

—

Secondary parkinsonism

296

1.29

0.77

1.3

1.4

235.95

271.69

ug/g

0.52

174

Tooth agenesis EXCLUDE clefts and syndromes

331

1.27

0.77

1.7

1.4

362.43

320.99

ug/g

0.65

158

Tuberculosis, wide

788

1.17

0.76

1.5

268.48

267.55

ug/g

0.01

474

Desensitization to allergens

522

1.21

0.76

1.4

311.04

317.71

ug/g

0.07

272

Cleft palate

1.59

0.76

1.4

1.5

439.17

289.37

ug/g

—

Atypical virus infections of central nervous system

108

1.50

0.75

1.6

1.3

269.90

293.17

ug/g

—

Use of biperiden

597

1.20

0.74

1.3

1.4

309.51

282.46

ug/g

0.47

352

Other mycoses, not elsewhere classified/unspecified, including avohilmo

193

1.36

0.74

1.4

287.36

289.59

ug/g

0.02

113

Peripheral retinal degeneration

334

1.27

0.74

1.5

1.4

269.30

294.84

ug/g

0.36

195

Maternal care for known or suspected abnormality of pelvic organs

272

2002

0.92

0.73

1.3

1.4

306.09

306.56

ug/g

0.01

128

1051

Meckel's diverticulum

1.70

0.73

1.2

1.4

381.00

283.60

ug/g

—

Pedal cyclist injured in collision with pedestrian or animal

1.64

0.73

1.5

1.3

116.00

317.09

ug/g

—

Congenital malformations of great arteries

207

1.34

0.72

1.3

1.4

259.24

340.23

ug/g

1.11

120

Pedestrian injured in collision with car, pick-up truck or van

264

1.30

0.72

1.6

1.4

273.88

291.98

ug/g

0.17

158

Carcinoma in situ of skin of ear and external auricular canal

134

1.43

0.72

1.4

1.5

293.36

255.20

ug/g

0.36

Other disorders originating in the perinatal period

101

1.51

0.71

1.4

1.3

335.50

363.52

ug/g

—

Viral infections of central nervous system, not elsewhere classified/unspecifie, including avohilmod

160

1.39

0.71

1.2

1.3

350.87

305.81

ug/g

0.72

Other, unspecified and serous retinal detachments

354

1.25

0.71

1.5

272.00

279.18

ug/g

0.09

211

Disorders of eyelid in diseases classified elsewhere

354

1.25

0.71

1.6

1.4

310.38

284.48

ug/g

0.39

213

Malignant neoplasm of mesothelium and soft tissue

390

1.24

0.71

1.4

259.64

296.75

ug/g

0.70

236

Lyme disease, including avohilmo

546

5151

1.06

0.71

1.4

283.49

274.85

ug/g

0.45

299

2998

Lyme disease

546

5151

1.06

0.71

1.4

283.49

274.85

ug/g

0.45

299

2998

Ankle and foot

1.53

0.70

1.5

1.4

288.67

299.75

ug/g

—

Arnold-Chiari syndrome

1.53

0.70

1.3

1.4

315.78

317.29

ug/g

—

Maternal care for other known or suspected fetal problems

280

1614

1.09

0.70

1.3

325.64

317.22

ug/g

0.22

121

802

Parkinson's disease, strict definition

206

1874

1.10

0.69

1.4

1.5

275.23

260.23

ug/g

0.53

140

1156

HSIL lesion of the vagina

161

1.38

0.69

2.0

1.4

253.76

305.79

ug/g

0.42

Optic neuritis

446

1.22

0.69

1.4

314.62

308.81

ug/g

0.06

246

Polycythaemia vera

329

1.25

0.68

1.5

1.4

290.63

299.55

ug/g

0.09

200

Aggressive periodontitis

249

1.30

0.68

1.8

1.4

308.85

283.77

ug/g

0.29

149

Malignant neoplasm of corpus uteri

128

1136

1.13

0.68

1.5

1.4

242.46

290.28

ug/g

1.68

682

Malignant neoplasm of corpus uteri, including Hilmo

139

1240

1.13

0.68

1.5

1.4

256.53

289.22

ug/g

0.95

737

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

179

1.35

0.67

1.4

1.3

248.65

333.76

ug/g

1.17

102

Xanthelasma of eyelid

1.53

0.67

1.0

1.4

292.43

292.72

ug/g

—

Atypical virus infections of central nervous system, including avohilmo

111

1.46

0.67

1.6

1.3

269.90

292.34

ug/g

—

Bullous pemphigoid

232

1.30

0.67

1.3

1.4

296.64

262.87

ug/g

0.38

139

Other infestations, including avohilmo

197

1.33

0.66

1.3

1.4

228.71

301.14

ug/g

0.70

116

Constitutional tall stature

1.81

0.66

1.0

1.3

452.40

365.88

ug/g

—

Non-small cell lung cancer

101

1138

0.87

0.66

1.3

1.4

266.43

275.59

ug/g

0.15

696

Acute poliomyelitis

154

1.38

0.66

1.6

1.4

252.50

286.07

ug/g

0.34

Acute poliomyelitis, including avohilmo

154

1.38

0.66

1.6

1.4

252.50

286.07

ug/g

0.34

Congenital malformations of spine and bony thorax, including avohilmo

1.64

0.66

1.7

1.4

244.80

306.10

ug/g

—

Other disorders of thyroid

154

1.38

0.66

1.6

1.3

258.31

313.31

ug/g

0.60

LSIL lesion of the vagina

180

1.35

0.66

1.7

1.4

349.56

300.76

ug/g

0.56

102

Mumps, including avohilmo

277

1.27

0.66

1.3

1.5

298.00

284.35

ug/g

0.15

169

Benign neoplasm: other/unspecified salivary gland

295

1.26

0.66

1.5

1.4

256.78

287.58

ug/g

0.45

184

Disorders of acoustic nerve

304

1.26

0.66

1.3

1.5

297.60

275.16

ug/g

0.29

190

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

103

1.47

0.65

1.2

1.4

390.25

357.02

ug/g

—

Use of interferon beta-1a

224

0.71

0.64

1.4

269.89

314.88

ug/g

—

121

Other and unspecified corneal deformities and disorders

368

1.23

0.64

1.4

232.22

291.31

ug/g

0.93

216

Trichomoniasis

104

1.47

0.64

2.5

1.4

224.70

264.45

ug/g

—

Liveborn infants according to place of birth

1.62

0.63

1.1

1.3

419.40

368.62

ug/g

—

Other and unspecified injuries of thorax

190

1.33

0.63

1.5

1.4

266.20

294.89

ug/g

0.34

110

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.53

0.63

1.2

1.3

302.17

317.64

ug/g

—

Mumps

270

1.27

0.63

1.4

1.5

298.00

280.58

ug/g

0.19

165

Pneumoconiosis due to asbestos and other mineral fibres

164

1.35

0.63

1.5

300.13

246.24

ug/g

0.78

110

Torsion of testis

121

1.41

0.62

1.4

1.5

107.46

296.26

ug/g

—

Vascular syndromes of brain in cerebrovascular disorders

489

1.19

0.62

1.6

1.5

253.87

271.44

ug/g

0.28

309

Postpartum haemorrhage due to retained placenta

111

1250

0.89

0.61

1.3

317.33

319.54

ug/g

0.03

633

Premature separation of placenta [abruptio placentae]

233

0.72

0.61

1.6

1.3

261.89

310.16

ug/g

—

119

Measles

122

1.41

0.61

1.8

1.4

220.26

322.18

ug/g

—

Measles, including avohilmo

122

1.41

0.61

1.8

1.4

220.26

322.18

ug/g

—

Complications of labour and delivery

934

5402

0.96

0.60

1.3

1.4

302.28

289.33

ug/g

1.01

478

3014

Sequelae of other accidents

148

1.36

0.60

1.1

1.4

255.73

301.36

ug/g

0.48

Other conjunctival vascular disorders and cysts

254

1.27

0.60

1.7

1.4

322.32

284.29

ug/g

0.40

150

Other specified disorders of external ear

399

1.21

0.60

1.3

1.5

344.84

268.25

ug/g

1.89

252

Obstructive hydrocephalus

157

1.35

0.60

1.2

1.4

315.07

295.44

ug/g

0.21

Hereditary lymphedema

0.00

0.59

0.0

1.3

—

276.87

—

Primary ovarian failure

201

1.30

0.59

1.5

1.4

319.75

329.64

ug/g

0.07

106

Congenital stenosis of pulmonary valve

1.58

0.59

1.3

1.4

240.00

285.69

ug/g

—

Other specified and unspecified disorders of eyelid

149

1.36

0.58

1.4

272.18

292.10

ug/g

0.13

Respiratory tuberculosis

539

1.17

0.58

1.5

266.14

267.25

ug/g

0.01

330

Respiratory tuberculosis, confirmed and not-confirmed

539

1.17

0.58

1.5

266.14

267.25

ug/g

0.01

330

Carcinoma in situ of breast, intraductal

136

1227

1.11

0.58

1.2

1.4

297.46

283.20

ug/g

0.36

719

Polyhydramnios

456

1.19

0.57

1.4

1.3

280.08

316.82

ug/g

0.45

222

Atrial septal defect, secundum type

300

1.24

0.57

1.6

1.4

284.64

315.21

ug/g

0.42

174

Hydatidiform mole

141

1.36

0.57

1.1

1.3

291.30

351.55

ug/g

—

Personal history of malignant neoplasm

122

1095

1.12

0.57

1.4

294.93

285.93

ug/g

0.20

634

Contact with nonpowered hand tool

457

1.19

0.57

1.4

1.5

270.06

271.01

ug/g

0.01

272

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

185

1.31

0.56

1.3

321.92

337.06

ug/g

0.07

Fetus and newborn affected by maternal complications of pregnancy

1.56

0.56

1.0

1.3

494.00

380.59

ug/g

—

Pregnancy examination and test

175

989

1.10

0.56

1.3

1.4

319.71

307.88

ug/g

0.27

496

Other retinal artery occlusion

230

1.27

0.56

1.5

1.4

220.58

275.87

ug/g

0.84

139

Maternal care related to the fetus and amniotic cavity and possible delivery problems

570

3509

0.95

0.56

1.3

1.4

310.66

298.23

ug/g

0.62

280

1878

malignant neoplasm of female genital organs, including Hilmo

272

2416

1.07

0.55

1.4

263.77

295.01

ug/g

1.71

153

1393

Iridocyclitis in diseases classified elsewhere

186

1.30

0.55

1.4

1.5

255.60

280.10

ug/g

—

112

Exposure to excessive natural cold

1.43

0.54

1.2

1.4

246.71

292.92

ug/g

—

L01XX Other antineoplastic agents

711

1.14

0.54

1.4

1.5

282.61

270.16

ug/g

0.25

435

Villonodular synovitis (pigmented)

1.50

0.54

1.3

1.5

388.50

301.01

ug/g

—

Hereditary ataxia

134

1.36

0.53

1.4

203.33

298.79

ug/g

1.31

Trichomoniasis, including avohilmo

117

1.39

0.53

2.4

1.4

224.70

281.77

ug/g

—

Polypectomy (DHB20)

741

1.14

0.53

1.5

254.39

262.89

ug/g

0.14

460

Injury of urinary and pelvic organs

205

1.28

0.53

1.3

1.5

253.85

272.19

ug/g

0.12

121

Benign neoplasm: Larynx

332

1.21

0.52

1.7

1.5

250.57

270.58

ug/g

0.25

195

Maxillary retrognathism

152

1.32

0.52

1.5

322.09

311.70

ug/g

0.07

Burn and corrosion of head and neck

215

1.26

0.51

1.4

1.5

226.49

267.85

ug/g

0.47

126

Benign neoplasm: Vagina

153

1.32

0.51

1.4

1.3

308.33

285.88

ug/g

0.24

Medical treatment for female infertility

206

2200

0.93

0.50

1.3

1.4

325.32

320.40

ug/g

0.10

1102

Carcinoma in situ of other and unspecified genital organs

252

1.24

0.50

1.3

1.4

295.31

305.96

ug/g

0.07

144

Other benign neoplasm of uterus: Other parts/unspecified

548

1.16

0.50

1.5

1.4

291.50

270.32

ug/g

0.36

315

Coarctation of the aorta

101

1.40

0.50

1.3

1.4

226.62

307.35

ug/g

—

Congenital malformations of eye, ear, face and neck

661

1.14

0.49

1.4

257.31

307.16

ug/g

0.89

360

Benign neoplasm: Spinal meninges

119

1.36

0.49

1.9

1.3

282.09

307.21

ug/g

0.19

Congenital malformations of breast

163

1.30

0.48

1.2

1.4

357.33

326.51

ug/g

—

Neuroendocrine tumor and carcinoma of lung

1.46

0.48

1.2

1.4

276.28

312.75

ug/g

—

Malignant neoplasm of tongue

172

1.29

0.48

1.5

1.4

276.33

292.47

ug/g

0.14

105

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

181

1.28

0.48

1.5

1.4

244.78

294.62

ug/g

0.68

106

Cellulitis of external ear

128

1.34

0.48

1.2

1.4

271.86

312.47

ug/g

—

Parkinson's disease

217

2022

1.08

0.48

1.4

1.5

275.43

259.95

ug/g

0.59

148

1256

Congenital musculoskeletal deformities of head, face, spine and chest

102

1.38

0.48

1.6

1.4

387.25

311.92

ug/g

—

Cardiomyopathy, Hypertrophic obstructive

177

0.73

0.47

1.2

1.4

275.88

275.80

ug/g

—

Abnormal findings on antenatal screening of mother

682

1.13

0.47

1.3

340.17

331.92

ug/g

0.11

301

Congenital malformations of uterus and cervix

199

0.75

0.47

1.6

1.4

295.92

345.90

ug/g

—

103

Maternal care for known or suspected malpresentation of fetus

186

1431

0.93

0.47

1.4

1.3

307.37

316.51

ug/g

0.20

713

Mixed conductive and sensorineural hearing loss

169

1562

1.08

0.46

1.4

264.49

264.20

ug/g

0.01

968

Benign neoplasm: Cranial nerves

338

1.19

0.46

1.3

1.5

285.19

285.97

ug/g

0.01

204

Family history of certain disabilities and chronic diseases leading to disablement

496

1.15

0.45

1.4

280.33

296.36

ug/g

0.15

255

Seronegative juvenile rheumatoid arthritis

156

1.29

0.45

1.3

1.4

177.60

334.70

ug/g

—

Arteriovenous malformation of cerebral vessels

112

1.35

0.45

1.9

1.5

346.50

266.34

ug/g

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

286

2494

0.94

0.45

1.4

257.10

275.18

ug/g

0.79

179

1513

Pre-eclampsia or eclampsia

295

2785

1.06

0.45

1.4

296.62

295.91

ug/g

0.02

168

1494

Isolated patent ductus arteriosus

102

1.37

0.45

1.8

1.3

283.11

347.25

ug/g

—

Kela-code for behavioural disturbances in mental retardation

1.46

0.45

1.4

1.3

242.00

301.05

ug/g

—

Paraplegia, diplegia of upper limbs

220

1.23

0.44

1.9

1.4

247.68

286.74

ug/g

0.54

123

Distal bite

346

1.18

0.44

1.4

356.54

329.19

ug/g

0.40

183

Increased muscle tone

1.43

0.44

1.6

1.4

325.50

327.33

ug/g

—

Retinal breaks without detachment

239

2245

1.07

0.43

1.5

1.4

273.31

274.04

ug/g

0.02

141

1343

Coronary artery bypass grafting

365

2571

1.05

0.43

1.4

229.84

256.37

ug/g

1.89

246

1569

Asymmetry of jaw

131

1.31

0.42

1.6

1.4

320.82

324.09

ug/g

0.02

Benign neoplasm: Peripheral nerves and autonomic nervous system

185

1.25

0.42

1.5

1.4

220.71

312.08

ug/g

1.33

107

Pleural plaque without asbestos

369

1.17

0.42

1.5

259.26

254.71

ug/g

0.04

247

Otosclerosis

102

927

1.10

0.42

1.3

1.4

282.48

270.46

ug/g

0.23

538

Erysipeloid

0.00

0.42

0.0

1.3

—

262.53

—

Melanocytic naevi of upper limb, including shoulder

249

1.21

0.42

1.7

1.4

286.00

296.60

ug/g

0.12

143

Accident to watercraft causing drowning and submersion

0.00

0.42

0.0

1.5

—

288.33

—

Heberden's nodes [with arthropathy]

105

1.35

0.42

1.6

1.3

283.75

289.24

ug/g

—

Benign neoplasm: Penis

0.00

0.41

0.0

1.6

—

296.03

—

Ankylosis of teeth

0.00

0.41

0.0

1.3

—

355.38

—

Cholesteatoma of middle ear

562

0.87

0.41

1.3

1.4

326.19

268.60

ug/g

1.27

345

Personal history of medical treatment

114

1.33

0.41

1.7

1.4

346.14

278.05

ug/g

—

Craniosynostosis EXCLUDE syndromes

0.00

0.41

0.0

1.5

—

367.25

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

114

1.32

0.41

1.6

1.4

376.56

309.10

ug/g

—

Outcome of delivery

161

1065

0.93

0.41

1.2

1.4

330.95

308.57

ug/g

0.61

549

Erosion and ectropion of cervix uteri

296

1.19

0.41

1.5

1.3

273.85

270.79

ug/g

0.03

167

Other congenital malformations of peripheral vascular system

132

1.30

0.40

1.9

1.3

258.67

305.99

ug/g

—

Mature T/NK-cell lymphomas, hilmo

141

1.29

0.40

1.8

1.5

269.83

285.40

ug/g

0.15

Dislocations, sprains and strains involving multiple body regions

0.00

0.40

0.0

1.3

—

402.41

—

Pre-eclampsia or poor fetal growth

397

3775

1.05

0.40

1.4

300.41

303.19

ug/g

0.08

216

1974

Caries in Clefts patients

1.37

0.40

1.7

1.4

407.33

268.46

ug/g

—

Pulmonary oedema

168

1.26

0.40

1.5

1.4

224.77

273.47

ug/g

0.47

Viral conjunctivitis

232

1.21

0.40

1.3

1.4

306.95

284.13

ug/g

0.22

134

Pregnancy hypertension

591

5087

1.04

0.40

1.4

297.48

297.70

ug/g

0.01

343

2708

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

1.35

0.40

1.4

245.29

325.45

ug/g

—

Acute myringitis

1.42

0.39

1.6

1.4

198.80

303.31

ug/g

—

Pigmented purpuric dermatosis

106

1.33

0.39

2.2

1.3

272.56

314.70

ug/g

—

Malignant otitis externa

0.00

0.39

0.0

1.5

—

293.48

—

Tuberculosis of other organs, strict, including avohilmo

251

1.20

0.39

1.6

1.4

292.15

272.00

ug/g

0.20

146

Foreign body or object entering through skin

664

1.12

0.39

1.5

1.4

299.12

282.21

ug/g

0.30

386

Rheumatic valve diseases

196

1.23

0.39

1.6

1.4

240.98

287.12

ug/g

0.55

109

Abnormal findings on diagnostic imaging of breast

178

1.25

0.39

1.1

1.4

312.27

292.00

ug/g

0.15

Other benign neoplasms of uterus

722

1.11

0.39

1.5

1.4

297.78

272.13

ug/g

0.48

419

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

504

0.87

0.37

1.8

1.4

309.31

285.93

ug/g

0.30

306

Malignant neoplasm of vulva, including Hilmo

152

1.26

0.37

1.5

1.4

268.00

304.73

ug/g

—

Benign neoplasm: Connective and other soft tissue of head, face and neck

180

0.77

0.37

1.3

1.4

328.78

307.26

ug/g

—

104

Benign neoplasm of thyroid gland

393

1.15

0.37

1.4

261.96

291.40

ug/g

0.40

232

Laparoscopic left hemicolectomy

198

1.22

0.37

1.2

1.4

259.32

277.31

ug/g

0.16

126

Use of amantadine

180

1.23

0.36

1.6

1.4

342.06

302.55

ug/g

0.37

107

Serous carcinoma of ovary, including Hilmo

406

0.86

0.36

1.2

1.4

281.52

305.70

ug/g

0.28

231

Tuberculosis of other organs

217

1.20

0.36

1.5

1.4

269.52

271.11

ug/g

0.01

126

Perioral dermatitis

254

1.19

0.36

1.3

1.4

355.20

303.29

ug/g

0.72

147

Benign neoplasm: Scapula and long bones of upper limb

108

1.31

0.35

1.6

1.3

217.73

325.16

ug/g

—

Infections of breast associated with childbirth

366

1.15

0.35

1.2

1.3

334.12

332.90

ug/g

0.01

181

Pedal cyclist injured in noncollision transport accidents

149

1391

1.07

0.35

1.4

297.90

287.23

ug/g

0.22

778

Undefined dementia

140

1203

1.08

0.35

1.4

278.70

257.58

ug/g

0.60

750

L02BB Anti-androgens

1003

0.92

0.34

1.3

1.5

270.64

246.12

ug/g

0.54

658

Gestational [pregnancy-induced] hypertension

325

3101

1.05

0.34

1.4

310.00

304.52

ug/g

0.17

186

1601

Juvenile osteochondrosis

302

1.16

0.34

1.3

1.5

333.38

305.20

ug/g

0.36

162

Lumbosacral root disorders, not elsewhere classified

109

1.29

0.34

1.5

1.4

291.57

309.11

ug/g

—

Reiter disease

1.31

0.33

1.2

1.4

161.83

286.43

ug/g

—

Schizoid personality disorder

173

1.22

0.33

1.2

1.5

222.25

287.84

ug/g

0.80

100

Endovascular or surgical operations to intracerebral aneurysms

750

0.90

0.33

1.6

1.4

280.30

282.19

ug/g

0.02

449

Crystal arthropathies, rheuma endpoint

210

1.20

0.33

1.6

1.5

244.30

261.16

ug/g

—

126

Crowding of teeth, including avohilmo

715

1.09

0.33

1.2

1.4

360.99

336.44

ug/g

0.47

360

Use of galantamine

958

0.92

0.33

1.4

261.32

263.17

ug/g

0.03

593

Impacted maxillary molar

529

0.89

0.32

1.2

1.3

297.41

323.28

ug/g

0.26

237

Other disorders of prostate

285

1.16

0.32

1.5

1.6

241.43

238.79

ug/g

0.03

189

Mandibular retrognathia AND surgery (BSSO)

262

0.84

0.31

1.3

1.4

345.98

297.46

ug/g

0.46

149

Loose body in joint

230

1.18

0.31

1.2

1.4

262.88

268.02

ug/g

0.04

138

L02BX Other hormone antagonists and related agents

621

0.90

0.31

1.4

1.5

274.38

245.23

ug/g

0.48

420

Small cell lung cancer, helper endpoint

239

0.83

0.30

1.4

1.5

302.67

257.44

ug/g

0.41

148

Pedal cyclist injured in collision with motor vehicle

325

1.14

0.30

1.6

1.5

196.52

281.95

ug/g

2.09

190

Rubella [German measles]

363

1.13

0.29

1.3

1.5

301.49

256.00

ug/g

0.60

231

Degenerative diseases of the nervous system

582

4061

1.03

0.29

1.4

255.07

258.40

ug/g

0.15

333

2540

Short Achilles tendon (acquired)

271

0.85

0.29

1.4

232.67

302.65

ug/g

0.98

158

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

713

0.91

0.29

1.4

276.59

296.02

ug/g

0.38

425

Malignant neoplasm of brain

324

0.86

0.29

1.3

1.4

298.56

306.67

ug/g

0.08

194

malignant neoplasm of female genital organs

236

2203

1.05

0.29

1.4

259.32

295.06

ug/g

1.85

131

1277

Unspecified dementia

139

1172

1.07

0.29

1.4

278.70

258.42

ug/g

0.57

738

Non-small cell lung cancer, adenocarcinoma, helper endpoint

785

0.91

0.29

1.4

1.5

282.47

266.27

ug/g

0.22

492

Embedded and impacted teeth

295

2296

1.04

0.29

1.4

290.09

311.11

ug/g

0.80

141

1150

Rubella [German measles], including avohilmo

364

1.13

0.29

1.3

1.5

301.49

255.07

ug/g

0.62

232

Benign neoplasm: Brain, supratentorial

158

1.21

0.28

1.5

1.4

267.33

315.13

ug/g

—

Whooping cough, including avohilmo

158

1.21

0.28

1.7

1.3

256.09

330.76

ug/g

0.96

Malignant neoplasm of breast, HER2-negative, including Hilmo

648

4041

1.03

0.27

1.4

276.33

301.99

ug/g

2.41

375

2241

Benign neoplasm: Bones of skull and face

113

1.25

0.27

1.6

1.3

235.96

317.91

ug/g

—

Malignant neoplasm of breast, including Hilmo

648

4041

1.03

0.27

1.4

276.33

301.99

ug/g

2.41

375

2241

Any dementia

647

4356

1.03

0.27

1.4

267.57

256.75

ug/g

0.67

370

2705

Occlusion and stenosis of arteries, not leading to stroke

113

1.24

0.27

1.6

1.4

201.67

296.57

ug/g

—

Injury of nerves and spinal cord at neck level

234

1.16

0.26

2.0

1.5

279.58

269.52

ug/g

0.08

141

Malignant neoplasm of breast, HER-positive

503

3636

1.03

0.26

1.4

273.70

300.07

ug/g

2.11

298

2045

Schizophrenia

182

1911

0.95

0.26

1.3

1.4

310.06

277.06

ug/g

1.14

105

1085

Family history of other conditions

141

1.21

0.26

1.4

330.97

313.95

ug/g

—

Malignant neoplasm of breast, ER-positive, including Hilmo

504

3640

1.03

0.26

1.4

273.70

300.08

ug/g

2.11

298

2047

Exposure to other specified electric current

235

0.85

0.26

1.5

1.4

321.00

311.40

ug/g

—

138

Malignant neoplasm of other and unspecified female genital organs

188

1.18

0.25

1.3

1.4

279.73

305.24

ug/g

0.37

108

Complications of the puerperium, not elsewhere classified

387

1.11

0.25

1.5

1.3

302.27

331.02

ug/g

0.39

187

Acute myeloid leukaemia, helper endpoint

105

1.24

0.25

1.4

1.3

260.00

315.58

ug/g

—

Acute myeloid leukaemia, including Hilmo

105

1.24

0.25

1.4

1.3

260.00

315.58

ug/g

—

Acute myeloid leukaemia

105

1.24

0.25

1.4

1.3

260.00

315.58

ug/g

—

Malignant neoplasm of brain, including Hilmo

476

0.90

0.24

1.3

1.4

275.12

306.46

ug/g

0.52

289

Open bite that required surgery (Lefort1 or BSSO)

1.27

0.24

1.2

1.3

361.94

332.25

ug/g

—

Mild mental retardation

244

0.86

0.24

1.6

1.5

271.69

300.54

ug/g

0.23

141

Non-small cell lung cancer, including Hilmo

171

1682

0.95

0.24

1.4

264.64

276.99

ug/g

0.30

101

1028

Myocardial infarction, unclassifiable

271

2511

0.96

0.24

1.4

1.5

254.63

254.96

ug/g

0.01

167

1555

Non-small cell lung cancer, adenocarcinoma

668

1.08

0.23

1.4

282.47

283.53

ug/g

0.01

419

Complications following abortion and ectopic and molar pregnancy

418

1.10

0.23

1.5

1.4

240.17

295.01

ug/g

0.73

240

Failed induction of labour

562

1.09

0.23

1.3

322.20

325.76

ug/g

0.04

263

Ulcer of oesophagus, drug-induced

1.32

0.23

1.4

1.6

322.60

249.44

ug/g

—

Mandibular prognathia

143

1.19

0.23

1.5

1.4

297.20

326.29

ug/g

—

Tuberculosis of other organs, strict

247

1.14

0.23

1.5

1.4

290.11

273.14

ug/g

0.15

144

Chronic mastoiditis

266

1.13

0.23

1.4

324.25

278.78

ug/g

0.41

158

Congenital malformations of breast, including avohilmo

181

1.16

0.22

1.2

1.4

357.33

326.25

ug/g

—

Alzheimer’s disease, strict definition

357

2970

0.97

0.22

1.3

1.4

261.15

259.56

ug/g

0.05

203

1855

Other diseases caused by chlamydiae, including avohilmo

157

0.82

0.22

1.2

1.3

213.40

327.32

ug/g

—

Mesial bite

1.27

0.22

1.5

1.3

264.40

329.08

ug/g

—

Carcinoma in situ of cervix uteri

101

1071

0.94

0.22

1.3

345.92

315.37

ug/g

0.63

517

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

324

1.12

0.22

1.3

1.4

259.47

300.56

ug/g

0.88

189

Irritant contact dermatitis due to drugs in contact with skin

0.00

0.22

0.0

1.9

—

144.60

—

Burkitt lymphoma, helper endpoint

0.00

0.22

0.0

1.7

—

264.60

—

Other congenital malformations of integument

0.00

0.22

0.0

1.5

—

409.80

—

Intentional self-harm by crashing of motor vehicle

0.00

0.22

0.0

1.6

—

254.20

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.21

0.0

1.1

—

266.83

—

Hereditary spastic paraplegia

0.00

0.21

0.0

1.7

—

382.26

—

Drowning to ice

0.00

0.21

0.0

1.3

—

234.67

—

Rhabdomyosarcoma, including Hilmo

0.00

0.21

0.0

1.2

—

363.19

—

Other puerperal infections

730

0.93

0.21

1.3

326.34

321.47

ug/g

0.06

334

Microtia (small ears)

0.00

0.21

0.0

1.3

—

250.00

—

Malignant neoplasm of breast, HER-negative

277

2749

0.97

0.21

1.3

1.4

275.68

294.42

ug/g

0.81

158

1575

Dementia

731

4895

1.02

0.21

1.4

267.76

257.18

ug/g

0.73

423

3031

Benign neoplasm: Spinal cord

154

1.17

0.21

1.6

1.4

228.90

292.92

ug/g

—

Other operation for atrial fibrillation

1.17

0.21

1.8

1.5

250.00

259.17

ug/g

—

Haemolytic disease of fetus and newborn

0.00

0.21

0.0

1.3

—

349.17

—

Certain zoonotic bacterial diseases, including avohilmo

325

1.11

0.21

1.6

1.4

235.13

286.88

ug/g

0.79

194

Benign neoplasm: Nasopharynx

1.24

0.21

1.4

335.00

279.04

ug/g

—

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

0.00

0.21

0.0

1.2

—

333.60

—

Benign neoplasm of other and unspecified female genital organs

537

1.08

0.21

1.3

1.4

297.44

301.48

ug/g

0.04

310

Pre-eclampsia

262

2533

1.04

0.21

1.4

299.12

298.11

ug/g

0.02

146

1342

Polyarteritis nodosa and related conditions

145

1.18

0.21

1.2

1.4

339.33

298.65

ug/g

—

Communicating hydrocephalus

219

0.86

0.20

1.2

1.4

327.91

289.16

ug/g

0.47

126

Actinic reticuloid

0.00

0.20

0.0

1.6

—

148.13

—

Corrosions classified according to extent of body surface involved

0.00

0.20

0.0

1.6

—

309.33

—

Other abnormal products of conception

381

2430

1.03

0.20

1.4

1.3

304.86

313.11

ug/g

0.30

204

1257

Rheumatic heart disease, other

0.00

0.20

0.0

1.3

—

325.78

—

Circumscribed brain atrophy

240

1.13

0.20

1.1

1.5

252.89

274.96

ug/g

0.31

146

Tuberculosis

625

1.07

0.20

1.5

268.38

266.32

ug/g

0.03

379

Respiratory distress of newborn

135

1.17

0.19

1.4

1.3

418.91

371.59

ug/g

0.68

Use of ropinirole

404

1.09

0.19

1.4

1.5

277.75

273.46

ug/g

0.05

250

Malignant neoplasm of breast, HER2-negative

633

4000

1.02

0.19

1.4

274.22

302.13

ug/g

2.72

367

2224

Demyelinating diseases of the central nervous system

929

1.06

0.19

1.5

1.4

281.45

299.85

ug/g

0.33

491

Use of selegiline

511

1.08

0.19

1.5

1.4

279.92

274.85

ug/g

0.07

317

Tularaemia

128

1.18

0.18

1.6

1.4

212.22

294.03

ug/g

—

Pregnancy, childbirth and the puerperium

443

2258

1.02

0.18

1.4

288.99

276.59

ug/g

0.53

239

1243

Delivery, wide proxy

502

2722

0.98

0.18

1.4

299.81

279.80

ug/g

1.16

270

1492

Benign neoplasm: Skin of lower limb, including hip

300

1.10

0.18

1.6

1.4

276.78

280.87

ug/g

0.05

178

Malignant neoplasm of breast

633

4004

1.02

0.17

1.4

274.41

302.18

ug/g

2.70

367

2226

Normal-pressure hydrocephalus

558

0.93

0.17

1.4

1.5

294.33

267.19

ug/g

0.39

340

Thyroiditis, unspecified

129

1.17

0.17

1.1

1.4

236.75

308.12

ug/g

—

Use of levodopa decarbox-comt-inhibitor

361

0.91

0.17

1.2

1.5

279.08

268.87

ug/g

0.10

226

Other congenital malformations of face and neck

288

0.90

0.16

1.3

1.5

266.98

301.69

ug/g

0.21

170

Subarachnoid haemorrhage

123

1280

0.96

0.15

1.4

297.09

271.00

ug/g

0.71

789

Mental and behavioural disorders associated with the puerperium

102

1.18

0.15

1.2

1.4

302.17

320.09

ug/g

—

Cysts of oral region, not elsewhere classified

663

1.06

0.15

1.5

1.4

256.58

281.23

ug/g

0.44

395

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

150

1.14

0.14

2.0

1.4

298.29

281.32

ug/g

—

Pityriasis rosea

1.20

0.14

1.4

169.00

324.88

ug/g

—

Seropositive rheumatoid arthritis, strict definition

204

2096

0.97

0.13

1.4

282.32

278.86

ug/g

0.10

118

1226

Obstructed labour due to maternal pelvic abnormality

203

2085

0.97

0.13

1.3

1.4

292.05

286.57

ug/g

0.14

106

1183

Venous complications and haemorrhoids in pregnancy

161

1.12

0.13

1.4

314.48

336.03

ug/g

0.12

Impacted teeth

199

1663

1.03

0.12

1.4

1.3

297.54

314.06

ug/g

0.42

800

Exposure to other and unspecified man-made environmental factors

200

0.90

0.12

1.1

1.4

384.50

300.60

ug/g

—

116

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

127

0.86

0.12

1.2

1.4

248.17

329.34

ug/g

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

262

0.91

0.12

1.2

1.5

315.31

280.38

ug/g

0.23

163

Malignant neoplasm of eye, brain and central nervous system

416

0.94

0.12

1.4

299.48

304.91

ug/g

0.07

249

Exclusion endpoint for supernumerary teeth

114

1.14

0.12

1.5

1.3

315.29

325.39

ug/g

—

Malignant neoplasm of breast, ER-negative, including Hilmo

305

2907

0.98

0.11

1.4

278.27

294.44

ug/g

0.71

176

1639

Heart failure and hypertrophic cardiomyopathy

198

0.91

0.11

1.3

1.4

241.67

269.33

ug/g

0.23

111

Multiple gestation

100

967

1.03

0.10

1.4

344.85

309.97

ug/g

0.83

492

Alzheimer’s disease (Early onset)

495

0.95

0.10

1.2

1.5

264.68

273.04

ug/g

0.12

311

Other and unspecified hydrocephalus

208

0.91

0.10

1.1

1.4

349.08

291.54

ug/g

0.92

122

Supervision of high-risk pregnancy

229

1347

1.02

0.10

1.4

316.10

304.99

ug/g

0.27

106

697

Lung cancer and mesothelioma

242

2012

1.02

0.10

1.4

261.32

256.27

ug/g

0.14

150

1231

Divergent concomitant strabismus

840

0.96

0.10

1.4

264.21

296.73

ug/g

0.59

470

Benign neoplasm of ovary

259

2542

1.02

0.10

1.4

267.61

285.47

ug/g

0.74

162

1457

Hydrocephalus

880

1.04

0.10

1.3

1.4

304.98

271.74

ug/g

0.89

536

Third [oculomotor] nerve palsy

197

0.91

0.10

1.6

1.4

246.91

300.88

ug/g

0.65

116

Overjet

222

1.08

0.09

1.4

1.5

413.80

340.66

ug/g

—

120

Asymptomatic human immunodeficiency virus [HIV] infection status

1.07

0.08

1.2

1.5

203.17

245.31

ug/g

—

Other hereditary haemolytic anaemias

1.07

0.08

1.5

1.4

198.13

314.73

ug/g

—

Malignant neoplasm of vulva

107

1.13

0.08

1.3

1.4

215.33

301.14

ug/g

—

Benign neoplasm: Vulva

263

1.07

0.08

1.2

1.4

278.50

299.56

ug/g

0.15

155

Other disorders of optic disc

154

0.91

0.08

1.4

1.3

188.37

298.00

ug/g

—

Scissor bite

223

0.93

0.08

1.3

1.4

274.11

335.28

ug/g

—

111

Other benign neoplasms of connective and other soft tissue

118

1208

0.98

0.07

1.5

1.4

313.40

284.32

ug/g

0.81

692

Tularaemia, including avohilmo

196

1.07

0.07

1.6

1.4

238.37

298.78

ug/g

0.63

114

Other congenital malformations of tongue, mouth and pharynx

127

1.10

0.07

1.7

1.4

248.89

352.56

ug/g

—

Disorders of globe

265

1.06

0.07

1.4

278.68

281.84

ug/g

0.03

152

Glaucoma secondary to eye inflammation

1.13

0.07

1.1

1.4

325.38

299.67

ug/g

—

Postpartum care and examination

137

877

0.98

0.07

1.3

1.4

344.56

314.37

ug/g

0.73

435

Poor fetal growth

120

1175

1.02

0.06

1.4

1.3

310.86

330.13

ug/g

0.39

555

Nontraumatic intracranial haemmorrhage

268

2714

0.99

0.06

1.4

267.88

263.20

ug/g

0.14

160

1657

Respiratory tuberculosis, not confirmed, including avohilmo

413

1.04

0.06

1.4

1.5

252.94

266.62

ug/g

0.18

245

Melanoma in situ of other and unspecified parts of face

138

1.09

0.06

1.3

1.4

255.46

274.84

ug/g

—

Vascular dementia (subcortical)

376

0.96

0.06

1.5

225.48

251.80

ug/g

0.37

241

Hypertrophic cardiomyopathy

467

0.96

0.06

1.4

1.5

256.79

270.28

ug/g

0.15

289

Dementia due to Parkinson's disease

276

1.05

0.06

1.4

307.00

264.45

ug/g

0.41

171

Use of glatiramer acetate

168

1.07

0.06

1.6

1.4

284.51

321.07

ug/g

—

Respiratory tuberculosis, not confirmed

405

1.04

0.05

1.4

1.5

252.94

265.87

ug/g

0.17

240

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

141

0.92

0.05

1.3

250.50

336.56

ug/g

—

Melanocytic naevi of eyelid, including canthus

100

1.10

0.05

1.5

1.3

332.00

334.22

ug/g

—

Other benign neoplasm of uterus: Corpus uteri

110

1.09

0.05

1.4

1.3

377.29

307.68

ug/g

—

MS-disease / Multiple Sclerosis

763

1.02

0.05

1.5

1.4

266.39

299.64

ug/g

0.61

400

Anoxic brain damage

120

0.91

0.05

1.5

1.4

297.17

287.33

ug/g

—

Twin gestation

942

1.02

0.05

1.4

342.82

309.07

ug/g

0.77

476

Intracerebral haemorrhage

160

1580

1.01

0.04

1.4

1.5

246.00

264.86

ug/g

0.55

987

Other demyelinating diseases of the central nervous system

382

0.97

0.04

1.5

1.4

322.97

306.65

ug/g

0.17

214

Conotruncal defects

121

1.08

0.03

1.4

1.5

211.57

315.29

ug/g

—

Systemic atrophies primarily affecting the central nervous system

482

0.97

0.03

1.4

1.5

257.16

272.67

ug/g

0.27

297

Keratoconus

250

1.04

0.03

1.6

1.5

331.31

284.27

ug/g

0.35

147

Other obstetric trauma

542

0.98

0.03

1.3

1.4

338.91

313.39

ug/g

0.30

264

Ventricular septal defect, a heart condition

239

0.96

0.03

1.9

1.4

269.76

358.13

ug/g

1.40

133

Benign neoplasm: Skin of upper limb, including shoulder

219

0.96

0.03

1.2

1.4

304.30

297.86

ug/g

0.06

122

Myocardial infarction, with ST-elevation

219

2204

0.99

0.02

1.4

1.5

260.41

254.20

ug/g

0.18

148

1369

Melanocytic naevi of other and unspecified parts of face

670

1.02

0.02

1.4

294.63

291.68

ug/g

0.04

372

Infections specific to the perinatal period

1.08

0.02

1.2

1.4

346.00

368.53

ug/g

—

Certain zoonotic bacterial diseases

187

0.96

0.01

1.6

1.4

222.60

287.84

ug/g

0.71

108

Alzheimer’s disease (Late onset)

332

2722

1.00

0.01

1.3

1.4

265.01

257.27

ug/g

0.29

185

1705

Benign neoplasm: Skin of scalp and neck

273

1.03

0.01

1.5

269.35

289.72

ug/g

0.16

158

Unspecified human immunodeficiency virus [HIV] disease

1.07

0.01

1.4

1.5

182.02

271.18

ug/g

—

Benign neoplasm: Short bones of lower limb

104

1.06

0.01

1.5

1.3

227.20

294.04

ug/g

—

Pedestrian injured in other and unspecified transport accidents

144

1.04

0.00

1.3

1.4

233.13

308.35

ug/g

—

Sequelae of tuberculosis, including avohilmo

156

0.96

0.00

2.2

1.4

253.22

273.09

ug/g

—

Ovarian hyperstimulation (induction)

166

0.96

0.00

1.3

377.25

366.61

ug/g

—

Bilateral sagittal split ramus osteotomy operation

344

1.02

0.00

1.3

1.5

331.83

307.10

ug/g

0.23

189

LeFortI or BSSO operation

416

0.99

0.00

1.4

332.76

308.72

ug/g

0.25

222

Labour and delivery complicated by umbilical cord complications

549

1.00

0.00

1.3

1.4

364.94

301.42

ug/g

1.35

284

Alzheimer’s disease (Atypical or mixed)

132

1299

1.00

0.00

1.4

1.5

230.51

258.58

ug/g

0.99

812

Beningn neoplasm: Meninges, unspecified

194

0.98

0.00

1.5

1.3

272.05

296.48

ug/g

0.15

118

Hereditary retinal dystrophy

147

1.02

0.00

1.6

1.4

300.00

301.30

ug/g

—

Wegener granulomatosis

157

1.02

0.00

1.9

1.4

277.80

284.15

ug/g

—

Carcinoma in situ of breast, other/unspecified

167

1.02

0.00

1.1

1.3

292.79

297.39

ug/g

—

Other congenital malformations of tongue, mouth and pharynx, including avohilmo

181

0.99

0.00

1.6

1.4

253.36

352.25

ug/g

0.99

Cleft lip, lip and palate or palate

146

1.03

0.00

1.6

1.4

380.25

296.53

ug/g

—

Postpartum haemorrhage due to anatomy

893

1.00

0.00

1.4

1.3

320.33

336.40

ug/g

0.28

402

Mental and behavioural disorders of puerperium, not classified elsewhere

119

1.01

0.00

1.2

1.4

302.17

330.67

ug/g

—

Benign neoplasm: Skin of lip

141

0.99

0.00

1.5

1.4

176.13

302.74

ug/g

—

Sequelae of tuberculosis

149

1.01

0.00

2.2

1.4

253.22

272.67

ug/g

—

Benign neoplasm: Short bones of upper limb

169

1.01

0.00

1.2

1.4

258.04

304.77

ug/g

—

101

Other obstructed labour

892

1.00

0.00

1.4

272.67

291.64

ug/g

0.43

488

Benign neoplasm of male genital organs

181

0.99

0.00

1.4

1.6

250.40

255.47

ug/g

—

117

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

289

1.00

0.00

1.4

1.5

221.19

263.29

ug/g

0.60

170

Enterobiasis, including avohilmo

221

1.00

0.00

1.2

1.4

316.00

350.86

ug/g

—

112

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

105

0.95

0.00

1.4

1.5

182.02

269.29

ug/g

—

Small cell lung cancer

195

1.03

0.00

1.4

302.67

307.82

ug/g

0.04

125

Small cell lung cancer, including Hilmo

195

1.03

0.00

1.4

302.67

307.82

ug/g

0.04

125

Slow fetal growth and fetal malnutrition

0.92

-0.00

1.8

1.4

401.60

340.03

ug/g

—

Traumatic amputation of wrist and hand

440

1.00

-0.00

1.5

245.33

252.38

ug/g

0.07

270

Convulsions of newborn

0.00

-0.00

0.0

1.6

—

301.40

—

Malignant neoplasm of other and unspecified male genital organs

0.00

-0.00

0.0

1.6

—

300.20

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Elastase.pancreatic [Mass/mass] in Stool

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS